activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	32336	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1cccc(Oc3ccccc3)c1)cn2C1CCCC1		CHEMBL69638	=	IC50	nM	3400.0	CHEMBL4128	Homo sapiens	IC50	uM	3.4
	32336	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1cccc(Oc3ccccc3)c1)cn2C1CCCC1		CHEMBL69638	=	IC50	nM	3400.0	CHEMBL4128	Homo sapiens	IC50	uM	3.4
	40694	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1O		CHEMBL419082	=	IC50	nM	600.0	CHEMBL4128	Homo sapiens	IC50	uM	0.6
	41980	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	c1ccc(Oc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL304760	=	IC50	nM	17870.0	CHEMBL4128	Homo sapiens	IC50	uM	17.87
	41987	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	CC(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL307982	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	uM	0.43
	43153	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1ccccc1Oc1ccccc1)cn2C1CCCC1		CHEMBL68774	=	IC50	nM	4900.0	CHEMBL4128	Homo sapiens	IC50	uM	4.9
	49413	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCC(O)C1		CHEMBL69129	=	IC50	nM	58.3	CHEMBL4128	Homo sapiens	IC50	uM	0.0583
	51887	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CC(O)C(O)C1		CHEMBL69827	=	IC50	nM	150.0	CHEMBL4128	Homo sapiens	IC50	uM	0.15
	53297	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	7000.0	CHEMBL4128	Homo sapiens	IC50	uM	7.0
	60801	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	CC(C)(C)n1cc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL306012	=	IC50	nM	7000.0	CHEMBL4128	Homo sapiens	IC50	uM	7.0
	62147	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	1980.0	CHEMBL4128	Homo sapiens	IC50	uM	1.98
	66114	CHEMBL847682	Inhibition of tie-2 at 5 uM ATP	B	CC(C)(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL302281	=	IC50	nM	2680.0	CHEMBL4128	Homo sapiens	IC50	uM	2.68
	228212	CHEMBL824161	Inhibition against human tie-2 kinase.	B	COc1cc(Cc2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)[C@@H]1C[C@H]1c1ccccc1		CHEMBL416091	=	IC50	nM	275.0	CHEMBL4128	Homo sapiens	IC50	uM	0.275
	230639	CHEMBL809318	Inhibition of TIE-2 kinase	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL44577	=	IC50	nM	750.0	CHEMBL4128	Homo sapiens	IC50	uM	0.75
	230701	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1ccccc1		CHEMBL297363	=	IC50	nM	4680.0	CHEMBL4128	Homo sapiens	IC50	uM	4.68
	233268	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)C(C)(C)Cc1ccccc1		CHEMBL417006	=	IC50	nM	1440.0	CHEMBL4128	Homo sapiens	IC50	uM	1.44
	233272	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1		CHEMBL47787	=	IC50	nM	521.0	CHEMBL4128	Homo sapiens	IC50	uM	0.521
	234548	CHEMBL824161	Inhibition against human tie-2 kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(NCc5cc6ccccc6[nH]5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45683	=	IC50	nM	203.0	CHEMBL4128	Homo sapiens	IC50	uM	0.203
	238325	CHEMBL697304	Inhibition of human tie-2 kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(C(=O)c5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45693	=	IC50	nM	5730.0	CHEMBL4128	Homo sapiens	IC50	uM	5.73
	242450	CHEMBL697304	Inhibition of human tie-2 kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL46785	=	IC50	nM	606.0	CHEMBL4128	Homo sapiens	IC50	uM	0.606
	246616	CHEMBL809318	Inhibition of TIE-2 kinase	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NCc1ccccc1		CHEMBL45582	=	IC50	nM	1130.0	CHEMBL4128	Homo sapiens	IC50	uM	1.13
	249300	CHEMBL824161	Inhibition against human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1		CHEMBL43773	=	IC50	nM	1020.0	CHEMBL4128	Homo sapiens	IC50	uM	1.02
	250612	CHEMBL809318	Inhibition of TIE-2 kinase	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	uM	0.25
	252043	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CCc1ccccc1		CHEMBL295601	=	IC50	nM	2450.0	CHEMBL4128	Homo sapiens	IC50	uM	2.45
	256156	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)Nc1ccccc1		CHEMBL46176	=	IC50	nM	888.0	CHEMBL4128	Homo sapiens	IC50	uM	0.888
	257551	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CC(C)(C)c1ccccc1		CHEMBL295528	=	IC50	nM	910.0	CHEMBL4128	Homo sapiens	IC50	uM	0.91
	258864	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)Nc1ccccc1		CHEMBL45651	=	IC50	nM	933.0	CHEMBL4128	Homo sapiens	IC50	uM	0.933
	260182	CHEMBL697304	Inhibition of human tie-2 kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)c1ccccc1		CHEMBL402673	=	IC50	nM	137.0	CHEMBL4128	Homo sapiens	IC50	uM	0.137
	316954	CHEMBL814623	Inhibition of Tyrosine protein kinase TIE-2 at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	328356	CHEMBL814624	Inhibition of Tyrosine protein kinase TIE-2 at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	=	IC50	nM	2500.0	CHEMBL4128	Homo sapiens	IC50	uM	2.5
	438323	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL67598	=	IC50	nM	580.0	CHEMBL4128	Homo sapiens	IC50	uM	0.58
	439639	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3O)cc1)cn2C1CCCC1		CHEMBL67268	=	IC50	nM	560.0	CHEMBL4128	Homo sapiens	IC50	uM	0.56
	439646	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccc(CO)cc3)cc2)c2c(N)ncnc21		CHEMBL70034	=	IC50	nM	246.0	CHEMBL4128	Homo sapiens	IC50	uM	0.246
	442413	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)(C)n1cc(-c2ccc(Oc3ccc(N)cc3)cc2)c2c(N)ncnc21		CHEMBL69068	=	IC50	nM	900.0	CHEMBL4128	Homo sapiens	IC50	uM	0.9
	443640	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL302281	=	IC50	nM	2680.0	CHEMBL4128	Homo sapiens	IC50	uM	2.68
	446438	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(CO)n2C1CCCC1		CHEMBL302279	=	IC50	nM	360.0	CHEMBL4128	Homo sapiens	IC50	uM	0.36
	446445	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3[N+](=O)[O-])cc2)c2c(N)ncnc21		CHEMBL304113	=	IC50	nM	1900.0	CHEMBL4128	Homo sapiens	IC50	uM	1.9
	447792	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(C(=O)O)n2C1CCCC1		CHEMBL305748	=	IC50	nM	410.0	CHEMBL4128	Homo sapiens	IC50	uM	0.41
	447799	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)(C)n1cc(-c2ccc(Oc3ccc(O)cc3)cc2)c2c(N)ncnc21		CHEMBL302481	=	IC50	nM	1800.0	CHEMBL4128	Homo sapiens	IC50	uM	1.8
	447806	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3CO)cc2)c2c(N)ncnc21		CHEMBL71541	=	IC50	nM	162.0	CHEMBL4128	Homo sapiens	IC50	uM	0.162
	447813	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3C(=O)O)cc2)c2c(N)ncnc21		CHEMBL67211	=	IC50	nM	677.0	CHEMBL4128	Homo sapiens	IC50	uM	0.677
	450345	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3N)cc2)c2c(N)ncnc21		CHEMBL303195	=	IC50	nM	400.0	CHEMBL4128	Homo sapiens	IC50	uM	0.4
	451605	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(Br)n2C1CCCC1		CHEMBL66716	=	IC50	nM	11100.0	CHEMBL4128	Homo sapiens	IC50	uM	11.1
	451612	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	N#Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL68888	=	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	uM	0.5
	455620	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	COc1ccc(Oc2ccc(-c3cn(C(C)(C)C)c4ncnc(N)c34)cc2)cc1		CHEMBL69649	=	IC50	nM	1220.0	CHEMBL4128	Homo sapiens	IC50	uM	1.22
	460758	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	COCc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL69544	=	IC50	nM	2260.0	CHEMBL4128	Homo sapiens	IC50	uM	2.26
	460765	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)(C)n1cc(-c2ccc(Oc3cccc(N)c3)cc2)c2c(N)ncnc21		CHEMBL433097	=	IC50	nM	1500.0	CHEMBL4128	Homo sapiens	IC50	uM	1.5
	460772	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3C#N)cc2)c2c(N)ncnc21		CHEMBL71722	=	IC50	nM	239.0	CHEMBL4128	Homo sapiens	IC50	uM	0.239
	463233	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL69868	=	IC50	nM	1810.0	CHEMBL4128	Homo sapiens	IC50	uM	1.81
	463240	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(O)c1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL67560	=	IC50	nM	610.0	CHEMBL4128	Homo sapiens	IC50	uM	0.61
	463247	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccc(C(=O)O)cc3)cc2)c2c(N)ncnc21		CHEMBL68773	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	uM	0.43
	464556	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	1980.0	CHEMBL4128	Homo sapiens	IC50	uM	1.98
	464570	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(CN1CCOCC1)n2C1CCCC1		CHEMBL68663	=	IC50	nM	1020.0	CHEMBL4128	Homo sapiens	IC50	uM	1.02
	464577	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	COc1ccccc1Oc1ccc(-c2cn(C3CCCC3)c3ncnc(N)c23)cc1		CHEMBL66102	=	IC50	nM	600.0	CHEMBL4128	Homo sapiens	IC50	uM	0.6
	465917	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(Cl)n2C1CCCC1		CHEMBL68430	=	IC50	nM	23400.0	CHEMBL4128	Homo sapiens	IC50	uM	23.4
	468583	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	NCc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL68082	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	uM	0.13
	469988	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL307982	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	uM	0.43
	472855	CHEMBL847683	Inhibitory activity against tie-2 at a concentration of 5 uM ATP.	B	CC(C)n1cc(-c2ccc(Oc3ccc(C#N)cc3)cc2)c2c(N)ncnc21		CHEMBL71985	=	IC50	nM	970.0	CHEMBL4128	Homo sapiens	IC50	uM	0.97
	506180	CHEMBL812633	Inhibition of Tek kinase	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	24000.0	CHEMBL4128	Homo sapiens	IC50	uM	24.0
	572155	CHEMBL772800	Inhibition of Protein kinase TEK at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	36.0	CHEMBL4128	Homo sapiens	Inhibition	%	36.0
	675225	CHEMBL814621	Inhibition of Tyrosine protein kinase receptor TIE-2	B	COC1=CC(=O)C=C(/C=C2\CCCC3CCCCC23)C1=O		CHEMBL98934	=	IC50	nM	14000.0	CHEMBL4128	Homo sapiens	IC50	uM	14.0
Not Active	676637	CHEMBL814622	Inhibition of Tyrosine protein kinase receptor TIE-2 (No effect)	B	CC1=CCC[C@@H]2[C@]1(C)CC[C@@H](C)[C@@]2(C)CC1=C(O)C(O)=C/C(=N\[C@@H](CO)C(=O)O)C1=O		CHEMBL330608		NI			CHEMBL4128	Homo sapiens	NI		
	686002	CHEMBL814621	Inhibition of Tyrosine protein kinase receptor TIE-2	B	CC(O)C(/N=C1/C=C(O)/C(=N\C(C(=O)O)C(C)O)C=C1O)C(=O)O		CHEMBL327725	=	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	uM	5.0
Not Active	692478	CHEMBL814622	Inhibition of Tyrosine protein kinase receptor TIE-2 (No effect)	B	COC1=CC(=O)C=CC1=O		CHEMBL430845		NI			CHEMBL4128	Homo sapiens	NI		
	702028	CHEMBL814621	Inhibition of Tyrosine protein kinase receptor TIE-2	B	CC(O)C(/N=C1\C(O)=CC(=O)C(O)=C1CC1CCCC2CCCCC21)C(=O)O		CHEMBL442388	=	IC50	nM	9000.0	CHEMBL4128	Homo sapiens	IC50	uM	9.0
Not Active	703253	CHEMBL814622	Inhibition of Tyrosine protein kinase receptor TIE-2 (No effect)	B	COC1=CC(=O)C(N[C@@H](CO)C(=O)O)=CC1=O		CHEMBL319347		NI			CHEMBL4128	Homo sapiens	NI		
	708487	CHEMBL814621	Inhibition of Tyrosine protein kinase receptor TIE-2	B	COC1=CC(=O)C=C(Cc2ccccc2)C1=O		CHEMBL99058	=	IC50	nM	18000.0	CHEMBL4128	Homo sapiens	IC50	uM	18.0
	987082	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CCc1ccccc1		CHEMBL295601	=	IC50	nM	2450.0	CHEMBL4128	Homo sapiens	IC50	uM	2.45
	994231	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1		CHEMBL43773	=	IC50	nM	1130.0	CHEMBL4128	Homo sapiens	IC50	uM	1.13
	1007936	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NCc1ccco1		CHEMBL431407	=	IC50	nM	1020.0	CHEMBL4128	Homo sapiens	IC50	uM	1.02
	1010453	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1		CHEMBL47787	=	IC50	nM	521.0	CHEMBL4128	Homo sapiens	IC50	uM	0.521
	1011760	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL314627	=	IC50	nM	1484.0	CHEMBL4128	Homo sapiens	IC50	uM	1.484
	1020849	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1ccccc1		CHEMBL297363	=	IC50	nM	4680.0	CHEMBL4128	Homo sapiens	IC50	uM	4.68
	1022078	CHEMBL814615	Inhibition of tyrosine protein kinase receptor TIE-2 with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2[nH]1		CHEMBL431609	=	IC50	nM	520.0	CHEMBL4128	Homo sapiens	IC50	uM	0.52
	1038865	CHEMBL814616	Inhibition of Tyrosine protein kinase receptor TIE-2	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	1144048	CHEMBL814617	Inhibition of Tyrosine protein kinase receptor TIE-2	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	=	IC50	nM	17100.0	CHEMBL4128	Homo sapiens	IC50	uM	17.1
	1152818	CHEMBL814618	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 (Tek) expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	1152866	CHEMBL814620	Inhibition of Tyrosine protein kinase receptor TIE-2	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	IC50	nM	11300.0	CHEMBL4128	Homo sapiens	IC50	uM	11.3
	1175325	CHEMBL814618	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 (Tek) expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	567.0	CHEMBL4128	Homo sapiens	IC50	nM	567.0
	1175340	CHEMBL814619	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	2500.0	CHEMBL4128	Homo sapiens	IC50	nM	2500.0
	1175350	CHEMBL814618	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 (Tek) expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	1176720	CHEMBL814620	Inhibition of Tyrosine protein kinase receptor TIE-2	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	=	IC50	nM	11300.0	CHEMBL4128	Homo sapiens	IC50	uM	11.3
	1180539	CHEMBL814618	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 (Tek) expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	1183191	CHEMBL814618	In vitro inhibition of Tyrosine protein kinase receptor TIE-2 (Tek) expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	=	IC50	nM	6800.0	CHEMBL4128	Homo sapiens	IC50	nM	6800.0
	1185351	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCOC1		CHEMBL48554	=	IC50	nM	5150.0	CHEMBL4128	Homo sapiens	IC50	uM	5.15
	1185355	CHEMBL809316	Inhibition of TIE-2 kinase.	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	5850.0	CHEMBL4128	Homo sapiens	IC50	uM	5.85
	1188061	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2CCO		CHEMBL297359	=	IC50	nM	16710.0	CHEMBL4128	Homo sapiens	IC50	uM	16.71
	1190786	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCNCC1		CHEMBL47202	=	IC50	nM	21380.0	CHEMBL4128	Homo sapiens	IC50	uM	21.38
	1194613	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCCCC2)CC1		CHEMBL431342	=	IC50	nM	12160.0	CHEMBL4128	Homo sapiens	IC50	uM	12.16
	1206517	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCOCC1		CHEMBL296103	=	IC50	nM	11620.0	CHEMBL4128	Homo sapiens	IC50	uM	11.62
	1207806	CHEMBL809317	Inhibition of TIE-2 kinase (Not tested)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCNC1		CHEMBL297278	=	IC50	nM		CHEMBL4128	Homo sapiens	IC50	uM	
	1210406	CHEMBL883493	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	9070.0	CHEMBL4128	Homo sapiens	IC50	uM	9.07
	1213063	CHEMBL809315	Inhibition of TIE-2 kinase	B	CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL47203	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	uM	0.25
	1219682	CHEMBL809315	Inhibition of TIE-2 kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CNOC1		CHEMBL296534	=	IC50	nM	6620.0	CHEMBL4128	Homo sapiens	IC50	uM	6.62
Not Determined	1219686	CHEMBL809317	Inhibition of TIE-2 kinase (Not tested)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCCCC2)CC1		CHEMBL44942		IC50	nM		CHEMBL4128	Homo sapiens	IC50	uM	
	1222196	CHEMBL809315	Inhibition of TIE-2 kinase	B	NCCn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL416444	>	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	uM	50.0
	1401260	CHEMBL832628	Inhibition of tyrosine protein kinase receptor TIE-2	B	CC(C)(Nc1nc(NO)nc(Nc2ccc3ncsc3c2)n1)c1ccccc1		CHEMBL177298	=	IC50	nM	700.0	CHEMBL4128	Homo sapiens	IC50	uM	0.7
	1401276	CHEMBL832628	Inhibition of tyrosine protein kinase receptor TIE-2	B	CC(C)(Nc1nc(O)nc(Nc2ccc3ncsc3c2)n1)c1ccccc1		CHEMBL175862	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	1401292	CHEMBL832628	Inhibition of tyrosine protein kinase receptor TIE-2	B	CCN(Cc1ccccc1)c1nc(O)nc(Nc2ccc3ncsc3c2)n1		CHEMBL176078	=	IC50	nM	400.0	CHEMBL4128	Homo sapiens	IC50	uM	0.4
	1401307	CHEMBL832628	Inhibition of tyrosine protein kinase receptor TIE-2	B	CC(C)N(Cc1ccccc1)c1nc(O)nc(Nc2ccc3ncsc3c2)n1		CHEMBL176019	=	IC50	nM	180.0	CHEMBL4128	Homo sapiens	IC50	uM	0.18
	1516912	CHEMBL832166	Selectivity for Tyrosine protein kinase receptor TIE-2 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	>	Selectivity	uM	10.0	CHEMBL4128	Homo sapiens	Selectivity	uM	10.0
	1517051	CHEMBL832166	Selectivity for Tyrosine protein kinase receptor TIE-2 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Selectivity	uM	1.4	CHEMBL4128	Homo sapiens	Selectivity	uM	1.4
	1517165	CHEMBL832166	Selectivity for Tyrosine protein kinase receptor TIE-2 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993	=	Selectivity	uM	1.8	CHEMBL4128	Homo sapiens	Selectivity	uM	1.8
	1519838	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(OC)cc2)cc1		CHEMBL196021	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	1519840	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	1519842	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	1519844	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2c(-c3ccc(Cl)c(Cl)c3)oc3ncnc(N)c23)cc1		CHEMBL362915	=	IC50	nM	1780.0	CHEMBL4128	Homo sapiens	IC50	uM	1.78
	1519846	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2c(-c3cccc(C(N)=O)c3)oc3ncnc(N)c23)cc1		CHEMBL363389	=	IC50	nM	540.0	CHEMBL4128	Homo sapiens	IC50	uM	0.54
	1519848	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2c(-c3cccc(C(=O)N(C)C)c3)oc3ncnc(N)c23)cc1		CHEMBL383603	=	IC50	nM	1480.0	CHEMBL4128	Homo sapiens	IC50	uM	1.48
	1519850	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2c(-c3cccc(NS(C)(=O)=O)c3)oc3ncnc(N)c23)cc1		CHEMBL194150	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	uM	0.3
	1519852	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(N(C)C)cc2)cc1		CHEMBL194057	=	IC50	nM	600.0	CHEMBL4128	Homo sapiens	IC50	uM	0.6
	1519854	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	CS(=O)(=O)Nc1cccc(-c2oc3ncnc(N)c3c2-c2ccc(-c3ccccc3)cc2)c1		CHEMBL196841	=	IC50	nM	190.0	CHEMBL4128	Homo sapiens	IC50	uM	0.19
	1519974	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2cccc(NC(C)=O)c2)cc1		CHEMBL195640	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	1519976	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)c3cccc(F)c3)cc2)cc1		CHEMBL372845	=	IC50	nM	501.0	CHEMBL4128	Homo sapiens	IC50	uM	0.501
	1519978	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NS(=O)(=O)c3cccc(Cl)c3)cc2)cc1		CHEMBL365773	=	IC50	nM	851.0	CHEMBL4128	Homo sapiens	IC50	uM	0.851
	1519980	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3ccccc3)cc2)cc1		CHEMBL194149	=	IC50	nM	28.0	CHEMBL4128	Homo sapiens	IC50	uM	0.028
	1519982	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1		CHEMBL194911	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	uM	0.002
	1519984	CHEMBL834763	Concentration required to inhibit autophosphorylation of tyrosine protein kinase receptor TIE-2 transfected in 3T3 cells	F	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1		CHEMBL194911	=	IC50	nM	6.3	CHEMBL4128	Homo sapiens	IC50	uM	0.0063
	1519987	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)cc1		CHEMBL372617	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	uM	0.022
	1519989	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)NC3CCCCC3)cc2)cc1		CHEMBL195567	=	IC50	nM	59.0	CHEMBL4128	Homo sapiens	IC50	uM	0.059
	1519991	CHEMBL828663	Inhibitory concentration against human tyrosine protein kinase receptor TIE-2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(N)=O)cc2)cc1		CHEMBL193752	=	IC50	nM	275.0	CHEMBL4128	Homo sapiens	IC50	uM	0.275
	1609096	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL197592	=	IC50	nM	1200.0	CHEMBL4128	Homo sapiens	IC50	nM	1200.0
	1609101	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371329	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
	1609121	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL366241	=	IC50	nM	340.0	CHEMBL4128	Homo sapiens	IC50	nM	340.0
	1609125	CHEMBL882608	Inhibitory concentration against Tie2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	730.0	CHEMBL4128	Homo sapiens	IC50	nM	730.0
	1609148	CHEMBL880280	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	720.0	CHEMBL4128	Homo sapiens	IC50	nM	720.0
	1609157	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1ccccc1NC(=O)Nc1ccc(-c2c(C)sc3ncnc(N)c23)cc1		CHEMBL438797	=	IC50	nM	1300.0	CHEMBL4128	Homo sapiens	IC50	nM	1300.0
	1609160	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1ccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)cc1		CHEMBL198267	=	IC50	nM	890.0	CHEMBL4128	Homo sapiens	IC50	nM	890.0
	1609168	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	COc1ccccc1NC(=O)Nc1ccc(-c2c(C)sc3ncnc(N)c23)cc1		CHEMBL445394	=	IC50	nM	920.0	CHEMBL4128	Homo sapiens	IC50	nM	920.0
	1609171	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	COc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371889	=	IC50	nM	360.0	CHEMBL4128	Homo sapiens	IC50	nM	360.0
	1609174	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	COc1ccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)cc1		CHEMBL365784	=	IC50	nM	1600.0	CHEMBL4128	Homo sapiens	IC50	nM	1600.0
	1609176	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2F)cc1		CHEMBL194270	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	1609179	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(F)c2)cc1		CHEMBL196747	=	IC50	nM	400.0	CHEMBL4128	Homo sapiens	IC50	nM	400.0
	1609182	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1		CHEMBL196499	=	IC50	nM	850.0	CHEMBL4128	Homo sapiens	IC50	nM	850.0
	1609185	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1		CHEMBL194321	=	IC50	nM	900.0	CHEMBL4128	Homo sapiens	IC50	nM	900.0
	1609188	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1		CHEMBL382517	=	IC50	nM	210.0	CHEMBL4128	Homo sapiens	IC50	nM	210.0
	1609193	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL372174	=	IC50	nM	1200.0	CHEMBL4128	Homo sapiens	IC50	nM	1200.0
	1609197	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Br)c2)cc1		CHEMBL195955	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	nM	130.0
	1609205	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(Br)cc2)cc1		CHEMBL194236	=	IC50	nM	1100.0	CHEMBL4128	Homo sapiens	IC50	nM	1100.0
	1609208	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL370325	=	IC50	nM	100.0	CHEMBL4128	Homo sapiens	IC50	nM	100.0
	1609213	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	CCOC(=O)c1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL195828	=	IC50	nM	510.0	CHEMBL4128	Homo sapiens	IC50	nM	510.0
	1609216	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	IC50	nM	170.0	CHEMBL4128	Homo sapiens	IC50	nM	170.0
	1609219	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(Cl)cc(Cl)c2)cc1		CHEMBL381034	=	IC50	nM	360.0	CHEMBL4128	Homo sapiens	IC50	nM	360.0
	1609232	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL381207	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	1609241	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCC(N)=O)sc4ncnc(N)c34)cc2)c1		CHEMBL197635	=	IC50	nM	120.0	CHEMBL4128	Homo sapiens	IC50	nM	120.0
	1609244	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	CNC(=O)CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL198601	=	IC50	nM	470.0	CHEMBL4128	Homo sapiens	IC50	nM	470.0
	1609247	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCC(=O)N(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL382112	=	IC50	nM	140.0	CHEMBL4128	Homo sapiens	IC50	nM	140.0
	1609250	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CN4CCOCC4)sc4ncnc(N)c34)cc2)c1		CHEMBL194842	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	nM	430.0
	1609260	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CN4CCN(C)CC4)sc4ncnc(N)c34)cc2)c1		CHEMBL372388	=	IC50	nM	630.0	CHEMBL4128	Homo sapiens	IC50	nM	630.0
	1609264	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	CCCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL371225	=	IC50	nM	290.0	CHEMBL4128	Homo sapiens	IC50	nM	290.0
	1609266	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(C(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL371890	=	IC50	nM	580.0	CHEMBL4128	Homo sapiens	IC50	nM	580.0
	1609268	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccccc4)sc4ncnc(N)c34)cc2)c1		CHEMBL372755	=	IC50	nM	880.0	CHEMBL4128	Homo sapiens	IC50	nM	880.0
	1609271	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4cccnc4)sc4ncnc(N)c34)cc2)c1		CHEMBL371379	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	1609274	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccncc4)sc4ncnc(N)c34)cc2)c1		CHEMBL369908	=	IC50	nM	270.0	CHEMBL4128	Homo sapiens	IC50	nM	270.0
	1609277	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCO)sc4ncnc(N)c34)cc2)c1		CHEMBL197353	=	IC50	nM	260.0	CHEMBL4128	Homo sapiens	IC50	nM	260.0
	1609280	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	COCCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL198155	=	IC50	nM	220.0	CHEMBL4128	Homo sapiens	IC50	nM	220.0
	1609283	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCCO)sc4ncnc(N)c34)cc2)c1		CHEMBL198297	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
	1609292	CHEMBL882607	Inhibitory concentration against TIE2 using biotinylated poly(Glu-Tyr) (10 ng/well) for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCN(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL196636	=	IC50	nM	190.0	CHEMBL4128	Homo sapiens	IC50	nM	190.0
Not Active	1650477	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4128	Homo sapiens	Kd		
	1650478	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2900.0	CHEMBL4128	Homo sapiens	Kd	uM	2.9
Not Active	1650479	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1650480	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1650481	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1650482	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4128	Homo sapiens	Kd		
	1650483	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL4128	Homo sapiens	Kd	uM	3.0
Not Active	1650484	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1650485	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4128	Homo sapiens	Kd		
	1651610	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	240.0	CHEMBL4128	Homo sapiens	Kd	uM	0.24
Not Active	1651611	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1651612	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1651613	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4128	Homo sapiens	Kd		
	1651614	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	11.0	CHEMBL4128	Homo sapiens	Kd	uM	0.011
Not Active	1651615	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1651616	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1651617	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4128	Homo sapiens	Kd		
Not Active	1651618	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4128	Homo sapiens	Kd		
	1651619	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	3600.0	CHEMBL4128	Homo sapiens	Kd	uM	3.6
Not Active	1651620	CHEMBL860794	Average Binding Constant for TEK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4128	Homo sapiens	Kd		
	1663203	CHEMBL863871	Inhibitory activity against tie2	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	>	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	uM	50.0
	1666763	CHEMBL865823	Inhibitory activity against Tie2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)ccc1O		CHEMBL202930	>	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	nM	50000.0
Not Determined	1666773	CHEMBL865823	Inhibitory activity against Tie2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2c[nH]c3ncccc23)ccc1O		CHEMBL383316		IC50			CHEMBL4128	Homo sapiens	IC50		
	1666786	CHEMBL865823	Inhibitory activity against Tie2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ncc[nH]2)ccc1O		CHEMBL199299	=	IC50	nM	23273.0	CHEMBL4128	Homo sapiens	IC50	nM	23273.0
	1680057	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1O		CHEMBL382128	=	Inhibition	%	101.0	CHEMBL4128	Homo sapiens	Inhibition	%	101.0
	1680058	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1O		CHEMBL382128	=	Inhibition	%	85.0	CHEMBL4128	Homo sapiens	Inhibition	%	85.0
	1680501	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL202378	=	Inhibition	%	32.0	CHEMBL4128	Homo sapiens	Inhibition	%	32.0
	1680502	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc2[nH]c3c4c(OC)c(OC)c(OC)cc4c4c(c3c2c1)C(=O)NC4=O		CHEMBL201090	=	Inhibition	%	61.0	CHEMBL4128	Homo sapiens	Inhibition	%	61.0
	1680503	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21		CHEMBL421087	=	Inhibition	%	136.0	CHEMBL4128	Homo sapiens	Inhibition	%	136.0
	1680504	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc2c3c(c4c5ccccc5[nH]c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL380898	=	Inhibition	%	81.0	CHEMBL4128	Homo sapiens	Inhibition	%	81.0
	1680505	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cc4ccccc4[nH]3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL202501	=	Inhibition	%	103.0	CHEMBL4128	Homo sapiens	Inhibition	%	103.0
	1680506	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cccc2ccccc12		CHEMBL202196	=	Inhibition	%	71.0	CHEMBL4128	Homo sapiens	Inhibition	%	71.0
	1680507	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c(-c4ccccc4)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL371449	=	Inhibition	%	119.0	CHEMBL4128	Homo sapiens	Inhibition	%	119.0
	1680508	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c(C)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201463	=	Inhibition	%	45.0	CHEMBL4128	Homo sapiens	Inhibition	%	45.0
	1680509	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201708	=	Inhibition	%	51.0	CHEMBL4128	Homo sapiens	Inhibition	%	51.0
	1680510	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc2[nH]cc(C3=C(c4cc(OC)c(OC)c(OC)c4)C(=O)NC3=O)c2c1		CHEMBL446182	=	Inhibition	%	61.0	CHEMBL4128	Homo sapiens	Inhibition	%	61.0
	1680511	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccc(Cl)cc1		CHEMBL371025	=	Inhibition	%	108.0	CHEMBL4128	Homo sapiens	Inhibition	%	108.0
	1680512	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL201264	=	Inhibition	%	65.0	CHEMBL4128	Homo sapiens	Inhibition	%	65.0
	1680513	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1		CHEMBL202504	=	Inhibition	%	93.0	CHEMBL4128	Homo sapiens	Inhibition	%	93.0
	1680514	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1		CHEMBL380598	=	Inhibition	%	51.0	CHEMBL4128	Homo sapiens	Inhibition	%	51.0
	1680515	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cc[nH]c3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201512	=	Inhibition	%	116.0	CHEMBL4128	Homo sapiens	Inhibition	%	116.0
	1680516	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	Inhibition	%	14.0	CHEMBL4128	Homo sapiens	Inhibition	%	14.0
	1680517	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccc(OC)cc3)C(=O)NC2=O)cc1		CHEMBL381099	=	Inhibition	%	109.0	CHEMBL4128	Homo sapiens	Inhibition	%	109.0
	1680518	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2ccccc2)=C1c1ccccc1		CHEMBL201949	=	Inhibition	%	99.0	CHEMBL4128	Homo sapiens	Inhibition	%	99.0
	1680519	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1		CHEMBL372076	=	Inhibition	%	101.0	CHEMBL4128	Homo sapiens	Inhibition	%	101.0
	1680520	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1OC		CHEMBL202135	=	Inhibition	%	100.0	CHEMBL4128	Homo sapiens	Inhibition	%	100.0
	1680521	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3ccccc3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL372944	=	Inhibition	%	103.0	CHEMBL4128	Homo sapiens	Inhibition	%	103.0
	1680522	CHEMBL865269	Inhibition of human TIE2 expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1		CHEMBL202215	=	Inhibition	%	108.0	CHEMBL4128	Homo sapiens	Inhibition	%	108.0
	1680523	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL202378	=	Inhibition	%	13.0	CHEMBL4128	Homo sapiens	Inhibition	%	13.0
	1680524	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc2[nH]c3c4c(OC)c(OC)c(OC)cc4c4c(c3c2c1)C(=O)NC4=O		CHEMBL201090	=	Inhibition	%	53.0	CHEMBL4128	Homo sapiens	Inhibition	%	53.0
	1680525	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21		CHEMBL421087	=	Inhibition	%	48.0	CHEMBL4128	Homo sapiens	Inhibition	%	48.0
	1680526	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc2c3c(c4c5ccccc5[nH]c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL380898	=	Inhibition	%	19.0	CHEMBL4128	Homo sapiens	Inhibition	%	19.0
	1680527	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cc4ccccc4[nH]3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL202501	=	Inhibition	%	57.0	CHEMBL4128	Homo sapiens	Inhibition	%	57.0
	1680528	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cccc2ccccc12		CHEMBL202196	=	Inhibition	%	34.0	CHEMBL4128	Homo sapiens	Inhibition	%	34.0
	1680529	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c(-c4ccccc4)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL371449	=	Inhibition	%	93.0	CHEMBL4128	Homo sapiens	Inhibition	%	93.0
	1680530	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c(C)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201463	=	Inhibition	%	66.0	CHEMBL4128	Homo sapiens	Inhibition	%	66.0
	1680531	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201708	=	Inhibition	%	16.0	CHEMBL4128	Homo sapiens	Inhibition	%	16.0
	1680532	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc2[nH]cc(C3=C(c4cc(OC)c(OC)c(OC)c4)C(=O)NC3=O)c2c1		CHEMBL446182	=	Inhibition	%	71.0	CHEMBL4128	Homo sapiens	Inhibition	%	71.0
	1680533	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccc(Cl)cc1		CHEMBL371025	=	Inhibition	%	92.0	CHEMBL4128	Homo sapiens	Inhibition	%	92.0
	1680534	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL201264	=	Inhibition	%	73.0	CHEMBL4128	Homo sapiens	Inhibition	%	73.0
	1680535	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1		CHEMBL202504	=	Inhibition	%	86.0	CHEMBL4128	Homo sapiens	Inhibition	%	86.0
	1680536	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1		CHEMBL380598	=	Inhibition	%	46.0	CHEMBL4128	Homo sapiens	Inhibition	%	46.0
	1680537	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cc[nH]c3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201512	=	Inhibition	%	77.0	CHEMBL4128	Homo sapiens	Inhibition	%	77.0
	1680538	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	Inhibition	%	11.0
	1680539	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccc(OC)cc3)C(=O)NC2=O)cc1		CHEMBL381099	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	Inhibition	%	12.0
	1680540	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2ccccc2)=C1c1ccccc1		CHEMBL201949	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	Inhibition	%	10.0
	1680541	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1		CHEMBL372076	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	Inhibition	%	12.0
	1680542	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1OC		CHEMBL202135	=	Inhibition	%	98.0	CHEMBL4128	Homo sapiens	Inhibition	%	98.0
	1680543	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3ccccc3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL372944	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	Inhibition	%	10.0
	1680544	CHEMBL865270	Inhibition of human TIE2 expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1		CHEMBL202215	=	Inhibition	%	92.0	CHEMBL4128	Homo sapiens	Inhibition	%	92.0
	1707906	CHEMBL866854	Inhibition of TIE2 at 10 uM in presence of 0.1 uM ATP	B	O=C1Nc2ccccc2C(=O)[C@@H]2[C@@H](c3cccc(Cl)c3)C[C@](O)(c3ccccc3)[C@@H]12		CHEMBL382654	>	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	Inhibition	%	50.0
	1748672	CHEMBL870366	Inhibition of Tie2	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	=	IC50	nM	200.0	CHEMBL4128	Homo sapiens	IC50	uM	0.2
	1752799	CHEMBL866113	Inhibition of Tie2 by HTRF assay	B	c1cn(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)cn1		CHEMBL212084	=	IC50	nM	17641.0	CHEMBL4128	Homo sapiens	IC50	nM	17641.0
	1752984	CHEMBL866113	Inhibition of Tie2 by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)CC1		CHEMBL213743	=	IC50	nM	47793.0	CHEMBL4128	Homo sapiens	IC50	nM	47793.0
	1753631	CHEMBL864250	Inhibition of TIE2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	IC50	nM	19.0	CHEMBL4128	Homo sapiens	IC50	uM	0.019
	1753647	CHEMBL864250	Inhibition of TIE2	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL214258	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	uM	0.022
	1753651	CHEMBL864250	Inhibition of TIE2	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213504	=	IC50	nM	28.0	CHEMBL4128	Homo sapiens	IC50	uM	0.028
	1753655	CHEMBL864250	Inhibition of TIE2	B	Cc1cccc(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL376951	=	IC50	nM	415.0	CHEMBL4128	Homo sapiens	IC50	uM	0.415
	1753735	CHEMBL864250	Inhibition of TIE2	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	730.0	CHEMBL4128	Homo sapiens	IC50	uM	0.73
	1755409	CHEMBL870451	Inhibition of Tie2 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5cccc(C(F)(F)F)c5)s4)c2C3)CC1		CHEMBL213910	=	IC50	nM	259.0	CHEMBL4128	Homo sapiens	IC50	nM	259.0
	1769470	CHEMBL910954	Inhibition of Tie2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	1790442	CHEMBL912730	Inhibition of human TIE2	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	2800.0	CHEMBL4128	Homo sapiens	IC50	M	0.0000028
	1793654	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(N)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL373397	=	IC50	nM	36.0	CHEMBL4128	Homo sapiens	IC50	nM	36.0
	1793728	CHEMBL856491	Inhibition of Tie2	B	COc1cccc(NC(=O)Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)c1		CHEMBL218817	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1793729	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)N(C)c3ccccc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219293	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1793730	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccccc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL216891	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	1793731	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL437876	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1793732	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL218252	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	1793733	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219555	=	IC50	nM	19.0	CHEMBL4128	Homo sapiens	IC50	nM	19.0
	1793734	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(C)cc3)cc2c2c3c(c4c(c21)CC(C=N)=CC4)C(=O)NC3		CHEMBL387174	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1793735	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(N(C)C)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL375311	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
	1793736	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(SC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219332	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1793737	CHEMBL856491	Inhibition of Tie2	B	CCCCn1c2ccc(NC(=O)Nc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL374736	=	IC50	nM	7.0	CHEMBL4128	Homo sapiens	IC50	nM	7.0
	1793738	CHEMBL856491	Inhibition of Tie2	B	COc1ccc(NC(=O)Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)cc1		CHEMBL218816	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1793739	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL218201	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1793740	CHEMBL856491	Inhibition of Tie2	B	CCn1c2ccc(NC(=O)Nc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL424757	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1793741	CHEMBL856491	Inhibition of Tie2	B	CC(C)Cn1c2ccc(N)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL218799	=	IC50	nM	48.0	CHEMBL4128	Homo sapiens	IC50	nM	48.0
	1793742	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL220406	=	IC50	nM	12.0	CHEMBL4128	Homo sapiens	IC50	nM	12.0
	1793743	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccccc3Br)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL375570	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1793744	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccccc3Cl)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219253	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1793745	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219581	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
	1793746	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccccc3F)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL424910	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1793747	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3cccc(F)c3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL426528	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1793748	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Nc3ccc(F)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL374745	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1793749	CHEMBL856491	Inhibition of Tie2	B	COc1ccccc1NC(=O)Nc1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL265600	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	1793757	CHEMBL856491	Inhibition of Tie2	B	CCCOC(=O)Nc1ccc2c(c1)c1c3c(c4c(c1n2CCC)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL373575	=	IC50	nM	7.0	CHEMBL4128	Homo sapiens	IC50	nM	7.0
	1793758	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)OCC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219493	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
	1793759	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)OC(C)C)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219492	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
	1793760	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Oc3ccc(F)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL265284	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
	1793761	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)Oc3ccc(OC)cc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL218557	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	1793762	CHEMBL856491	Inhibition of Tie2	B	CC(C)Cn1c2ccc(NC(=O)c3ccco3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219080	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	1793763	CHEMBL856491	Inhibition of Tie2	B	CCCn1c2ccc(NC(=O)c3ccco3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL425109	=	IC50	nM	29.0	CHEMBL4128	Homo sapiens	IC50	nM	29.0
	1793764	CHEMBL856491	Inhibition of Tie2	B	CC(C)Cn1c2ccc(NC(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL426703	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1793798	CHEMBL856491	Inhibition of Tie2	B	CCCCn1c2ccc(N)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL219543	=	IC50	nM	230.0	CHEMBL4128	Homo sapiens	IC50	nM	230.0
	1807173	CHEMBL908990	Inhibition of Tie2	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	678.0	CHEMBL4128	Homo sapiens	IC50	uM	0.678
	1810799	CHEMBL907883	Inhibition of Tie2 kinase at 3 uM	B	CCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F		CHEMBL223892	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1810803	CHEMBL907883	Inhibition of Tie2 kinase at 3 uM	B	COCCO/N=C/c1c(N)ncnc1Oc1ccc2[nH]c(C)cc2c1F		CHEMBL219983	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1815089	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1815120	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C4CC4)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL375793	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	1815121	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(C)C)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL266311	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
	1815122	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	30.0	CHEMBL4128	Homo sapiens	IC50	nM	30.0
	1815123	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL221087	=	IC50	nM	53.0	CHEMBL4128	Homo sapiens	IC50	nM	53.0
	1815124	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)ccc2C)n1		CHEMBL278965	=	IC50	nM	59.0	CHEMBL4128	Homo sapiens	IC50	nM	59.0
	1815125	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cc(C)cnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2C)n1		CHEMBL219218	=	IC50	nM	108.0	CHEMBL4128	Homo sapiens	IC50	nM	108.0
	1815126	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL426211	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1815127	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL218646	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1815128	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL219583	=	IC50	nM	40.0	CHEMBL4128	Homo sapiens	IC50	nM	40.0
	1815129	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cc(C)cnc2Oc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2C)n1		CHEMBL218431	=	IC50	nM	388.0	CHEMBL4128	Homo sapiens	IC50	nM	388.0
	1815130	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2C)n1		CHEMBL218576	=	IC50	nM	39.0	CHEMBL4128	Homo sapiens	IC50	nM	39.0
	1815131	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2Cl)n1		CHEMBL374997	=	IC50	nM	30.0	CHEMBL4128	Homo sapiens	IC50	nM	30.0
	1815132	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2F)n1		CHEMBL374259	=	IC50	nM	62.0	CHEMBL4128	Homo sapiens	IC50	nM	62.0
	1815133	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL221119	=	IC50	nM	99.0	CHEMBL4128	Homo sapiens	IC50	nM	99.0
	1815134	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1ccc(C2CCCCC2)cc1NC(=O)c1ccc(C)c(Oc2ncccc2-c2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL375792	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	1815135	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1ccc(C2CCCCC2)cc1NC(=O)c1ccc(C)c(Oc2ncccc2-c2ccnc3ccccc23)c1		CHEMBL375577	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	1815136	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1cc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)ccn1		CHEMBL218040	=	IC50	nM	62.0	CHEMBL4128	Homo sapiens	IC50	nM	62.0
	1815137	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)n1		CHEMBL220640	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	nM	22.0
	1815138	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)n1		CHEMBL220550	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	1815139	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCOCC3)ccc2C)n1		CHEMBL219158	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1815140	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCOCC2)cc1Oc1ncccc1-c1ccncn1		CHEMBL220052	=	IC50	nM	399.0	CHEMBL4128	Homo sapiens	IC50	nM	399.0
	1815141	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL218632	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	1815142	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1Oc1ncccc1-c1ccncn1		CHEMBL276395	=	IC50	nM	366.0	CHEMBL4128	Homo sapiens	IC50	nM	366.0
	1815143	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(Oc2ncccc2-c2ccncn2)c1		CHEMBL220549	=	IC50	nM	103.0	CHEMBL4128	Homo sapiens	IC50	nM	103.0
	1815144	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1Oc1ncccc1-c1ccncn1		CHEMBL375447	=	IC50	nM	2700.0	CHEMBL4128	Homo sapiens	IC50	nM	2700.0
	1815145	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Oc1ncccc1-c1ccncn1		CHEMBL218425	=	IC50	nM	153.0	CHEMBL4128	Homo sapiens	IC50	nM	153.0
	1815146	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1Nc1ncccc1-c1ccncn1		CHEMBL373682	=	IC50	nM	181.0	CHEMBL4128	Homo sapiens	IC50	nM	181.0
	1815147	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(Nc2ncccc2-c2ccncn2)c1		CHEMBL219996	=	IC50	nM	43.0	CHEMBL4128	Homo sapiens	IC50	nM	43.0
	1815148	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(CCCN(C)C)cc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL221484	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	1815149	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1Nc1ncccc1-c1ccncn1		CHEMBL222067	=	IC50	nM	504.0	CHEMBL4128	Homo sapiens	IC50	nM	504.0
	1815150	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1ncccc1-c1ccncn1		CHEMBL221121	=	IC50	nM	1220.0	CHEMBL4128	Homo sapiens	IC50	nM	1220.0
	1815151	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1cc(Nc2ncnc(-c3cccnc3Nc3cccc(C(=O)Nc4ccc(Oc5ccccc5)cc4)c3)n2)cc(OC)c1OC		CHEMBL220540	=	IC50	nM	85.0	CHEMBL4128	Homo sapiens	IC50	nM	85.0
	1815152	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1		CHEMBL385178	>=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	1815153	CHEMBL908503	Inhibition of Tie2 by HTRF assay	B	COc1cc(Nc2ncnc(-c3cccnc3Nc3ccccc3)n2)cc(OC)c1OC		CHEMBL218057	=	IC50	nM	68.0	CHEMBL4128	Homo sapiens	IC50	nM	68.0
	1815155	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C4CC4)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL375793	=	IC50	nM	39.0	CHEMBL4128	Homo sapiens	IC50	nM	39.0
	1815156	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL218632	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1815157	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(C)C)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL266311	=	IC50	nM	25.0	CHEMBL4128	Homo sapiens	IC50	nM	25.0
	1815158	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	62.0	CHEMBL4128	Homo sapiens	IC50	nM	62.0
	1815159	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL221087	=	IC50	nM	852.0	CHEMBL4128	Homo sapiens	IC50	nM	852.0
	1815160	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)ccc2C)n1		CHEMBL278965	=	IC50	nM	140.0	CHEMBL4128	Homo sapiens	IC50	nM	140.0
	1815161	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cc(C)cnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2C)n1		CHEMBL219218	=	IC50	nM	810.0	CHEMBL4128	Homo sapiens	IC50	nM	810.0
	1815162	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL426211	=	IC50	nM	38.0	CHEMBL4128	Homo sapiens	IC50	nM	38.0
	1815163	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL218646	=	IC50	nM	46.0	CHEMBL4128	Homo sapiens	IC50	nM	46.0
	1815164	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL219583	=	IC50	nM	244.0	CHEMBL4128	Homo sapiens	IC50	nM	244.0
	1815165	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2Cl)n1		CHEMBL374997	=	IC50	nM	121.0	CHEMBL4128	Homo sapiens	IC50	nM	121.0
	1815166	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2F)n1		CHEMBL374259	=	IC50	nM	105.0	CHEMBL4128	Homo sapiens	IC50	nM	105.0
	1815167	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)n1		CHEMBL221119	=	IC50	nM	368.0	CHEMBL4128	Homo sapiens	IC50	nM	368.0
	1815168	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1cc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)ccn1		CHEMBL218040	=	IC50	nM	111.0	CHEMBL4128	Homo sapiens	IC50	nM	111.0
	1815169	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)n1		CHEMBL220640	=	IC50	nM	61.0	CHEMBL4128	Homo sapiens	IC50	nM	61.0
	1815170	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C4CCCCC4)ccc3OC)ccc2C)n1		CHEMBL220550	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	nM	16.0
	1815171	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCOCC3)ccc2C)n1		CHEMBL219158	=	IC50	nM	317.0	CHEMBL4128	Homo sapiens	IC50	nM	317.0
	1815206	CHEMBL908505	Inhibition of angiopoietin-1-stimulated Tie2 phosphorylation in EA.hy926 cells	F	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)ccc2C)n1		CHEMBL218576	=	IC50	nM	462.0	CHEMBL4128	Homo sapiens	IC50	nM	462.0
	1815248	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL218632	<	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	1815251	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc(N)nc1		CHEMBL427998	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1815252	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	1815257	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)[C@H]1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL220750	=	IC50	nM	140.0	CHEMBL4128	Homo sapiens	IC50	nM	140.0
	1815258	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)[C@@H]1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL221544	=	IC50	nM	220.0	CHEMBL4128	Homo sapiens	IC50	nM	220.0
	1815259	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCC[C@H](N)C3)c2)cn1		CHEMBL374079	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	1815260	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL220532	=	IC50	nM	14.0	CHEMBL4128	Homo sapiens	IC50	nM	14.0
	1815261	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	1815262	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)[C@@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL218110	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	nM	44.0
	1815263	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)C1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)CC1		CHEMBL221193	=	IC50	nM	620.0	CHEMBL4128	Homo sapiens	IC50	nM	620.0
	1815264	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)CC1		CHEMBL376475	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	1815265	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CN(C)CCCN(C)c1ccc(C(F)(F)F)cc1NC(=O)c1cc(C#Cc2cnc(N)nc2)ccc1F		CHEMBL373621	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	1815266	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	COc1ccc(C#Cc2cnc(N)nc2)cc1C(=O)Nc1cc(C(F)(F)F)ccc1N1CCCCC1		CHEMBL375617	=	IC50	nM	21.0	CHEMBL4128	Homo sapiens	IC50	nM	21.0
	1815267	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1		CHEMBL374985	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	1815268	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Nc1ncc(C#Cc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1		CHEMBL220482	=	IC50	nM	63.0	CHEMBL4128	Homo sapiens	IC50	nM	63.0
	1815269	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1C#Cc1cnc(N)nc1		CHEMBL219103	=	IC50	nM	30.0	CHEMBL4128	Homo sapiens	IC50	nM	30.0
	1815270	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL218631	=	IC50	nM	47.0	CHEMBL4128	Homo sapiens	IC50	nM	47.0
	1815271	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Nc1ncc(C#Cc2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL375819	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
	1815272	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc2ccccc2n1		CHEMBL221019	=	IC50	nM	85.0	CHEMBL4128	Homo sapiens	IC50	nM	85.0
	1815273	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc2ccccc2c1		CHEMBL219584	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1815274	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	CNC(=O)c1ccc(C#Cc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)cn1		CHEMBL450024	=	IC50	nM	623.0	CHEMBL4128	Homo sapiens	IC50	nM	623.0
	1815275	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]cnc2c1		CHEMBL375840	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	1815276	CHEMBL910166	Inhibition of TIE2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1ccc(N)nc1		CHEMBL220874	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
Not Determined	1815317	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc(N)nc1		CHEMBL427998		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815318	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)[C@H]1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL220750		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815319	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)[C@@H]1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL221544		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815320	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)C1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)CC1		CHEMBL221193		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815321	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)CCCN(C)c1ccc(C(F)(F)F)cc1NC(=O)c1cc(C#Cc2cnc(N)nc2)ccc1F		CHEMBL373621		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815322	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL218631		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1815323	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Nc1ncc(C#Cc2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL375819		IC50			CHEMBL4128	Homo sapiens	IC50		
	1815324	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc1C#Cc1cnc(N)nc1		CHEMBL219103	=	IC50	nM	39.0	CHEMBL4128	Homo sapiens	IC50	nM	39.0
	1815325	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCC[C@H](N)C3)c2)cn1		CHEMBL374079	=	IC50	nM	33.0	CHEMBL4128	Homo sapiens	IC50	nM	33.0
	1815326	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL220532	=	IC50	nM	26.0	CHEMBL4128	Homo sapiens	IC50	nM	26.0
	1815327	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	1815328	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN(C)[C@@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL218110	=	IC50	nM	98.0	CHEMBL4128	Homo sapiens	IC50	nM	98.0
	1815329	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	CN1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)CC1		CHEMBL376475	=	IC50	nM	84.0	CHEMBL4128	Homo sapiens	IC50	nM	84.0
	1815330	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	COc1ccc(C#Cc2cnc(N)nc2)cc1C(=O)Nc1cc(C(F)(F)F)ccc1N1CCCCC1		CHEMBL375617	=	IC50	nM	1200.0	CHEMBL4128	Homo sapiens	IC50	nM	1200.0
	1815331	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Nc1ncc(C#Cc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1		CHEMBL374985	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	nM	22.0
	1815332	CHEMBL910169	Inhibition of Ang1-stimulated TIE2 phosphorylation in EA.hy 926 endothelial cell line	F	Nc1ncc(C#Cc2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCCC3)c2)cn1		CHEMBL220482	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	1816523	CHEMBL911993	Inhibition of TIE2 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3		CHEMBL148471	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1816550	CHEMBL911993	Inhibition of TIE2 at 1 uM	B	O=C1NCc2c1c1c3ccccc3sc1c1[nH]c3ccccc3c21		CHEMBL221536	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1816551	CHEMBL911993	Inhibition of TIE2 at 1 uM	B	O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1		CHEMBL357490	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1816552	CHEMBL911993	Inhibition of TIE2 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)CCc1ccccc1-3		CHEMBL374581	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1816553	CHEMBL911993	Inhibition of TIE2 at 1 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1		CHEMBL386636	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	1826435	CHEMBL919912	Inhibition of TIE2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	170.0	CHEMBL4128	Homo sapiens	IC50	nM	170.0
	1849894	CHEMBL914199	Inhibition of Tie2	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1		CHEMBL390156	=	IC50	nM	4600.0	CHEMBL4128	Homo sapiens	IC50	nM	4600.0
	1849906	CHEMBL914199	Inhibition of Tie2	B	COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1		CHEMBL223971	=	IC50	nM	8100.0	CHEMBL4128	Homo sapiens	IC50	nM	8100.0
	1922379	CHEMBL895910	Inhibition of Tie2 kinase	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1		CHEMBL231568	=	IC50	nM	3180.0	CHEMBL4128	Homo sapiens	IC50	uM	3.18
	1926612	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1		CHEMBL243891	=	IC50	nM	3200.0	CHEMBL4128	Homo sapiens	IC50	nM	3200.0
	1926613	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CS(=O)(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1		CHEMBL244300	=	IC50	nM	3200.0	CHEMBL4128	Homo sapiens	IC50	nM	3200.0
	1926614	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CN1CCN(CCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1		CHEMBL390696	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	nM	130.0
	1926615	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CN1CCN(CC(=O)Nc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1		CHEMBL389333	=	IC50	nM	4.9	CHEMBL4128	Homo sapiens	IC50	nM	4.9
	1926616	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COCCOCC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244106	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	1926617	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	O=C(Nc1ccc(Oc2ccc3nc(NC(=O)c4cccnc4)[nH]c3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL244486	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	nM	16.0
	1926618	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL244297	=	IC50	nM	5.2	CHEMBL4128	Homo sapiens	IC50	nM	5.2
	1926619	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	O=C(Nc1ccc(Oc2ccc3nc(NC(=O)c4ccccc4-c4ccc[nH]4)[nH]c3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL243919	=	IC50	nM	1300.0	CHEMBL4128	Homo sapiens	IC50	nM	1300.0
	1926620	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL243917	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	1926621	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL243916	=	IC50	nM	2.6	CHEMBL4128	Homo sapiens	IC50	nM	2.6
	1926622	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL387817	=	IC50	nM	60.0	CHEMBL4128	Homo sapiens	IC50	nM	60.0
	1926623	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ncc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL387604	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	nM	130.0
	1926624	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)nc2[nH]1		CHEMBL244101	=	IC50	nM	5.6	CHEMBL4128	Homo sapiens	IC50	nM	5.6
	1926625	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1cn2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1		CHEMBL243915	=	IC50	nM	3.4	CHEMBL4128	Homo sapiens	IC50	nM	3.4
	1926626	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2o1		CHEMBL243914	=	IC50	nM	8.9	CHEMBL4128	Homo sapiens	IC50	nM	8.9
	1926627	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1		CHEMBL244482	=	IC50	nM	6.5	CHEMBL4128	Homo sapiens	IC50	nM	6.5
	1926628	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1C		CHEMBL244481	=	IC50	nM	5600.0	CHEMBL4128	Homo sapiens	IC50	nM	5600.0
	1926629	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2n1C		CHEMBL244291	=	IC50	nM	60.0	CHEMBL4128	Homo sapiens	IC50	nM	60.0
	1926630	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(C(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244100	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
	1926631	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244099	=	IC50	nM	120.0	CHEMBL4128	Homo sapiens	IC50	nM	120.0
	1926632	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc([S+]([O-])c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244098	=	IC50	nM	69.0	CHEMBL4128	Homo sapiens	IC50	nM	69.0
	1926633	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL243912	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1926634	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)nc3)cc2[nH]1		CHEMBL243911	=	IC50	nM	2.9	CHEMBL4128	Homo sapiens	IC50	nM	2.9
	1926635	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c[n+]3[O-])cc2[nH]1		CHEMBL397757	=	IC50	nM	71.0	CHEMBL4128	Homo sapiens	IC50	nM	71.0
	1926636	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cn3)cc2[nH]1		CHEMBL243910	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	1926637	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1		CHEMBL244289	=	IC50	nM	28.0	CHEMBL4128	Homo sapiens	IC50	nM	28.0
	1926638	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(CC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244288	=	IC50	nM	5400.0	CHEMBL4128	Homo sapiens	IC50	nM	5400.0
	1926639	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Cc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL397756	=	IC50	nM	3200.0	CHEMBL4128	Homo sapiens	IC50	nM	3200.0
	1926640	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244287	=	IC50	nM	3200.0	CHEMBL4128	Homo sapiens	IC50	nM	3200.0
	1926641	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1		CHEMBL244097	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	1926642	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(N)ccc4F)cc3)cc2[nH]1		CHEMBL396284	=	IC50	nM	2190.0	CHEMBL4128	Homo sapiens	IC50	nM	2190.0
	1926643	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(SC)c4)cc3)cc2[nH]1		CHEMBL244096	=	IC50	nM	58.0	CHEMBL4128	Homo sapiens	IC50	nM	58.0
	1926644	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(SC(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244095	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1926645	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(F)ccc4F)cc3)cc2[nH]1		CHEMBL243909	=	IC50	nM	390.0	CHEMBL4128	Homo sapiens	IC50	nM	390.0
	1926646	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1		CHEMBL396283	=	IC50	nM	40.0	CHEMBL4128	Homo sapiens	IC50	nM	40.0
	1926647	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1		CHEMBL243908	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	1926648	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
	1926649	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cc2[nH]1		CHEMBL244286	=	IC50	nM	6.3	CHEMBL4128	Homo sapiens	IC50	nM	6.3
	1926650	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1		CHEMBL396056	=	IC50	nM	6.9	CHEMBL4128	Homo sapiens	IC50	nM	6.9
	1926651	CHEMBL895709	Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244079	=	IC50	nM	5.2	CHEMBL4128	Homo sapiens	IC50	nM	5.2
Not Determined	1926815	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1		CHEMBL243891		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926818	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CS(=O)(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1		CHEMBL244300		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926819	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	O=C(Nc1ccc(Oc2ccc3nc(NC(=O)c4ccccc4-c4ccc[nH]4)[nH]c3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL243919		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926820	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1C		CHEMBL244481		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926821	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(C(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244100		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926822	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(CC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244288		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926823	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Cc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL397756		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926824	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1		CHEMBL244097		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	1926825	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(N)ccc4F)cc3)cc2[nH]1		CHEMBL396284		IC50			CHEMBL4128	Homo sapiens	IC50		
	1926826	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244079	=	IC50	nM	2.6	CHEMBL4128	Homo sapiens	IC50	nM	2.6
	1926827	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CN1CCN(CCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1		CHEMBL390696	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	nM	430.0
	1926828	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CN1CCN(CC(=O)Nc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1		CHEMBL389333	=	IC50	nM	5.9	CHEMBL4128	Homo sapiens	IC50	nM	5.9
	1926829	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COCCOCC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244106	=	IC50	nM	2.8	CHEMBL4128	Homo sapiens	IC50	nM	2.8
	1926830	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	O=C(Nc1ccc(Oc2ccc3nc(NC(=O)c4cccnc4)[nH]c3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL244486	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	1926831	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL244297	=	IC50	nM	6.2	CHEMBL4128	Homo sapiens	IC50	nM	6.2
	1926832	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL243917	=	IC50	nM	120.0	CHEMBL4128	Homo sapiens	IC50	nM	120.0
	1926833	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL243916	=	IC50	nM	3.3	CHEMBL4128	Homo sapiens	IC50	nM	3.3
	1926834	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL387817	=	IC50	nM	1100.0	CHEMBL4128	Homo sapiens	IC50	nM	1100.0
	1926835	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ncc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL387604	=	IC50	nM	91.0	CHEMBL4128	Homo sapiens	IC50	nM	91.0
	1926836	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)nc2[nH]1		CHEMBL244101	=	IC50	nM	6.5	CHEMBL4128	Homo sapiens	IC50	nM	6.5
	1926837	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1cn2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1		CHEMBL243915	=	IC50	nM	1.5	CHEMBL4128	Homo sapiens	IC50	nM	1.5
	1926838	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2o1		CHEMBL243914	=	IC50	nM	3.7	CHEMBL4128	Homo sapiens	IC50	nM	3.7
	1926839	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1		CHEMBL244482	=	IC50	nM	7.2	CHEMBL4128	Homo sapiens	IC50	nM	7.2
	1926840	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2n1C		CHEMBL244291	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
	1926841	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244099	=	IC50	nM	160.0	CHEMBL4128	Homo sapiens	IC50	nM	160.0
	1926842	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc([S+]([O-])c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL244098	=	IC50	nM	60.0	CHEMBL4128	Homo sapiens	IC50	nM	60.0
	1926843	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1		CHEMBL243912	=	IC50	nM	76.0	CHEMBL4128	Homo sapiens	IC50	nM	76.0
	1926844	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)nc3)cc2[nH]1		CHEMBL243911	=	IC50	nM	6.4	CHEMBL4128	Homo sapiens	IC50	nM	6.4
	1926845	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c[n+]3[O-])cc2[nH]1		CHEMBL397757	=	IC50	nM	350.0	CHEMBL4128	Homo sapiens	IC50	nM	350.0
	1926846	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cn3)cc2[nH]1		CHEMBL243910	=	IC50	nM	81.0	CHEMBL4128	Homo sapiens	IC50	nM	81.0
	1926847	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1		CHEMBL244289	=	IC50	nM	81.0	CHEMBL4128	Homo sapiens	IC50	nM	81.0
	1926848	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244287	=	IC50	nM	680.0	CHEMBL4128	Homo sapiens	IC50	nM	680.0
	1926849	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(SC)c4)cc3)cc2[nH]1		CHEMBL244096	=	IC50	nM	56.0	CHEMBL4128	Homo sapiens	IC50	nM	56.0
	1926850	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(SC(F)(F)F)c4)cc3)cc2[nH]1		CHEMBL244095	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
	1926851	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(F)ccc4F)cc3)cc2[nH]1		CHEMBL243909	=	IC50	nM	71.0	CHEMBL4128	Homo sapiens	IC50	nM	71.0
	1926852	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1		CHEMBL396283	=	IC50	nM	50.0	CHEMBL4128	Homo sapiens	IC50	nM	50.0
	1926853	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1		CHEMBL243908	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	1926854	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	IC50	nM	170.0	CHEMBL4128	Homo sapiens	IC50	nM	170.0
	1926855	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cc2[nH]1		CHEMBL244286	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	1926856	CHEMBL895711	Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1		CHEMBL396056	=	IC50	nM	8.7	CHEMBL4128	Homo sapiens	IC50	nM	8.7
	1964242	CHEMBL897080	Inhibition of Tie2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	pIC50		5.0
	1964252	CHEMBL897080	Inhibition of Tie2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	pIC50		5.0
	1964489	CHEMBL897112	Inhibition of Tie2	B	CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL232542	>	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	uM	50.0
	1964494	CHEMBL897112	Inhibition of Tie2	B	COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395664	=	IC50	nM	3700.0	CHEMBL4128	Homo sapiens	IC50	uM	3.7
	1964499	CHEMBL897112	Inhibition of Tie2	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395665	=	IC50	nM	1900.0	CHEMBL4128	Homo sapiens	IC50	uM	1.9
	1964504	CHEMBL897112	Inhibition of Tie2	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395666	=	IC50	nM	570.0	CHEMBL4128	Homo sapiens	IC50	uM	0.57
	1964509	CHEMBL897112	Inhibition of Tie2	B	COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233958	=	IC50	nM	10100.0	CHEMBL4128	Homo sapiens	IC50	uM	10.1
	1978360	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	nM	20000.0
	1978361	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	CCCn1c(-c2ccc([S+](C)[O-])cc2)nc(-c2ccncc2)c1-c1ccc2cc(OC)ccc2c1		CHEMBL237565	=	IC50	nM	437.0	CHEMBL4128	Homo sapiens	IC50	nM	437.0
	1978362	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3CC(C)C)ccc2c1		CHEMBL237564	=	IC50	nM	3890.0	CHEMBL4128	Homo sapiens	IC50	nM	3890.0
	1978363	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	CCn1c(-c2ccc([S+](C)[O-])cc2)nc(-c2ccncc2)c1-c1ccc2cc(OC)ccc2c1		CHEMBL237353	=	IC50	nM	5370.0	CHEMBL4128	Homo sapiens	IC50	nM	5370.0
	1978364	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	COc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4)n(C)c3-c3ccncc3)ccc2c1		CHEMBL237358	=	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	nM	20000.0
	1978365	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	IC50	nM	60.0	CHEMBL4128	Homo sapiens	IC50	nM	60.0
	1978366	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	COc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4)[nH]c3-c3ccncc3)ccc2c1		CHEMBL237352	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	1978367	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	Cc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4)[nH]c3-c3ccncc3)ccc2c1		CHEMBL400840	=	IC50	nM	219.0	CHEMBL4128	Homo sapiens	IC50	nM	219.0
	1978368	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc4cc(-c5ccccc5)ccc4c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL237351	=	IC50	nM	5500.0	CHEMBL4128	Homo sapiens	IC50	nM	5500.0
	1978369	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc4cc(Br)ccc4c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL400839	=	IC50	nM	339.0	CHEMBL4128	Homo sapiens	IC50	nM	339.0
	1978370	CHEMBL897815	Inhibition of Tie2 kinase by autophosphorylation assay	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc4ccccc4c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17023	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	nM	300.0
	1986185	CHEMBL899825	Inhibition of Tie2 at 10 uM	B	COc1ccc2cc(-c3nc(-c4ccccc4)[nH]c3-c3ccncc3)ccc2c1		CHEMBL391697	=	Inhibition	%	60.0	CHEMBL4128	Homo sapiens	Inhibition	%	60.0
	1986186	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236686	=	IC50	nM	387.0	CHEMBL4128	Homo sapiens	IC50	nM	387.0
	1986187	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	IC50	nM	114.0	CHEMBL4128	Homo sapiens	IC50	nM	114.0
	1986188	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	IC50	nM	12.0	CHEMBL4128	Homo sapiens	IC50	nM	12.0
	1986189	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(SC)cc4C)n3C)ccc2c1		CHEMBL237359	=	IC50	nM	335.0	CHEMBL4128	Homo sapiens	IC50	nM	335.0
	1986190	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc(S(C)(=O)=O)cc4Cl)[nH]c3-c3ccncc3)ccc2c1		CHEMBL392332	=	IC50	nM	59.0	CHEMBL4128	Homo sapiens	IC50	nM	59.0
	1986191	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4Cl)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236924	=	IC50	nM	51.0	CHEMBL4128	Homo sapiens	IC50	nM	51.0
	1986192	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc(SC)cc4Cl)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236717	=	IC50	nM	1500.0	CHEMBL4128	Homo sapiens	IC50	nM	1500.0
	1986193	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc(S(C)(=O)=O)cc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL391891	=	IC50	nM	40.0	CHEMBL4128	Homo sapiens	IC50	nM	40.0
	1986194	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236716	=	IC50	nM	36.0	CHEMBL4128	Homo sapiens	IC50	nM	36.0
	1986195	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc(SC)cc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236715	=	IC50	nM	1300.0	CHEMBL4128	Homo sapiens	IC50	nM	1300.0
	1986196	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	IC50	nM	60.0	CHEMBL4128	Homo sapiens	IC50	nM	60.0
	1986197	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc(S(C)(=O)=O)cc4)[nH]c3-c3ccncc3)ccc2c1		CHEMBL391890	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	1986198	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4C(C)C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236505	=	IC50	nM	836.0	CHEMBL4128	Homo sapiens	IC50	nM	836.0
	1986199	CHEMBL899826	Inhibition of Tie2	B	CCc1ccccc1-c1nc(-c2ccc3cc(OC)ccc3c2)c(-c2ccncc2)[nH]1		CHEMBL236504	=	IC50	nM	346.0	CHEMBL4128	Homo sapiens	IC50	nM	346.0
	1986200	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4c(Cl)cccc4Cl)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236503	=	IC50	nM	78.0	CHEMBL4128	Homo sapiens	IC50	nM	78.0
	1986201	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4C(F)(F)F)[nH]c3-c3ccncc3)ccc2c1		CHEMBL391889	=	IC50	nM	260.0	CHEMBL4128	Homo sapiens	IC50	nM	260.0
	1986202	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4Br)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236300	=	IC50	nM	82.0	CHEMBL4128	Homo sapiens	IC50	nM	82.0
	1986203	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4Cl)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236299	=	IC50	nM	157.0	CHEMBL4128	Homo sapiens	IC50	nM	157.0
	1986204	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccccc4F)[nH]c3-c3ccncc3)ccc2c1		CHEMBL236298	=	IC50	nM	1600.0	CHEMBL4128	Homo sapiens	IC50	nM	1600.0
	1986224	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc([S+](C)[O-])cc4)[nH]c3-c3ccncc3)ccc2c1		CHEMBL237352	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	nM	20000.0
	1986225	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc([S@+](C)[O-])cc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL2448122	=	IC50	nM	95.0	CHEMBL4128	Homo sapiens	IC50	nM	95.0
	1986226	CHEMBL899826	Inhibition of Tie2	B	COc1ccc2cc(-c3nc(-c4ccc([S@@+](C)[O-])cc4C)[nH]c3-c3ccncc3)ccc2c1		CHEMBL2096892	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	nM	22.0
Active	1989339	CHEMBL899082	Inhibitory of TIE2	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127		Activity			CHEMBL4128	Homo sapiens	Activity		
Active	1989340	CHEMBL899082	Inhibitory of TIE2	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(CN4CCOCC4)n3)c(S(C)(=O)=O)cc12		CHEMBL399208		Activity			CHEMBL4128	Homo sapiens	Activity		
Active	1989341	CHEMBL899082	Inhibitory of TIE2	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347		Activity			CHEMBL4128	Homo sapiens	Activity		
	1996177	CHEMBL898752	Inhibition of Tek at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	<	Inhibition	%	30.0	CHEMBL4128	Homo sapiens	Inhibition	%	30.0
	2000783	CHEMBL901558	Inhibition of TIE2 at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1	Outside typical range	CHEMBL240158	=	Inhibition	%	-51.7	CHEMBL4128	Homo sapiens	Inhibition	%	-51.7
	2000804	CHEMBL901558	Inhibition of TIE2 at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	90.9	CHEMBL4128	Homo sapiens	Inhibition	%	90.9
	2011584	CHEMBL902103	Inhibition of human recombinant GST-Tie2 by HTRF method	B	Nc1ncc(-c2ccccc2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241681	=	IC50	nM	46.0	CHEMBL4128	Homo sapiens	IC50	nM	46.0
	2011585	CHEMBL902103	Inhibition of human recombinant GST-Tie2 by HTRF method	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241682	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	2011586	CHEMBL902103	Inhibition of human recombinant GST-Tie2 by HTRF method	B	Nc1ncc(-c2cccc(Cl)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL391692	=	IC50	nM	2188.0	CHEMBL4128	Homo sapiens	IC50	nM	2188.0
	2011604	CHEMBL902103	Inhibition of human recombinant GST-Tie2 by HTRF method	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	2019931	CHEMBL903334	Inhibition of Tie2	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
Not Determined	2021657	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1		CHEMBL194911		Log IC50			CHEMBL4128	Homo sapiens	Log IC50		
	2021658	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	13.49	CHEMBL4128	Homo sapiens	Log IC50		-7.87
	2021660	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	IC50	nM	81.28	CHEMBL4128	Homo sapiens	Log IC50		-7.09
	2021661	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc5ccccc45)cc3)c12		CHEMBL247252	=	IC50	nM	181.97	CHEMBL4128	Homo sapiens	Log IC50		-6.74
	2021662	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	COc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL391184	=	IC50	nM	223.87	CHEMBL4128	Homo sapiens	Log IC50		-6.65
	2021663	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	=	IC50	nM	204.17	CHEMBL4128	Homo sapiens	Log IC50		-6.69
	2021664	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	IC50	nM	10.23	CHEMBL4128	Homo sapiens	Log IC50		-7.99
	2021665	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Oc5ccccc5)c4)cc3)c12		CHEMBL247790	=	IC50	nM	407.38	CHEMBL4128	Homo sapiens	Log IC50		-6.39
	2021666	CHEMBL902485	Inhibition of human Tie2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	IC50	nM	380.19	CHEMBL4128	Homo sapiens	Log IC50		-6.42
	2021676	CHEMBL903552	Inhibition of c-fms/Tie2 chimeric receptor transfected in 3T3 cell assessed as autophosphorylation activity	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	18.3	CHEMBL4128	Homo sapiens	IC50	nM	18.3
	2022210	CHEMBL886501	Inhibition of Tie2	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1		CHEMBL247468	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	uM	25.0
	2022218	CHEMBL886501	Inhibition of Tie2	B	CC(C)Nc1ncnc2oc(-c3ccc(OCCN4CCCC4)cc3)c(-c3ccccc3)c12		CHEMBL247866	>	IC50	nM	8333.0	CHEMBL4128	Homo sapiens	IC50	uM	8.333
	2025203	CHEMBL887031	Inhibition of human Tie2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	109.0	CHEMBL4128	Homo sapiens	Inhibition	%	109.0
	2025501	CHEMBL887031	Inhibition of human Tie2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	110.0	CHEMBL4128	Homo sapiens	Inhibition	%	110.0
	2025502	CHEMBL887031	Inhibition of human Tie2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	107.0	CHEMBL4128	Homo sapiens	Inhibition	%	107.0
	2025503	CHEMBL887031	Inhibition of human Tie2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	96.0	CHEMBL4128	Homo sapiens	Inhibition	%	96.0
	2025921	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	Cc1ccc(C(=O)Nc2cc(CCCN(C)C)cc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL221484	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2025923	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)F)c3)ccc2C)n1		CHEMBL246152	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	2025925	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)F)c3)ccc2C)n1		CHEMBL246152	=	IC50	nM	15.0	CHEMBL4128	Homo sapiens	IC50	nM	15.0
	2025928	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1cc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)ccn1		CHEMBL397090	=	IC50	nM	9.0	CHEMBL4128	Homo sapiens	IC50	nM	9.0
	2025929	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1		CHEMBL246356	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	nM	16.0
	2025930	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(-n4cccc4)c3)ccc2C)n1		CHEMBL246355	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	2025931	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2C)n1		CHEMBL397089	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	2025932	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1cc(-c2cccnc2Oc2ccc(Cl)c(NC(=O)c3cccc(C(C)C)c3)c2)ccn1		CHEMBL246151	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
	2025933	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1cc(-c2cccnc2Oc2cccc(NC(=O)c3cccc(C(C)C)c3)c2)ccn1		CHEMBL246150	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	2025934	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)cc(C(F)(F)F)c2)n1		CHEMBL245949	=	IC50	nM	55.0	CHEMBL4128	Homo sapiens	IC50	nM	55.0
	2025935	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2F)n1		CHEMBL394694	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	2025936	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cccc(NC(=O)c3cccc(C(C)C)c3)c2)n1		CHEMBL245948	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
	2025937	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1cc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)ccn1		CHEMBL245947	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2025938	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)n1		CHEMBL245746	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2025939	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)n1		CHEMBL394693	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2025940	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1cc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(C)C)c3)ccc2C)ccn1		CHEMBL245745	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	2025941	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(C)C)c3)ccc2C)n1		CHEMBL245744	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2025942	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(C)C)c3)ccc2C)n1		CHEMBL394692	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	2025943	CHEMBL887076	Inhibition of Tie2 after 90 mins by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL245549	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	2025960	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1cc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)ccn1		CHEMBL397090	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	2025961	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1		CHEMBL246356	=	IC50	nM	33.0	CHEMBL4128	Homo sapiens	IC50	nM	33.0
	2025962	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(-n4cccc4)c3)ccc2C)n1		CHEMBL246355	=	IC50	nM	23.0	CHEMBL4128	Homo sapiens	IC50	nM	23.0
	2025963	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1ncnc(-c2cccnc2Oc2cccc(NC(=O)c3cccc(C(C)C)c3)c2)n1		CHEMBL245948	=	IC50	nM	85.0	CHEMBL4128	Homo sapiens	IC50	nM	85.0
	2025964	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1cc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)ccn1		CHEMBL245947	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
	2025965	CHEMBL887078	Inhibition of Tie2 autophosphorylation in EA.hy926 cells after 2.5 hrs	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(C(C)C)c3)ccc2C)n1		CHEMBL245746	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	2027326	CHEMBL906394	Inhibition of Tie2 by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245769	=	IC50	nM	40595.0	CHEMBL4128	Homo sapiens	IC50	uM	40.595
	2027340	CHEMBL906394	Inhibition of Tie2 by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1		CHEMBL245377	=	IC50	nM	4877.0	CHEMBL4128	Homo sapiens	IC50	uM	4.877
	2027341	CHEMBL906394	Inhibition of Tie2 by HTRF assay	B	CCOC(=O)CC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL395427	>	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	uM	50.0
	2027342	CHEMBL906394	Inhibition of Tie2 by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL246166	=	IC50	nM	24747.0	CHEMBL4128	Homo sapiens	IC50	uM	24.747
	2027343	CHEMBL906394	Inhibition of Tie2 by HTRF assay	B	COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245968	=	IC50	nM	13025.0	CHEMBL4128	Homo sapiens	IC50	uM	13.025
	2029844	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030048	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030049	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030050	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030051	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030052	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030053	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030054	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030055	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030056	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030057	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030058	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030059	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030060	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2030061	CHEMBL886311	Inhibition of TIE2 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	Inhibition	%	40.0
	2080197	CHEMBL929552	Inhibition of Tie2	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	uM	0.3
	2081885	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
	2081887	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3c(F)cccc3C(F)(F)F)cc2)cc1		CHEMBL401860	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2081889	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	Cn1cc2c(n1)CCc1c-2c2c(c3c1[nH]c1ccccc13)CNC2=O		CHEMBL258437	=	IC50	nM	1300.0	CHEMBL4128	Homo sapiens	IC50	uM	1.3
	2081890	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL257787	=	IC50	nM	148.0	CHEMBL4128	Homo sapiens	IC50	nM	148.0
	2081891	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCn1c2ccc(/C(C)=N/OCC(C)C)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401897	=	IC50	nM	45.0	CHEMBL4128	Homo sapiens	IC50	nM	45.0
	2081892	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OCC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258436	=	IC50	nM	46.0	CHEMBL4128	Homo sapiens	IC50	nM	46.0
	2081893	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL429138	=	IC50	nM	66.0	CHEMBL4128	Homo sapiens	IC50	nM	66.0
	2081894	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401896	=	IC50	nM	26.0	CHEMBL4128	Homo sapiens	IC50	nM	26.0
	2081895	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OCC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258222	=	IC50	nM	23.0	CHEMBL4128	Homo sapiens	IC50	nM	23.0
	2081896	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OC(C)C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL403823	=	IC50	nM	52.0	CHEMBL4128	Homo sapiens	IC50	nM	52.0
	2081897	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL428433	=	IC50	nM	25.0	CHEMBL4128	Homo sapiens	IC50	nM	25.0
	2081898	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCCCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL403606	=	IC50	nM	108.0	CHEMBL4128	Homo sapiens	IC50	nM	108.0
	2081899	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	=	IC50	nM	30.0	CHEMBL4128	Homo sapiens	IC50	nM	30.0
	2081900	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401876	=	IC50	nM	97.0	CHEMBL4128	Homo sapiens	IC50	nM	97.0
	2081901	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258014	=	IC50	nM	30.0	CHEMBL4128	Homo sapiens	IC50	nM	30.0
	2081902	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCn1c2ccc(/C(C)=N/OC)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255283	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	nM	300.0
	2081903	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255282	=	IC50	nM	347.0	CHEMBL4128	Homo sapiens	IC50	nM	347.0
	2081904	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OC(C)(C)C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL255281	=	IC50	nM	93.0	CHEMBL4128	Homo sapiens	IC50	nM	93.0
	2081905	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OCC(C)C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL258433	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	2081906	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\OC(C)C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL258000	=	IC50	nM	28.0	CHEMBL4128	Homo sapiens	IC50	nM	28.0
	2081907	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	C/C(=N\O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL404322	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	nM	44.0
	2081908	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCO/N=C(/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4)C(C)C		CHEMBL257794	=	IC50	nM	92.0	CHEMBL4128	Homo sapiens	IC50	nM	92.0
	2081909	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C(/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4)C(C)C		CHEMBL257793	=	IC50	nM	264.0	CHEMBL4128	Homo sapiens	IC50	nM	264.0
	2081910	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL404718	=	IC50	nM	23.0	CHEMBL4128	Homo sapiens	IC50	nM	23.0
	2081911	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CO/N=C(\C)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL257789	=	IC50	nM	71.0	CHEMBL4128	Homo sapiens	IC50	nM	71.0
	2081912	CHEMBL929872	Inhibition of human recombinant TIE2 by HTRF assay	B	CCO/N=C/c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL257788	=	IC50	nM	264.0	CHEMBL4128	Homo sapiens	IC50	nM	264.0
	2096361	CHEMBL948992	Inhibition of Tie2	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2096383	CHEMBL948992	Inhibition of Tie2	B	COc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2F)ccc1C		CHEMBL257858	=	IC50	nM	3440.0	CHEMBL4128	Homo sapiens	IC50	nM	3440.0
	2096385	CHEMBL948992	Inhibition of Tie2	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(OC)n1		CHEMBL271018	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096402	CHEMBL948992	Inhibition of Tie2	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(NC)n1		CHEMBL269936	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096403	CHEMBL948992	Inhibition of Tie2	B	COc1nc(NCCCCN(C)C)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255132	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096404	CHEMBL948992	Inhibition of Tie2	B	COc1nc(NCCCN2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255989	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096405	CHEMBL948992	Inhibition of Tie2	B	COc1nc(NCCN2CCOCC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL270793	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096406	CHEMBL948992	Inhibition of Tie2	B	COc1nc(NC2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL271650	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096407	CHEMBL948992	Inhibition of Tie2	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(NCCN2CCOCC2)nc1Oc1ccccc1		CHEMBL408292	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096408	CHEMBL948992	Inhibition of Tie2	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(Oc2ccccc2)n1		CHEMBL271099	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096409	CHEMBL948992	Inhibition of Tie2	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3C)ccc2C)c(OC)n1		CHEMBL271101	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2096410	CHEMBL948992	Inhibition of Tie2	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(OC)n1		CHEMBL255533	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
Not Active	2102900	CHEMBL931009	Inhibition of Tie2 upto 50 uM	B	CCOC(=O)c1cc2ccc3c4cccc(Cl)c4[nH]c3c2[nH]1		CHEMBL272186		Activity			CHEMBL4128	Homo sapiens	Activity		
	2109088	CHEMBL947976	Inhibition of TIE2 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	=	IC50	nM	249.0	CHEMBL4128	Homo sapiens	IC50	nM	249.0
	2109098	CHEMBL947976	Inhibition of TIE2 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2109099	CHEMBL947976	Inhibition of TIE2 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	=	IC50	nM	270.0	CHEMBL4128	Homo sapiens	IC50	nM	270.0
	2112053	CHEMBL934204	Inhibition of Tie-2 by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL410295	=	IC50	nM	750.0	CHEMBL4128	Homo sapiens	IC50	uM	0.75
	2118813	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)c2cc1OC		CHEMBL429430	=	IC50	nM	386.0	CHEMBL4128	Homo sapiens	IC50	nM	386.0
	2118861	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)N[C@H](C)c3ccccc3)c2cc1OC		CHEMBL409933	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118862	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)N[C@@H](C)c3ccccc3)c2cc1OC		CHEMBL270306	=	IC50	nM	260.0	CHEMBL4128	Homo sapiens	IC50	nM	260.0
	2118863	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)NCc3ccc(C)cc3)c2cc1OC		CHEMBL270093	=	IC50	nM	1500.0	CHEMBL4128	Homo sapiens	IC50	nM	1500.0
	2118864	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)NCc3ccccc3)c2cc1OC		CHEMBL272874	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118865	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)NC(C)C)c2cc1OC		CHEMBL270545	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118866	CHEMBL950177	Inhibition of Tie2	B	CCNC(=O)N1CCOc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc21		CHEMBL272875	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118867	CHEMBL950177	Inhibition of Tie2	B	CNC(=O)N1CCOc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc21		CHEMBL272609	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118868	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(N)=O)c2cc1OC		CHEMBL405040	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118869	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3)c2cc1OC		CHEMBL272822	=	IC50	nM	1500.0	CHEMBL4128	Homo sapiens	IC50	nM	1500.0
	2118870	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(Cl)cc3)c2cc1OC		CHEMBL270548	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
	2118871	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3cccc(Cl)c3)c2cc1OC		CHEMBL272878	=	IC50	nM	9.0	CHEMBL4128	Homo sapiens	IC50	nM	9.0
	2118872	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccccc3Cl)c2cc1OC		CHEMBL270550	=	IC50	nM	2200.0	CHEMBL4128	Homo sapiens	IC50	nM	2200.0
	2118873	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(C)cc3)c2cc1OC		CHEMBL411630	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2118874	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3cccc(C)c3)c2cc1OC		CHEMBL270057	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2118875	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C)c2cc1OC		CHEMBL270058	=	IC50	nM	1600.0	CHEMBL4128	Homo sapiens	IC50	nM	1600.0
	2118912	CHEMBL950177	Inhibition of Tie2	B	CNC(=O)c1cc(Oc2ccc3c(c2)OCCN3C(=O)Nc2ccc(C)cc2)ccn1		CHEMBL272688	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118913	CHEMBL950177	Inhibition of Tie2	B	CNC(=O)c1cc(Oc2ccc3c(c2)OCCN3C(=O)Nc2ccc(Cl)cc2)ccn1		CHEMBL271960	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118914	CHEMBL950177	Inhibition of Tie2	B	Cc1ccc(NC(=O)N2CCOc3cc(Oc4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL272170	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118915	CHEMBL950177	Inhibition of Tie2	B	O=C(Nc1ccc(Cl)cc1)N1CCOc2cc(Oc3ncnc4[nH]ccc34)ccc21		CHEMBL270953	>	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2118916	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(C)cc3)c2cc1C(N)=O		CHEMBL270954	=	IC50	nM	430.0	CHEMBL4128	Homo sapiens	IC50	nM	430.0
	2118917	CHEMBL950177	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(c3)OCCN4C(=O)Nc3ccc(Cl)cc3)c2cc1C(N)=O		CHEMBL409867	=	IC50	nM	290.0	CHEMBL4128	Homo sapiens	IC50	nM	290.0
	2120246	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2120276	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4c(Cl)cccc4Cl)cn3)cc2)CC1		CHEMBL541726	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120277	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)c(C)c1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL438016	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120278	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	CCc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL270765	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120279	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4cc(NC(=O)c5ccc6c(c5)OC(F)(F)O6)ccc4Cl)cn3)cc2)CC1		CHEMBL271154	>	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	nM	5000.0
	2120280	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	COc1cc(OC)cc(C(=O)Nc2ccc(C)c(C(=O)Nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3)c2)c1		CHEMBL272850	>	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120281	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405401	>	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120282	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271141	>	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120283	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271140	>	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120284	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	COc1ccccc1C(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL409734	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120285	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2ccccc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271760	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120286	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cnoc2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL411050	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120287	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	CC(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL271201	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120288	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NC2CCN(C)CC2)nc1		CHEMBL271372	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120289	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCN2CCOCC2)nc1		CHEMBL272673	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120290	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCCN2CCOCC2)nc1		CHEMBL259465	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120291	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL259247	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120292	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405666	>	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120293	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL271375	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120294	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL411632	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120295	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL272902	>	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	nM	5000.0
	2120370	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cc(F)cc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL407063	=	IC50	nM	6078.0	CHEMBL4128	Homo sapiens	IC50	nM	6078.0
	2120371	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL409914	=	IC50	nM	93.0	CHEMBL4128	Homo sapiens	IC50	nM	93.0
	2120372	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	=	IC50	nM	9950.0	CHEMBL4128	Homo sapiens	IC50	nM	9950.0
	2120373	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL429582	=	IC50	nM	21.0	CHEMBL4128	Homo sapiens	IC50	nM	21.0
	2120374	CHEMBL951932	Inhibition of Tie2 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL408070	=	IC50	nM	123.0	CHEMBL4128	Homo sapiens	IC50	nM	123.0
	2120631	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	580.0	CHEMBL4128	Homo sapiens	IC50	nM	580.0
	2120632	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1C(N)=O		CHEMBL260532	=	IC50	nM	5300.0	CHEMBL4128	Homo sapiens	IC50	nM	5300.0
	2120633	CHEMBL951281	Inhibition of Tie2	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(C(N)=O)cc34)ccc12		CHEMBL260531	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120634	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1C(N)=O		CHEMBL272250	=	IC50	nM	1800.0	CHEMBL4128	Homo sapiens	IC50	nM	1800.0
	2120635	CHEMBL951281	Inhibition of Tie2	B	COc1ccc2c(Oc3ccc4c(C(N)=O)cccc4c3)ccnc2c1		CHEMBL272252	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120636	CHEMBL951281	Inhibition of Tie2	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)ccc34)ccc12		CHEMBL272251	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120637	CHEMBL951281	Inhibition of Tie2	B	COc1ccc2c(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)ccnc2c1		CHEMBL270342	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120638	CHEMBL951281	Inhibition of Tie2	B	COc1cc2ncnc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL270556	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120639	CHEMBL951281	Inhibition of Tie2	B	COCCNC(=O)c1cccc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12		CHEMBL412278	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120640	CHEMBL951281	Inhibition of Tie2	B	COc1cc2ncnc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL411284	=	IC50	nM	7400.0	CHEMBL4128	Homo sapiens	IC50	nM	7400.0
	2120641	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120642	CHEMBL951281	Inhibition of Tie2	B	COCCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271189	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	nM	8300.0
	2120643	CHEMBL951281	Inhibition of Tie2	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120644	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC(F)(F)F)cccc4c3)c2cc1OC		CHEMBL410840	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120645	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)(C)C)cccc4c3)c2cc1OC		CHEMBL406914	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120646	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)C)cccc4c3)c2cc1OC		CHEMBL408211	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120647	CHEMBL951281	Inhibition of Tie2	B	CCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL409103	=	IC50	nM	4300.0	CHEMBL4128	Homo sapiens	IC50	nM	4300.0
	2120648	CHEMBL951281	Inhibition of Tie2	B	CCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL269871	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120649	CHEMBL951281	Inhibition of Tie2	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL270754	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2120650	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC5CC5)cccc4c3)c2cc1OC		CHEMBL270755	=	IC50	nM	9400.0	CHEMBL4128	Homo sapiens	IC50	nM	9400.0
	2120651	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5(C)CC5)cccc4c3)c2cc1OC		CHEMBL428961	=	IC50	nM	1100.0	CHEMBL4128	Homo sapiens	IC50	nM	1100.0
	2120652	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCCC5)cccc4c3)c2cc1OC		CHEMBL410903	=	IC50	nM	1400.0	CHEMBL4128	Homo sapiens	IC50	nM	1400.0
	2120653	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCC5)cccc4c3)c2cc1OC		CHEMBL259252	=	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	nM	4000.0
	2120654	CHEMBL951281	Inhibition of Tie2	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	nM	25000.0
	2122333	CHEMBL950344	Inhibition of TIE2	B	Cn1cc2c(n1)CCc1c-2c2c(c3c1[nH]c1ccccc13)CNC2=O		CHEMBL258437	=	IC50	nM	1357.0	CHEMBL4128	Homo sapiens	IC50	nM	1357.0
	2122335	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3ccoc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL411520	=	IC50	nM	58.0	CHEMBL4128	Homo sapiens	IC50	nM	58.0
	2122336	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3ccco3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL410100	=	IC50	nM	72.0	CHEMBL4128	Homo sapiens	IC50	nM	72.0
	2122337	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3ccsc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL271849	=	IC50	nM	63.0	CHEMBL4128	Homo sapiens	IC50	nM	63.0
	2122338	CHEMBL950344	Inhibition of TIE2	B	Cc1csc(C(=O)c2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)c1		CHEMBL271861	=	IC50	nM	43.0	CHEMBL4128	Homo sapiens	IC50	nM	43.0
	2122339	CHEMBL950344	Inhibition of TIE2	B	Cc1ccsc1C(=O)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401881	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	2122340	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3sccc3Br)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL403158	=	IC50	nM	15.0	CHEMBL4128	Homo sapiens	IC50	nM	15.0
	2122341	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3sccc3Cl)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL269924	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
	2122342	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL444105	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	2122343	CHEMBL950344	Inhibition of TIE2	B	CC(C)n1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL402182	=	IC50	nM	24.0	CHEMBL4128	Homo sapiens	IC50	nM	24.0
	2122344	CHEMBL950344	Inhibition of TIE2	B	CCCn1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255959	=	IC50	nM	26.0	CHEMBL4128	Homo sapiens	IC50	nM	26.0
	2122345	CHEMBL950344	Inhibition of TIE2	B	CCn1c2ccc(C(=O)c3cccs3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL402531	=	IC50	nM	43.0	CHEMBL4128	Homo sapiens	IC50	nM	43.0
	2122346	CHEMBL950344	Inhibition of TIE2	B	Cn1cc2c(n1)CCc1c-2c2c(c3c1[nH]c1ccc(C(=O)c4cccs4)cc13)CNC2=O		CHEMBL428876	=	IC50	nM	136.0	CHEMBL4128	Homo sapiens	IC50	nM	136.0
	2122347	CHEMBL950344	Inhibition of TIE2	B	CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401900	=	IC50	nM	83.0	CHEMBL4128	Homo sapiens	IC50	nM	83.0
	2122348	CHEMBL950344	Inhibition of TIE2	B	CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255404	=	IC50	nM	726.0	CHEMBL4128	Homo sapiens	IC50	nM	726.0
	2122349	CHEMBL950344	Inhibition of TIE2	B	CCCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255405	=	IC50	nM	272.0	CHEMBL4128	Homo sapiens	IC50	nM	272.0
	2122350	CHEMBL950344	Inhibition of TIE2	B	CC(=O)c1ccc2c(c1)c1c3c(c4c(c1n2C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL271301	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	2122351	CHEMBL950344	Inhibition of TIE2	B	CC(C)Cn1c2ccccc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL270827	=	IC50	nM	372.0	CHEMBL4128	Homo sapiens	IC50	nM	372.0
	2122352	CHEMBL950344	Inhibition of TIE2	B	CCCn1c2ccccc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL271042	=	IC50	nM	136.0	CHEMBL4128	Homo sapiens	IC50	nM	136.0
	2122353	CHEMBL950344	Inhibition of TIE2	B	CCn1c2ccccc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL270828	=	IC50	nM	1101.0	CHEMBL4128	Homo sapiens	IC50	nM	1101.0
	2122354	CHEMBL950344	Inhibition of TIE2	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCOC(=O)CN(C)C)Cc1ccccc1-4)C(=O)NC3		CHEMBL346631	=	IC50	nM	1357.0	CHEMBL4128	Homo sapiens	IC50	nM	1357.0
	2122378	CHEMBL950345	Inhibition of TIE2 at 1000 nM	B	CC(=O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL404497	=	Inhibition	%	28.0	CHEMBL4128	Homo sapiens	Inhibition	%	28.0
	2122379	CHEMBL950345	Inhibition of TIE2 at 1000 nM	B	CCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL406909	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	Inhibition	%	50.0
	2122380	CHEMBL950346	Inhibition of TIE2 at 300 nM	B	CCCCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255406	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	Inhibition	%	50.0
	2122424	CHEMBL950344	Inhibition of TIE2	B	CC(=O)c1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1cn(C)nc1CC4		CHEMBL404497	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2122425	CHEMBL950344	Inhibition of TIE2	B	CCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL406909	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2122426	CHEMBL950344	Inhibition of TIE2	B	CCCCn1c2ccc(C(C)=O)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL255406	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	nM	300.0
	2137220	CHEMBL920959	Inhibition of Tie2	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	2147400	CHEMBL922186	Activity of human Tie2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	51.0	CHEMBL4128	Homo sapiens	Activity	%	51.0
	2167938	CHEMBL924790	Inhibition of Tie2 at 100 nM	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Inhibition	%	81.0	CHEMBL4128	Homo sapiens	Inhibition	%	81.0
	2182837	CHEMBL941463	Inhibition of TEK at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	INH	%	12.0
	2197998	CHEMBL1005540	Inhibition of Tel-fused Tie2 kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1167.0	CHEMBL4128	Homo sapiens	IC50	uM	1.167
	2198018	CHEMBL1006348	Inhibition of Tie2 kinase	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	Potential transcription error	CHEMBL509032	=	IC50	nM	12000.0	CHEMBL4128	Homo sapiens	IC50	uM	12.0
	2206835	CHEMBL974012	Inhibition of Tie2 by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	200.0	CHEMBL4128	Homo sapiens	EC50	nM	200.0
	2206841	CHEMBL990562	Inhibition of Tie2	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	12.0	CHEMBL4128	Homo sapiens	IC50	nM	12.0
	2206935	CHEMBL974012	Inhibition of Tie2 by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	EC50	nM	1167.0	CHEMBL4128	Homo sapiens	EC50	nM	1167.0
	2206971	CHEMBL974012	Inhibition of Tie2 by cellular assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	448.0	CHEMBL4128	Homo sapiens	IC50	nM	448.0
	2227875	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL497114	=	IC50	nM	6000.0	CHEMBL4128	Homo sapiens	IC50	uM	6.0
	2227876	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C#Cc1ccnc(N)n1		CHEMBL499864	=	IC50	nM	6400.0	CHEMBL4128	Homo sapiens	IC50	uM	6.4
	2227877	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C1CC1c1ccnc(N)n1		CHEMBL526880	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227878	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1NCCc1ccnc(N)n1		CHEMBL499863	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227879	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1CNc1ccnc(N)n1		CHEMBL450886	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227880	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1NC(=O)c1ccnc(N)n1		CHEMBL525048	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227881	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C(=O)Nc1ccnc(N)n1		CHEMBL500152	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227882	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1Nc1ccnc(N)n1		CHEMBL525047	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227883	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2Cc2ccccc2)n1		CHEMBL499891	=	IC50	nM	2800.0	CHEMBL4128	Homo sapiens	IC50	uM	2.8
	2227884	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CCN2CCCC2)n1		CHEMBL500153	=	IC50	nM	21000.0	CHEMBL4128	Homo sapiens	IC50	uM	21.0
	2227885	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CC(=O)O)n1		CHEMBL451173	=	IC50	nM	68000.0	CHEMBL4128	Homo sapiens	IC50	uM	68.0
	2227886	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1/C=C/c1ccnc(N)n1		CHEMBL526925	=	IC50	nM	3800.0	CHEMBL4128	Homo sapiens	IC50	uM	3.8
	2227887	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1cnc(/C=C/c2ccnc(N)n2)c1-c1ccccc1		CHEMBL453195	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227888	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2[nH]cnc2-c2ccccc2)n1		CHEMBL502279	=	IC50	nM	8400.0	CHEMBL4128	Homo sapiens	IC50	uM	8.4
	2227889	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2ccsc2-c2ccccc2)n1		CHEMBL499883	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227890	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3n2CCS3)n1		CHEMBL524322	=	IC50	nM	2900.0	CHEMBL4128	Homo sapiens	IC50	uM	2.9
	2227891	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3ccccn23)n1		CHEMBL525065	=	IC50	nM	5600.0	CHEMBL4128	Homo sapiens	IC50	uM	5.6
	2227892	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2sccc2-c2ccccc2)n1		CHEMBL500930	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227893	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2[nH]ncc2-c2ccccc2)n1		CHEMBL500929	=	IC50	nM	64000.0	CHEMBL4128	Homo sapiens	IC50	uM	64.0
	2227894	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cn1c(-c2ccccc2)c(/C=C/c2ccnc(N)n2)c2ccccc21		CHEMBL527111	=	IC50	nM	83000.0	CHEMBL4128	Homo sapiens	IC50	uM	83.0
	2227895	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1cc(/C=C/c2c(-c3ccccc3)nc3sccn23)ncn1		CHEMBL502543	=	IC50	nM	5200.0	CHEMBL4128	Homo sapiens	IC50	uM	5.2
	2227896	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1ccnc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL527110	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227897	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	C(=C/c1c(-c2ccccc2)nc2sccn12)\c1ccncn1		CHEMBL505610	=	IC50	nM	27000.0	CHEMBL4128	Homo sapiens	IC50	uM	27.0
	2227898	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Clc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL501444	=	IC50	nM	55000.0	CHEMBL4128	Homo sapiens	IC50	uM	55.0
	2227899	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	CC(C)(C)C(=O)Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL524708	=	IC50	nM	41000.0	CHEMBL4128	Homo sapiens	IC50	uM	41.0
	2227900	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	CC(=O)Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL503074	=	IC50	nM	11000.0	CHEMBL4128	Homo sapiens	IC50	uM	11.0
	2227901	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	C(=C/c1c(-c2ccccc2)nc2sccn12)\c1ccnc(Nc2ccccc2)n1		CHEMBL526932	=	IC50	nM	68000.0	CHEMBL4128	Homo sapiens	IC50	uM	68.0
	2227902	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	CC(Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1)c1ccccc1		CHEMBL502803	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227903	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	CNc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL497290	=	IC50	nM	14000.0	CHEMBL4128	Homo sapiens	IC50	uM	14.0
	2227904	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(Cl)nc3sccn23)n1		CHEMBL507202	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227905	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Cc1nc2sccn2c1/C=C/c1ccnc(N)n1		CHEMBL444654	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	2227906	CHEMBL995225	Inhibition of recombinant Tie2 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccc(F)cc3)nc3sccn23)n1		CHEMBL524799	=	IC50	nM	13000.0	CHEMBL4128	Homo sapiens	IC50	uM	13.0
Not Determined	2227971	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Cn1c(-c2ccccc2)c(/C=C/c2ccnc(N)n2)c2ccccc21		CHEMBL527111		IC50			CHEMBL4128	Homo sapiens	IC50		
	2227972	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Cn1cnc(-c2ccccc2)c1/C=C/c1ccnc(N)n1		CHEMBL526925	=	IC50	nM	340.0	CHEMBL4128	Homo sapiens	IC50	uM	0.34
	2227973	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2[nH]cnc2-c2ccccc2)n1		CHEMBL502279	=	IC50	nM	370.0	CHEMBL4128	Homo sapiens	IC50	uM	0.37
Not Determined	2227974	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2[nH]ncc2-c2ccccc2)n1		CHEMBL500929		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227975	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2Cc2ccccc2)n1		CHEMBL499891		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227976	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CCN2CCCC2)n1		CHEMBL500153		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227977	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CC(=O)O)n1		CHEMBL451173		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227978	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Cn1cnc(/C=C/c2ccnc(N)n2)c1-c1ccccc1		CHEMBL453195		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227979	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2ccsc2-c2ccccc2)n1		CHEMBL499883		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227980	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3n2CCS3)n1		CHEMBL524322		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227981	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3ccccn23)n1		CHEMBL525065		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2227982	CHEMBL995222	Inhibition of human Tie2 autophosphorylation expressed in CHOK1 cells by ELISA	B	Nc1nccc(/C=C/c2sccc2-c2ccccc2)n1		CHEMBL500930		IC50			CHEMBL4128	Homo sapiens	IC50		
	2227990	CHEMBL997894	Inhibition of human recombinant Tie2	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	620.0	CHEMBL4128	Homo sapiens	IC50	uM	0.62
	2232194	CHEMBL973637	Inhibition of Tie 2	B	COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C(F)(F)F)c5)nn(C)c4c3)c2cc1OC		CHEMBL462168	=	IC50	nM	121.0	CHEMBL4128	Homo sapiens	IC50	uM	0.121
	2239386	CHEMBL980075	Inhibition of Tie2 assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	111.0	CHEMBL4128	Homo sapiens	Activity	%	111.0
	2257000	CHEMBL1001233	Inhibition of TIE2	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270381	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270382	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473761	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270383	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	CNc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc(OC)c(OC)cc2n1		CHEMBL514941	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270384	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Cc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1Cl		CHEMBL473354	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270385	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1		CHEMBL514016	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270386	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1-c1nc2ccccc2s1		CHEMBL474544	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270387	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL514929	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270388	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5ccsc45)cc3)nc2c1		CHEMBL472946	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2270436	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1		CHEMBL462338	=	IC50	nM	8700.0	CHEMBL4128	Homo sapiens	IC50	uM	8.7
	2270437	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1		CHEMBL462162	=	IC50	nM	8600.0	CHEMBL4128	Homo sapiens	IC50	uM	8.6
	2270438	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	8300.0	CHEMBL4128	Homo sapiens	IC50	uM	8.3
	2270448	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1		CHEMBL474543	=	IC50	nM	7000.0	CHEMBL4128	Homo sapiens	IC50	uM	7.0
	2270468	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	4400.0	CHEMBL4128	Homo sapiens	IC50	uM	4.4
	2270469	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Clc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL474346	=	IC50	nM	4400.0	CHEMBL4128	Homo sapiens	IC50	uM	4.4
	2270472	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2ccsc12		CHEMBL474347	=	IC50	nM	4100.0	CHEMBL4128	Homo sapiens	IC50	uM	4.1
	2270486	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	3000.0	CHEMBL4128	Homo sapiens	IC50	uM	3.0
	2270494	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1		CHEMBL475351	=	IC50	nM	2500.0	CHEMBL4128	Homo sapiens	IC50	uM	2.5
	2270503	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1		CHEMBL518803	=	IC50	nM	1900.0	CHEMBL4128	Homo sapiens	IC50	uM	1.9
	2270519	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1		CHEMBL475352	=	IC50	nM	1300.0	CHEMBL4128	Homo sapiens	IC50	uM	1.3
	2270521	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	=	IC50	nM	1200.0	CHEMBL4128	Homo sapiens	IC50	uM	1.2
	2270529	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(Cl)ccc12		CHEMBL473557	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	2270543	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	840.0	CHEMBL4128	Homo sapiens	IC50	uM	0.84
Not Determined	2270585	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1		CHEMBL515598		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2270586	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2270587	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC		CHEMBL473351		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2270588	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC		CHEMBL473553		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2270589	CHEMBL964950	Inhibition of TIE2 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906		IC50			CHEMBL4128	Homo sapiens	IC50		
	2270713	CHEMBL954375	Inhibition of Tie2 at 100 nM	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccc(F)cc6)C5=O)cc4F)c3s2)c1		CHEMBL464211	=	Inhibition	%	99.0	CHEMBL4128	Homo sapiens	INH	%	99.0
Not Active	2301933	CHEMBL950810	Inhibition of TIE2	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	2301957	CHEMBL950810	Inhibition of TIE2	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	2301981	CHEMBL950810	Inhibition of TIE2	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	2302005	CHEMBL950810	Inhibition of TIE2	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	2302029	CHEMBL950810	Inhibition of TIE2	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	2302053	CHEMBL950809	Inhibition of TIE2 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	2302077	CHEMBL950810	Inhibition of TIE2	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246	=	IC50	nM	95000.0	CHEMBL4128	Homo sapiens	IC50	uM	95.0
	2302101	CHEMBL950810	Inhibition of TIE2	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155	=	IC50	nM	85000.0	CHEMBL4128	Homo sapiens	IC50	uM	85.0
Not Active	2302139	CHEMBL950810	Inhibition of TIE2	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	2353888	CHEMBL953222	Inhibition of Tie2	B	COc1ccc2c(OCc3nnc4ccc(-c5cc(F)c(F)c(F)c5)nn34)ccnc2c1		CHEMBL494979	>	Activity	uM	10.0	CHEMBL4128	Homo sapiens	Activity	uM	10.0
	2361175	CHEMBL971827	Inhibition of Tie2 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	=	IC50	nM	285.0	CHEMBL4128	Homo sapiens	IC50	nM	285.0
	2361197	CHEMBL971827	Inhibition of Tie2 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	=	IC50	nM	26.0	CHEMBL4128	Homo sapiens	IC50	nM	26.0
	2361221	CHEMBL971827	Inhibition of Tie2 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602	=	IC50	nM	221.0	CHEMBL4128	Homo sapiens	IC50	nM	221.0
	2372054	CHEMBL990803	Inhibition of Tie2	B	O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12		CHEMBL491429	>	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	uM	5.0
	2395461	CHEMBL963589	Binding affinity to TIE2 at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL4128	Homo sapiens	Activity	%	10.0
	2395469	CHEMBL963597	Inhibition of Tie2 by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	2396086	CHEMBL1006325	Inhibition of TEK at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	INH	%	4.0
	2461805	CHEMBL965366	Inhibition of recombinant TIE2	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	7.0	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	7.0
	2462909	CHEMBL965366	Inhibition of recombinant TIE2	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	8.8	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	8.8
	2462910	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	>	IC50	ug.mL-1	10.0	CHEMBL4128	Homo sapiens	IC50	10'-5g/ml	1.0
	2462911	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL4128	Homo sapiens	IC50	10'-5g/ml	1.0
	2462912	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL4128	Homo sapiens	IC50	10'-5g/ml	1.0
	2462913	CHEMBL965366	Inhibition of recombinant TIE2	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	3.8	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	3.8
	2462914	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	9.8	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	9.8
	2462915	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	1.4	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	1.4
	2462916	CHEMBL965366	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	3.5	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	3.5
	2462917	CHEMBL965366	Inhibition of recombinant TIE2	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	6.8	CHEMBL4128	Homo sapiens	IC50	10'-6g/ml	6.8
	2465008	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	740.0	CHEMBL4128	Homo sapiens	IC50	uM	0.74
	2465132	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc1		CHEMBL507056	=	IC50	nM	48000.0	CHEMBL4128	Homo sapiens	IC50	uM	48.0
	2465133	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453593	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	uM	25.0
	2465134	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(CC4COC(C)(C)O4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL509635	=	IC50	nM	31000.0	CHEMBL4128	Homo sapiens	IC50	uM	31.0
	2465135	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453336	=	IC50	nM	11000.0	CHEMBL4128	Homo sapiens	IC50	uM	11.0
	2465136	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	1700.0	CHEMBL4128	Homo sapiens	IC50	uM	1.7
	2465137	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	11000.0	CHEMBL4128	Homo sapiens	IC50	uM	11.0
	2465138	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(COC(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488645	=	IC50	nM	11000.0	CHEMBL4128	Homo sapiens	IC50	uM	11.0
	2465139	CHEMBL957984	Inhibition of human recombinant TIE2	B	CCOCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL529217	=	IC50	nM	24000.0	CHEMBL4128	Homo sapiens	IC50	uM	24.0
	2465140	CHEMBL957984	Inhibition of human recombinant TIE2	B	COCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL519590	=	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	uM	25.0
	2465141	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL486437	=	IC50	nM	26000.0	CHEMBL4128	Homo sapiens	IC50	uM	26.0
	2465142	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	34000.0	CHEMBL4128	Homo sapiens	IC50	uM	34.0
	2465143	CHEMBL957984	Inhibition of human recombinant TIE2	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	5200.0	CHEMBL4128	Homo sapiens	IC50	uM	5.2
	2470412	CHEMBL981794	Inhibition of TIE2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	2476633	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	34.7	CHEMBL4128	Homo sapiens	Activity	%	34.7
Not Evaluated	2476836	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2478675	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2478878	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2479733	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4128	Homo sapiens	Activity		
	2480732	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.4	CHEMBL4128	Homo sapiens	Activity	%	0.4
	2506983	CHEMBL942631	Inhibition of Tie2 at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	2506984	CHEMBL942631	Inhibition of Tie2 at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	2511611	CHEMBL973465	Inhibition of TIE2/TEK	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	52.0	CHEMBL4128	Homo sapiens	IC50	uM	0.052
	2558440	CHEMBL989984	Inhibition of TEK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2567284	CHEMBL975471	Inhibition of human Tie2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	75.0	CHEMBL4128	Homo sapiens	Activity	%	75.0
Not Evaluated	2577354	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4128	Homo sapiens	Activity		
	2582011	CHEMBL962242	Inhibition of human TIE2	B	N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL487254	=	IC50	nM	8900.0	CHEMBL4128	Homo sapiens	IC50	uM	8.9
	2585360	CHEMBL1018104	Inhibition of Tie2	B	CCOc1ccccc1Oc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1C(=O)Nc1c(C)cccc1C		CHEMBL459044	>	Ki	nM	8300.0	CHEMBL4128	Homo sapiens	Ki	uM	8.3
	2585361	CHEMBL1018104	Inhibition of Tie2	B	COC(C)(C)CCn1nc(Nc2c(C)cccc2C)c2cnc(Nc3ccc(OCCN4CCCC4)cc3)nc21		CHEMBL458333	=	Ki	nM	1160.0	CHEMBL4128	Homo sapiens	Ki	uM	1.16
	2585362	CHEMBL1018104	Inhibition of Tie2	B	COC(C)(C)CCn1nc(Nc2c(C)cccc2C)c2cnc(Nc3ccc(OCCN4CCCC4)c(F)c3)nc21		CHEMBL502156	>	Ki	nM	2500.0	CHEMBL4128	Homo sapiens	Ki	uM	2.5
	2593559	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.4	CHEMBL4128	Homo sapiens	Activity	%	0.4
	2593762	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	2.5	CHEMBL4128	Homo sapiens	Activity	%	2.5
Not Evaluated	2593825	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4128	Homo sapiens	Activity		
	2594028	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	2.7	CHEMBL4128	Homo sapiens	Activity	%	2.7
Not Evaluated	2594971	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2595240	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2596168	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2596371	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2597640	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Evaluated	2597843	CHEMBL1035897	Binding affinity to human TIE2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4128	Homo sapiens	Activity		
	2603074	CHEMBL1023869	Inhibition of TIE2	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	2613479	CHEMBL1031521	Inhibition of Tie2	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	2616272	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL468612	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	2616274	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2C)n1		CHEMBL516817	=	IC50	nM	23.0	CHEMBL4128	Homo sapiens	IC50	nM	23.0
	2616275	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)cc2C)n1		CHEMBL517559	=	IC50	nM	460.0	CHEMBL4128	Homo sapiens	IC50	nM	460.0
	2616276	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)cc2C)n1		CHEMBL468618	=	IC50	nM	470.0	CHEMBL4128	Homo sapiens	IC50	nM	470.0
	2616280	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCOCC3)ccc2C)n1		CHEMBL219158	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	2616281	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2616282	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	nM	44.0
	2616283	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	nM	16.0
	2616284	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4n3C)c3ccccc23)n1		CHEMBL457984	=	IC50	nM	240.0	CHEMBL4128	Homo sapiens	IC50	nM	240.0
	2616285	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	IC50	nM	27.0	CHEMBL4128	Homo sapiens	IC50	nM	27.0
	2616286	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4cccc(C)c4[nH]3)c3ccccc23)n1		CHEMBL457100	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
	2616287	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	2616288	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
	2616289	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c(C)c2C)n1		CHEMBL465792	=	IC50	nM	310.0	CHEMBL4128	Homo sapiens	IC50	nM	310.0
	2616290	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c(C)c2)n1		CHEMBL462083	=	IC50	nM	590.0	CHEMBL4128	Homo sapiens	IC50	nM	590.0
	2616291	CHEMBL1029838	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2)n1		CHEMBL462082	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
Not Determined	2616304	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2)n1		CHEMBL462082		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2616305	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2616306	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c(C)c2C)n1		CHEMBL465792		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	2616307	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c(C)c2)n1		CHEMBL462083		IC50			CHEMBL4128	Homo sapiens	IC50		
	2616308	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
	2616311	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
	2616316	CHEMBL1029842	Ratio of IC50 for Tie2 to IC50 for Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2C)n1		CHEMBL516817	=	Ratio IC50		10.0	CHEMBL4128	Homo sapiens	Ratio IC50		10.0
	2616332	CHEMBL1029840	Inhibition of Tie2 autophosphorylation in human Ea.hy926 cells	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)cc2C)n1		CHEMBL516817	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	2672243	CHEMBL1026243	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	=	IC50	ug.mL-1	8.9	CHEMBL4128	Homo sapiens	IC50	ug ml-1	8.9
	2672260	CHEMBL1026243	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	=	IC50	ug.mL-1	4.5	CHEMBL4128	Homo sapiens	IC50	ug ml-1	4.5
	2672278	CHEMBL1026243	Inhibition of recombinant TIE2	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	3.3	CHEMBL4128	Homo sapiens	IC50	ug ml-1	3.3
	2672292	CHEMBL1026243	Inhibition of recombinant TIE2	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	=	IC50	ug.mL-1	1.9	CHEMBL4128	Homo sapiens	IC50	ug ml-1	1.9
	2705007	CHEMBL1055629	Inhibition of TIE2 at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	8.17	CHEMBL4128	Homo sapiens	INH	%	8.17
	2721732	CHEMBL1053577	Inhibition of Tie2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	2722261	CHEMBL1063594	Inhibition of Tie2	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	10000.0	CHEMBL4128	Homo sapiens	Ki	uM	10.0
	2892501	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	450.0	CHEMBL4128	Homo sapiens	Kd	nM	450.0
	2892502	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892503	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	19.0	CHEMBL4128	Homo sapiens	Kd	nM	19.0
	2892504	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	2892505	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	20.0	CHEMBL4128	Homo sapiens	Kd	nM	20.0
	2892506	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892507	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892508	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1300.0	CHEMBL4128	Homo sapiens	Kd	nM	1300.0
	2892509	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892510	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892511	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892512	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892513	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892514	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892515	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892516	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892517	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892518	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892519	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892520	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	950.0	CHEMBL4128	Homo sapiens	Kd	nM	950.0
	2892521	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892522	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892523	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892524	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	300.0	CHEMBL4128	Homo sapiens	Kd	nM	300.0
	2892525	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892526	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	2892527	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892528	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892529	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892530	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892531	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892532	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2100.0	CHEMBL4128	Homo sapiens	Kd	nM	2100.0
	2892533	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	140.0	CHEMBL4128	Homo sapiens	Kd	nM	140.0
	2892534	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892535	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892536	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	450.0	CHEMBL4128	Homo sapiens	Kd	nM	450.0
	2892537	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	2892538	CHEMBL1051315	Binding constant for TIE2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1000.0	CHEMBL4128	Homo sapiens	Kd	nM	1000.0
	2897241	CHEMBL1060173	Percent residual Tek activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL4128	Homo sapiens	Activity	%	80.0
	2921895	CHEMBL1047422	Inhibition of Tie2	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	IC50	nM	120.0	CHEMBL4128	Homo sapiens	IC50	nM	120.0
	2921896	CHEMBL1047422	Inhibition of Tie2	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5ccc6c(c5)NC(=O)C6(C)C)nccc34)ccc2n1		CHEMBL576985	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2921897	CHEMBL1047422	Inhibition of Tie2	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5cc(C(C)(C)C)nn5C)nccc34)ccc2n1		CHEMBL569882	=	IC50	nM	200.0	CHEMBL4128	Homo sapiens	IC50	nM	200.0
	2921898	CHEMBL1047422	Inhibition of Tie2	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5ccc(Cl)cc5)nccc34)ccc2n1		CHEMBL576787	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	2921899	CHEMBL1047422	Inhibition of Tie2	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc5sc(C)nc5c4)nccc23)ncn1		CHEMBL570573	=	IC50	nM	5.8	CHEMBL4128	Homo sapiens	IC50	nM	5.8
	2921900	CHEMBL1047422	Inhibition of Tie2	B	C#Cc1cccc(Nc2nccc3c(Nc4ncccc4-c4cc(NC)ncn4)c(C)ccc23)c1		CHEMBL571278	=	IC50	nM	8.1	CHEMBL4128	Homo sapiens	IC50	nM	8.1
	2921901	CHEMBL1047422	Inhibition of Tie2	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc(C#N)cc4)nccc23)ncn1		CHEMBL570567	=	IC50	nM	400.0	CHEMBL4128	Homo sapiens	IC50	nM	400.0
	2921902	CHEMBL1047422	Inhibition of Tie2	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc(Cl)cc4)nccc23)ncn1		CHEMBL565885	=	IC50	nM	24.0	CHEMBL4128	Homo sapiens	IC50	nM	24.0
	2921903	CHEMBL1047422	Inhibition of Tie2	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ccncn1		CHEMBL565884	=	IC50	nM	520.0	CHEMBL4128	Homo sapiens	IC50	nM	520.0
	2921904	CHEMBL1047422	Inhibition of Tie2	B	Cc1ccc2c(Nc3cccc(C(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ccncn1		CHEMBL571703	=	IC50	nM	47.0	CHEMBL4128	Homo sapiens	IC50	nM	47.0
	2921905	CHEMBL1047422	Inhibition of Tie2	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212964	=	IC50	nM	1.8	CHEMBL4128	Homo sapiens	IC50	nM	1.8
	2921906	CHEMBL1047422	Inhibition of Tie2	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	=	IC50	nM	3.6	CHEMBL4128	Homo sapiens	IC50	nM	3.6
	2922019	CHEMBL1059378	Inhibition of TIE2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	1.6	CHEMBL4128	Homo sapiens	Activity	%	1.6
	2924060	CHEMBL1041540	Inhibition of TIE2 by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	2924061	CHEMBL1041540	Inhibition of TIE2 by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	2938435	CHEMBL1036953	Inhibition of TIE2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	2943676	CHEMBL1044072	Inhibition of Tek	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	=	IC50	nM	2200.0	CHEMBL4128	Homo sapiens	IC50	microM	2.2
	2943680	CHEMBL1044072	Inhibition of Tek	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	=	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	microM	5.0
	2944869	CHEMBL1049992	Inhibition of TEK at 2 uM	B	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1		CHEMBL583194	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	2947592	CHEMBL1047368	Inhibition of Tie-2 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	23.0	CHEMBL4128	Homo sapiens	INH	%	23.0
	2989952	CHEMBL1050673	Inhibition of Tei-2 at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	100.0	CHEMBL4128	Homo sapiens	INH	%	100.0
	2992245	CHEMBL1044548	Inhibition of human TEK at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	3052497	CHEMBL1072535	Residual activity of TIE2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	53.0	CHEMBL4128	Homo sapiens	Residual activity	%	53.0
	3052749	CHEMBL1043828	Residual activity of TIE2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	16.0	CHEMBL4128	Homo sapiens	Residual activity	%	16.0
	3054058	CHEMBL1073408	Residual activity of TIE2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	4.0	CHEMBL4128	Homo sapiens	Residual activity	%	4.0
	3055345	CHEMBL1072535	Residual activity of TIE2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	38.0	CHEMBL4128	Homo sapiens	Residual activity	%	38.0
	3055597	CHEMBL1043828	Residual activity of TIE2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	22.0	CHEMBL4128	Homo sapiens	Residual activity	%	22.0
	3056902	CHEMBL1073408	Residual activity of TIE2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	3.0	CHEMBL4128	Homo sapiens	Residual activity	%	3.0
	3057154	CHEMBL1072535	Residual activity of TIE2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	50.0	CHEMBL4128	Homo sapiens	Residual activity	%	50.0
	3058474	CHEMBL1043828	Residual activity of TIE2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	23.0	CHEMBL4128	Homo sapiens	Residual activity	%	23.0
	3059758	CHEMBL1073408	Residual activity of TIE2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	4.0	CHEMBL4128	Homo sapiens	Residual activity	%	4.0
	3059825	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059826	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	EC50	nM	2100.0	CHEMBL4128	Homo sapiens	EC50	uM	2.1
	3059827	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059828	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059829	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059830	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059831	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059832	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059833	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	>	EC50	nM	10000.0	CHEMBL4128	Homo sapiens	EC50	uM	10.0
	3059834	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	EC50	nM	300.0	CHEMBL4128	Homo sapiens	EC50	uM	0.3
	3059835	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	EC50	nM	540.0	CHEMBL4128	Homo sapiens	EC50	uM	0.54
	3059836	CHEMBL1073388	Inhibition of TIE2 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	EC50	nM	140.0	CHEMBL4128	Homo sapiens	EC50	uM	0.14
	3063561	CHEMBL1050476	Binding affinity to human TIE2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	65.0	CHEMBL4128	Homo sapiens	Activity	%	65.0
	3063651	CHEMBL1043380	Binding affinity to human TIE2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	38.0	CHEMBL4128	Homo sapiens	Activity	%	38.0
	3063741	CHEMBL1045147	Binding affinity to human TIE2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	3066899	CHEMBL1066105	Inhibition of TIE2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	6.0	CHEMBL4128	Homo sapiens	INH	%	6.0
	3066989	CHEMBL1066105	Inhibition of TIE2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
Not Determined	3072689	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556		IC50			CHEMBL4128	Homo sapiens	IC50		
	3072690	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	840.0	CHEMBL4128	Homo sapiens	IC50	uM	0.84
Not Determined	3072691	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OC		CHEMBL593293		IC50			CHEMBL4128	Homo sapiens	IC50		
Not Determined	3072692	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OC)cc12		CHEMBL596059		IC50			CHEMBL4128	Homo sapiens	IC50		
	3072693	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595615	=	IC50	nM	54.0	CHEMBL4128	Homo sapiens	IC50	uM	0.054
	3072694	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595406	=	IC50	nM	38.0	CHEMBL4128	Homo sapiens	IC50	uM	0.038
	3072695	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595142	=	IC50	nM	230.0	CHEMBL4128	Homo sapiens	IC50	uM	0.23
	3072696	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	IC50	nM	330.0	CHEMBL4128	Homo sapiens	IC50	uM	0.33
	3072697	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593245	=	IC50	nM	590.0	CHEMBL4128	Homo sapiens	IC50	uM	0.59
	3072698	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	IC50	nM	29.0	CHEMBL4128	Homo sapiens	IC50	uM	0.029
	3072699	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596087	=	IC50	nM	68.0	CHEMBL4128	Homo sapiens	IC50	uM	0.068
	3072700	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	IC50	nM	120.0	CHEMBL4128	Homo sapiens	IC50	uM	0.12
	3072701	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	uM	0.11
	3072702	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	IC50	nM	9.0	CHEMBL4128	Homo sapiens	IC50	uM	0.009
	3072703	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	IC50	nM	37.0	CHEMBL4128	Homo sapiens	IC50	uM	0.037
	3072704	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1		CHEMBL593306	=	IC50	nM	390.0	CHEMBL4128	Homo sapiens	IC50	uM	0.39
	3072705	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	=	IC50	nM	235.0	CHEMBL4128	Homo sapiens	IC50	uM	0.235
	3072706	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593275	=	IC50	nM	410.0	CHEMBL4128	Homo sapiens	IC50	uM	0.41
	3072707	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	=	IC50	nM	510.0	CHEMBL4128	Homo sapiens	IC50	uM	0.51
	3072708	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	=	IC50	nM	3300.0	CHEMBL4128	Homo sapiens	IC50	uM	3.3
	3072709	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593909	=	IC50	nM	615.0	CHEMBL4128	Homo sapiens	IC50	uM	0.615
	3072710	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593770	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	3072711	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	IC50	nM	88.0	CHEMBL4128	Homo sapiens	IC50	uM	0.088
	3072712	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	uM	0.044
	3072713	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	IC50	nM	72.0	CHEMBL4128	Homo sapiens	IC50	uM	0.072
	3072806	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593292	=	IC50	nM	670.0	CHEMBL4128	Homo sapiens	IC50	uM	0.67
	3072807	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OCCCN1CCN(C)CC1		CHEMBL595374	=	IC50	nM	350.0	CHEMBL4128	Homo sapiens	IC50	uM	0.35
	3072808	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OCCCN1CCN(C)CC1		CHEMBL593294	=	IC50	nM	880.0	CHEMBL4128	Homo sapiens	IC50	uM	0.88
	3072809	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OCCCN3CCN(C)CC3)cc12		CHEMBL593910	=	IC50	nM	6100.0	CHEMBL4128	Homo sapiens	IC50	uM	6.1
	3072810	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3F)c2cc1OCCCN1CCN(C)CC1		CHEMBL594661	=	IC50	nM	360.0	CHEMBL4128	Homo sapiens	IC50	uM	0.36
	3072811	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604485	=	IC50	nM	5300.0	CHEMBL4128	Homo sapiens	IC50	uM	5.3
	3072812	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593911	=	IC50	nM	1400.0	CHEMBL4128	Homo sapiens	IC50	uM	1.4
	3072813	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593760	=	IC50	nM	3100.0	CHEMBL4128	Homo sapiens	IC50	uM	3.1
	3072814	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604893	=	IC50	nM	510.0	CHEMBL4128	Homo sapiens	IC50	uM	0.51
	3072815	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593971	=	IC50	nM	4000.0	CHEMBL4128	Homo sapiens	IC50	uM	4.0
	3072816	CHEMBL1073380	Inhibition of TIE2 by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593905	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	3098410	CHEMBL1067997	Inhibition of human Tie2 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
Not Active	3098414	CHEMBL1067037	Inhibition of human Tie2	B	O=C(CC(Nc1ccc(Oc2cc(NC(=O)N3CCCC3)ncn2)c(F)c1)C(F)(F)F)Nc1ccccc1		CHEMBL612137		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	3102192	CHEMBL1070752	Inhibition of TIE2 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL597492	=	IC50	nM	3961.0	CHEMBL4128	Homo sapiens	IC50	nM	3961.0
	3102193	CHEMBL1070752	Inhibition of TIE2 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL605957	=	IC50	nM	2367.0	CHEMBL4128	Homo sapiens	IC50	nM	2367.0
	3102194	CHEMBL1070752	Inhibition of TIE2 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	2633.0	CHEMBL4128	Homo sapiens	IC50	nM	2633.0
	3102195	CHEMBL1070752	Inhibition of TIE2 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL606168	=	IC50	nM	1567.0	CHEMBL4128	Homo sapiens	IC50	nM	1567.0
	3186276	CHEMBL1111483	Inhibition of Tie2	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5cccc(C(F)(F)F)c5)s4)c2C3)CC1		CHEMBL213910	=	IC50	nM	259.0	CHEMBL4128	Homo sapiens	IC50	nM	259.0
	3186441	CHEMBL1113288	Inhibition of TIE2 at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	7.0	CHEMBL4128	Homo sapiens	INH	%	7.0
	3210381	CHEMBL1109441	Inhibition of Tie2 after 1 hr	B	COc1ccc(Br)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080639	=	IC50	nM	75.0	CHEMBL4128	Homo sapiens	IC50	nM	75.0
	3210382	CHEMBL1109441	Inhibition of Tie2 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1079850	=	IC50	nM	37.0	CHEMBL4128	Homo sapiens	IC50	nM	37.0
	3210383	CHEMBL1109441	Inhibition of Tie2 after 1 hr	B	COc1ccc(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079846	=	IC50	nM	33.0	CHEMBL4128	Homo sapiens	IC50	nM	33.0
	3210384	CHEMBL1109441	Inhibition of Tie2 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	67.0	CHEMBL4128	Homo sapiens	IC50	uM	0.067
	3211553	CHEMBL1115706	Inhibition of Tie2 autophosphorylation by cell based assay	B	COc1ccc(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079846	=	IC50	nM	50.0	CHEMBL4128	Homo sapiens	IC50	nM	50.0
	3211554	CHEMBL1115706	Inhibition of Tie2 autophosphorylation by cell based assay	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1079850	=	IC50	nM	100.0	CHEMBL4128	Homo sapiens	IC50	nM	100.0
	3211555	CHEMBL1115706	Inhibition of Tie2 autophosphorylation by cell based assay	B	COc1ccc(Br)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080639	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	3213860	CHEMBL1111276	Inhibition of TIE2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	INH	%	4.0
	3219903	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cn1cnc(-c2ccccc2)c1-c1cc2c(N)ncnc2s1		CHEMBL1079428	=	IC50	nM	1800.0	CHEMBL4128	Homo sapiens	IC50	uM	1.8
	3219904	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cc1ccc(Sc2cccc(-c3ncn(C)c3-c3cc4c(N)ncnc4s3)c2)cc1		CHEMBL1079429	=	IC50	nM	1400.0	CHEMBL4128	Homo sapiens	IC50	uM	1.4
	3219905	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cn1cnc(-c2cccc(NC(=O)Nc3ccccc3)c2)c1-c1cc2c(N)ncnc2s1		CHEMBL1080127	=	IC50	nM	1400.0	CHEMBL4128	Homo sapiens	IC50	uM	1.4
	3219906	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cn1cnc(-c2cccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c2)c1-c1cc2c(N)ncnc2s1		CHEMBL1080303	=	IC50	nM	70.0	CHEMBL4128	Homo sapiens	IC50	uM	0.07
	3219907	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cc1cc(NC(=O)Nc2cccc(-c3ncn(C)c3-c3cc4c(N)ncnc4s3)c2)on1		CHEMBL1080479	=	IC50	nM	340.0	CHEMBL4128	Homo sapiens	IC50	uM	0.34
	3219908	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Cn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1		CHEMBL1076330	=	IC50	nM	2700.0	CHEMBL4128	Homo sapiens	IC50	uM	2.7
	3219909	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	CCn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1		CHEMBL1079588	=	IC50	nM	3000.0	CHEMBL4128	Homo sapiens	IC50	uM	3.0
	3219910	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Nc1ncnc2sc(-c3c(-c4ccccc4)ncn3CC3CCCCC3)nc12		CHEMBL1079589	=	IC50	nM	540.0	CHEMBL4128	Homo sapiens	IC50	uM	0.54
	3219911	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	CC(C)Cn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1		CHEMBL1079590	=	IC50	nM	490.0	CHEMBL4128	Homo sapiens	IC50	uM	0.49
	3219912	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Nc1ncnc2sc(-c3c(-c4ccccc4)ncn3C[C@H]3CCCO3)nc12		CHEMBL1079772	=	IC50	nM	370.0	CHEMBL4128	Homo sapiens	IC50	uM	0.37
	3219913	CHEMBL1115829	Inhibition of Tie-2 phosphorylation by cell based assay	B	Nc1ncnc2sc(-c3c(-c4ccccc4)ncn3Cc3ccccc3N3CCOCC3)nc12		CHEMBL1079773	=	IC50	nM	440.0	CHEMBL4128	Homo sapiens	IC50	uM	0.44
	3219926	CHEMBL1115836	Inhibition of Tie-2	B	Cn1cnc(-c2ccccc2)c1-c1cc2c(N)ncnc2s1		CHEMBL1079428	=	IC50	nM	34000.0	CHEMBL4128	Homo sapiens	IC50	uM	34.0
	3219936	CHEMBL1115836	Inhibition of Tie-2	B	Cn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1		CHEMBL1076330	=	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	3224978	CHEMBL1101782	Inhibition of Tie2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3226357	CHEMBL1101782	Inhibition of Tie2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3294245	CHEMBL1104801	Inhibition of TIE2	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	59.0	CHEMBL4128	Homo sapiens	IC50	nM	59.0
	3294628	CHEMBL1103940	Inhibition of Tie2	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	3301998	CHEMBL1118605	Inhibition of TEK at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	3302667	CHEMBL1120725	Inhibition of Tie2	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	uM	0.001
	3302676	CHEMBL1120725	Inhibition of Tie2	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	uM	0.002
	3302685	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	uM	0.002
	3302694	CHEMBL1120725	Inhibition of Tie2	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	IC50	nM	82.0	CHEMBL4128	Homo sapiens	IC50	uM	0.082
	3302703	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	uM	0.001
	3302712	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	IC50	nM	86.0	CHEMBL4128	Homo sapiens	IC50	uM	0.086
	3302721	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	uM	0.005
	3302730	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	uM	0.016
	3302739	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	uM	0.044
	3302748	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	IC50	nM	27.0	CHEMBL4128	Homo sapiens	IC50	uM	0.027
	3302757	CHEMBL1120725	Inhibition of Tie2	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	IC50	nM	215.0	CHEMBL4128	Homo sapiens	IC50	uM	0.215
	3302766	CHEMBL1120725	Inhibition of Tie2	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	IC50	nM	248.0	CHEMBL4128	Homo sapiens	IC50	uM	0.248
	3302819	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	3302820	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	3302821	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	3302822	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	3302823	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	3302824	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	3302825	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	3302826	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	3302827	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	INH	%	4.0
	3302828	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	Inhibition	%	3.0	CHEMBL4128	Homo sapiens	INH	%	3.0
	3302829	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	Inhibition	%	18.0	CHEMBL4128	Homo sapiens	INH	%	18.0
	3302830	CHEMBL1120734	Inhibition of Tie2 at 1 uM relative to control	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	Inhibition	%	20.0	CHEMBL4128	Homo sapiens	INH	%	20.0
	3307842	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c1[nH]c1ccc(C4CCCCO4)cc13)CNC2=O		CHEMBL1082503	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	nM	44.0
	3307843	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C)c13)CNC2=O		CHEMBL1082826	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
	3307844	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1083757	=	IC50	nM	14.0	CHEMBL4128	Homo sapiens	IC50	nM	14.0
	3307845	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084061	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	3307846	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CC(C)n1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084062	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	3307847	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	3307848	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
	3307849	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CC(C)CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084338	=	IC50	nM	21.0	CHEMBL4128	Homo sapiens	IC50	nM	21.0
	3307850	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1083144	=	IC50	nM	78.0	CHEMBL4128	Homo sapiens	IC50	nM	78.0
	3307851	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C4CCCC4)c13)CNC2=O		CHEMBL1083454	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
	3307852	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C4CCCCC4)c13)CNC2=O		CHEMBL1085291	=	IC50	nM	102.0	CHEMBL4128	Homo sapiens	IC50	nM	102.0
	3307853	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CC4CCCCC4)c13)CNC2=O		CHEMBL1085292	=	IC50	nM	469.0	CHEMBL4128	Homo sapiens	IC50	nM	469.0
	3307854	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	C=CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082755	=	IC50	nM	9.0	CHEMBL4128	Homo sapiens	IC50	nM	9.0
	3307968	CHEMBL1119371	Inhibition of human Tie2	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	82.0	CHEMBL4128	Homo sapiens	INH	%	82.0
	3308277	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCOCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082756	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
	3308278	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CCO)c13)CNC2=O		CHEMBL1085293	=	IC50	nM	27.0	CHEMBL4128	Homo sapiens	IC50	nM	27.0
	3308279	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1cc2c(n1)CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CCCO)c13)CNC2=O		CHEMBL1085540	=	IC50	nM	16.0	CHEMBL4128	Homo sapiens	IC50	nM	16.0
	3308280	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCN(CC)CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1085541	=	IC50	nM	142.0	CHEMBL4128	Homo sapiens	IC50	nM	142.0
	3308281	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1ncc2c1CCc1c-2c2c(c3c1[nH]c1ccc(C4CCCCO4)cc13)CNC2=O		CHEMBL1083071	=	IC50	nM	715.0	CHEMBL4128	Homo sapiens	IC50	nM	715.0
	3308282	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1ncc2c1CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C)c13)CNC2=O		CHEMBL1082437	=	IC50	nM	554.0	CHEMBL4128	Homo sapiens	IC50	nM	554.0
	3308283	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL1082438	=	IC50	nM	88.0	CHEMBL4128	Homo sapiens	IC50	nM	88.0
	3308284	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL1083042	=	IC50	nM	24.0	CHEMBL4128	Homo sapiens	IC50	nM	24.0
	3308285	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CC(C)n1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL1083350	=	IC50	nM	103.0	CHEMBL4128	Homo sapiens	IC50	nM	103.0
	3308286	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL1083386	=	IC50	nM	53.0	CHEMBL4128	Homo sapiens	IC50	nM	53.0
	3308287	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL1085294	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
	3308288	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1ncc2c1CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(C4CCCC4)c13)CNC2=O		CHEMBL1085295	=	IC50	nM	300.0	CHEMBL4128	Homo sapiens	IC50	nM	300.0
	3308289	CHEMBL1119624	Inhibition of human recombinant TIE-2 by time resolved fluorescence measurements	B	Cn1ncc2c1CCc1c-2c2c(c3c4cc(C5CCCCO5)ccc4n(CCO)c13)CNC2=O		CHEMBL1085296	=	IC50	nM	350.0	CHEMBL4128	Homo sapiens	IC50	nM	350.0
	3315888	CHEMBL1120234	Inhibition of tie2	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	3326146	CHEMBL1168995	Inhibition of TIE2 at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3333190	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3333592	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3334997	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3336417	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3337661	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3338992	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3339248	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3340553	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3341959	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3343406	CHEMBL1168129	Inhibition of TIE2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	3351783	CHEMBL1175097	Inhibition of TIE2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
Not Active	3352246	CHEMBL1175408	Inhibition of Tie2 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	3352247	CHEMBL1175408	Inhibition of Tie2 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	3352248	CHEMBL1175408	Inhibition of Tie2 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	3358835	CHEMBL1175097	Inhibition of TIE2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL4128	Homo sapiens	INH	%	0.05
	3370111	CHEMBL1176698	Inhibition of Tie2 at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	25.5	CHEMBL4128	Homo sapiens	INH	%	25.5
	3439111	CHEMBL1247958	Inhibition of Tie-2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	=	IC50	nM	630.0	CHEMBL4128	Homo sapiens	IC50	nM	630.0
	3440610	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL197592	=	IC50	nM	1202.26	CHEMBL4128	Homo sapiens	pIC50		5.92
	3440611	CHEMBL1243605	Inhibition of Tie2	B	Cc1ccccc1NC(=O)Nc1ccc(-c2c(C)sc3ncnc(N)c23)cc1		CHEMBL438797	=	IC50	nM	1288.25	CHEMBL4128	Homo sapiens	pIC50		5.89
	3440612	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371329	=	IC50	nM	109.65	CHEMBL4128	Homo sapiens	pIC50		6.96
	3440613	CHEMBL1243605	Inhibition of Tie2	B	Cc1ccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)cc1		CHEMBL198267	=	IC50	nM	891.25	CHEMBL4128	Homo sapiens	pIC50		6.05
	3440614	CHEMBL1243605	Inhibition of Tie2	B	COc1ccccc1NC(=O)Nc1ccc(-c2c(C)sc3ncnc(N)c23)cc1		CHEMBL445394	=	IC50	nM	912.01	CHEMBL4128	Homo sapiens	pIC50		6.04
	3440615	CHEMBL1243605	Inhibition of Tie2	B	COc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371889	=	IC50	nM	363.08	CHEMBL4128	Homo sapiens	pIC50		6.44
	3440616	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)cc1		CHEMBL365784	=	IC50	nM	1584.89	CHEMBL4128	Homo sapiens	pIC50		5.8
	3440617	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2F)cc1		CHEMBL194270	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	pIC50		6.0
	3440618	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(F)c2)cc1		CHEMBL196747	=	IC50	nM	398.11	CHEMBL4128	Homo sapiens	pIC50		6.4
	3440619	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1		CHEMBL196499	=	IC50	nM	851.14	CHEMBL4128	Homo sapiens	pIC50		6.07
	3440620	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1		CHEMBL194321	=	IC50	nM	891.25	CHEMBL4128	Homo sapiens	pIC50		6.05
	3440621	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1		CHEMBL382517	=	IC50	nM	208.93	CHEMBL4128	Homo sapiens	pIC50		6.68
	3440622	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL372174	=	IC50	nM	1202.26	CHEMBL4128	Homo sapiens	pIC50		5.92
	3440623	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(Br)c2)cc1		CHEMBL195955	=	IC50	nM	128.82	CHEMBL4128	Homo sapiens	pIC50		6.89
	3440624	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2ccc(Br)cc2)cc1		CHEMBL194236	=	IC50	nM	1096.48	CHEMBL4128	Homo sapiens	pIC50		5.96
	3440625	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL370325	=	IC50	nM	100.0	CHEMBL4128	Homo sapiens	pIC50		7.0
	3440626	CHEMBL1243605	Inhibition of Tie2	B	COC(=O)c1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL1242107	=	IC50	nM	512.86	CHEMBL4128	Homo sapiens	pIC50		6.29
	3440627	CHEMBL1243605	Inhibition of Tie2	B	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	IC50	nM	169.82	CHEMBL4128	Homo sapiens	pIC50		6.77
	3440628	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(Cl)cc(Cl)c2)cc1		CHEMBL381034	=	IC50	nM	363.08	CHEMBL4128	Homo sapiens	pIC50		6.44
	3440629	CHEMBL1243605	Inhibition of Tie2	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL381207	=	IC50	nM	16.98	CHEMBL4128	Homo sapiens	pIC50		7.77
	3440630	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCC(N)=O)sc4ncnc(N)c34)cc2)c1		CHEMBL197635	=	IC50	nM	120.23	CHEMBL4128	Homo sapiens	pIC50		6.92
	3440631	CHEMBL1243605	Inhibition of Tie2	B	CNC(=O)CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL198601	=	IC50	nM	467.74	CHEMBL4128	Homo sapiens	pIC50		6.33
	3440632	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCC(=O)N(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL382112	=	IC50	nM	141.25	CHEMBL4128	Homo sapiens	pIC50		6.85
	3440633	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CN4CCOCC4)sc4ncnc(N)c34)cc2)c1		CHEMBL194842	=	IC50	nM	426.58	CHEMBL4128	Homo sapiens	pIC50		6.37
	3440634	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CN4CCN(C)CC4)sc4ncnc(N)c34)cc2)c1		CHEMBL372388	=	IC50	nM	630.96	CHEMBL4128	Homo sapiens	pIC50		6.2
	3440635	CHEMBL1243605	Inhibition of Tie2	B	CCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL366241	=	IC50	nM	338.84	CHEMBL4128	Homo sapiens	pIC50		6.47
	3440636	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	724.44	CHEMBL4128	Homo sapiens	pIC50		6.14
	3440637	CHEMBL1243605	Inhibition of Tie2	B	CCCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL371225	=	IC50	nM	288.4	CHEMBL4128	Homo sapiens	pIC50		6.54
	3440638	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(C(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL371890	=	IC50	nM	575.44	CHEMBL4128	Homo sapiens	pIC50		6.24
	3440639	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccccc4)sc4ncnc(N)c34)cc2)c1		CHEMBL372755	=	IC50	nM	870.96	CHEMBL4128	Homo sapiens	pIC50		6.06
	3440640	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4cccnc4)sc4ncnc(N)c34)cc2)c1		CHEMBL371379	=	IC50	nM	251.19	CHEMBL4128	Homo sapiens	pIC50		6.6
	3440641	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(Cc4ccncc4)sc4ncnc(N)c34)cc2)c1		CHEMBL369908	=	IC50	nM	269.15	CHEMBL4128	Homo sapiens	pIC50		6.57
	3440642	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCO)sc4ncnc(N)c34)cc2)c1		CHEMBL197353	=	IC50	nM	257.04	CHEMBL4128	Homo sapiens	pIC50		6.59
	3440643	CHEMBL1243605	Inhibition of Tie2	B	COCCc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C)c2)cc1		CHEMBL198155	=	IC50	nM	218.78	CHEMBL4128	Homo sapiens	pIC50		6.66
	3440644	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCCO)sc4ncnc(N)c34)cc2)c1		CHEMBL198297	=	IC50	nM	109.65	CHEMBL4128	Homo sapiens	pIC50		6.96
	3440645	CHEMBL1243605	Inhibition of Tie2	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(CCN(C)C)sc4ncnc(N)c34)cc2)c1		CHEMBL196636	=	IC50	nM	190.55	CHEMBL4128	Homo sapiens	pIC50		6.72
	3440646	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(OC)cc2)cc1		CHEMBL196021	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	pIC50		6.0
	3440647	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(N(C)C)cc2)cc1		CHEMBL194057	=	IC50	nM	602.56	CHEMBL4128	Homo sapiens	pIC50		6.22
	3440648	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2c(-c3cccc(C(N)=O)c3)oc3ncnc(N)c23)cc1		CHEMBL363389	=	IC50	nM	537.03	CHEMBL4128	Homo sapiens	pIC50		6.27
	3440649	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2c(-c3cccc(NS(C)(=O)=O)c3)oc3ncnc(N)c23)cc1		CHEMBL194150	=	IC50	nM	302.0	CHEMBL4128	Homo sapiens	pIC50		6.52
	3440650	CHEMBL1243605	Inhibition of Tie2	B	CS(=O)(=O)Nc1cccc(-c2oc3ncnc(N)c3c2-c2ccc(-c3ccccc3)cc2)c1		CHEMBL196841	=	IC50	nM	190.55	CHEMBL4128	Homo sapiens	pIC50		6.72
	3440651	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3ccccc3)cc2)cc1		CHEMBL194149	=	IC50	nM	28.18	CHEMBL4128	Homo sapiens	pIC50		7.55
	3440652	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1		CHEMBL194911	=	IC50	nM	1.995	CHEMBL4128	Homo sapiens	pIC50		8.7
	3440653	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)NC3CCCCC3)cc2)cc1		CHEMBL195567	=	IC50	nM	58.88	CHEMBL4128	Homo sapiens	pIC50		7.23
	3440654	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(N)=O)cc2)cc1		CHEMBL193752	=	IC50	nM	275.42	CHEMBL4128	Homo sapiens	pIC50		6.56
	3440655	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2c(-c3ccc(Cl)c(Cl)c3)oc3ncnc(N)c23)cc1		CHEMBL362915	=	IC50	nM	1778.28	CHEMBL4128	Homo sapiens	pIC50		5.75
	3440656	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2c(-c3cccc(C(=O)N(C)C)c3)oc3ncnc(N)c23)cc1		CHEMBL383603	=	IC50	nM	1479.11	CHEMBL4128	Homo sapiens	pIC50		5.83
	3440657	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)c3cccc(F)c3)cc2)cc1		CHEMBL372845	=	IC50	nM	501.19	CHEMBL4128	Homo sapiens	pIC50		6.3
	3440658	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NS(=O)(=O)c3cccc(Cl)c3)cc2)cc1		CHEMBL365773	=	IC50	nM	851.14	CHEMBL4128	Homo sapiens	pIC50		6.07
	3440659	CHEMBL1243605	Inhibition of Tie2	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)cc1		CHEMBL372617	=	IC50	nM	21.88	CHEMBL4128	Homo sapiens	pIC50		7.66
	3443324	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	INH	%	12.0
	3443541	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	3445320	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	7.0	CHEMBL4128	Homo sapiens	INH	%	7.0
	3445537	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	3445754	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	20.0	CHEMBL4128	Homo sapiens	INH	%	20.0
	3445944	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	INH	%	11.0
	3446134	CHEMBL1244307	Inhibition of Tie2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	INH	%	11.0
	3446247	CHEMBL1244590	Inhibition of TIE2	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1191.0	CHEMBL4128	Homo sapiens	IC50	nM	1191.0
	3446273	CHEMBL1244594	Inhibition of TIE2 at 10 mM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	48.0	CHEMBL4128	Homo sapiens	INH	%	48.0
	3447189	CHEMBL1249719	Inhibition of Tie2 kinase	B	Cc1cccc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371329	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	uM	0.11
	3447193	CHEMBL1249719	Inhibition of Tie2 kinase	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1		CHEMBL396056	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	uM	0.01
	3448046	CHEMBL1249679	Inhibition of human Tie2 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	3448122	CHEMBL1249679	Inhibition of human Tie2 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	66.0	CHEMBL4128	Homo sapiens	INH	%	66.0
	3448650	CHEMBL1245003	Binding affinity to TIE2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	3448807	CHEMBL1245003	Binding affinity to TIE2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	630.0	CHEMBL4128	Homo sapiens	Kd	nM	630.0
	3449061	CHEMBL1245003	Binding affinity to TIE2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	3449521	CHEMBL1245003	Binding affinity to TIE2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2100.0	CHEMBL4128	Homo sapiens	Kd	nM	2100.0
	3449875	CHEMBL1245003	Binding affinity to TIE2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	3450423	CHEMBL1245003	Binding affinity to TIE2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	3451168	CHEMBL1245003	Binding affinity to TIE2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	uM	10.0
	3463374	CHEMBL1251707	Inhibition of TEK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-1.0	CHEMBL4128	Homo sapiens	INH	%	-1.0
	3463918	CHEMBL1251707	Inhibition of TEK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	INH	%	12.0
	3464137	CHEMBL1251707	Inhibition of TEK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	INH	%	11.0
	3465477	CHEMBL1250691	Inhibition of Tie-2	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	<	IC50	nM	100.0	CHEMBL4128	Homo sapiens	IC50	nM	100.0
	3471607	CHEMBL1250648	Inhibition of Tie2	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
Not Active	3499147	CHEMBL1259891	Inhibition of TIE2 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	3556133	CHEMBL1285880	Inhibition of TEK	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	IC50	nM	293.0	CHEMBL4128	Homo sapiens	IC50	nM	293.0
	3556144	CHEMBL1285870	Inhibition of TEK at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	81.0	CHEMBL4128	Homo sapiens	INH	%	81.0
	3590790	CHEMBL1292134	Inhibition of human TIE2	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL4128	Homo sapiens	Ki	uM	1000.0
Not Active	3599537	CHEMBL1291153	Displacement of radiolabeled Poly(Glu:Tyr) from TEK at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL4128	Homo sapiens	Activity		
	5120277	CHEMBL1646669	Inhibition of human Tie2 Y897S mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	92.0	CHEMBL4128	Homo sapiens	INH	%	92.0
	5120287	CHEMBL1646668	Inhibition of human Tie2 R849W mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	94.0	CHEMBL4128	Homo sapiens	INH	%	94.0
	5120355	CHEMBL1646667	Inhibition of human Tie2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	103.0	CHEMBL4128	Homo sapiens	INH	%	103.0
	5123947	CHEMBL1647806	Inhibition of Tie2 at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL4128	Homo sapiens	INH	%	80.0
Not Active	5239595	CHEMBL1687083	Inhibition of Tie2 up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	5243775	CHEMBL1685879	Inhibition of Tie2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	83.0	CHEMBL4128	Homo sapiens	INH	%	83.0
	5243883	CHEMBL1686095	Inhibition of Tie2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	5243996	CHEMBL1685879	Inhibition of Tie2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	17.0	CHEMBL4128	Homo sapiens	INH	%	17.0
	5244104	CHEMBL1686095	Inhibition of Tie2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	5244977	CHEMBL1685879	Inhibition of Tie2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	94.0	CHEMBL4128	Homo sapiens	INH	%	94.0
	5245085	CHEMBL1686095	Inhibition of Tie2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	81.0	CHEMBL4128	Homo sapiens	INH	%	81.0
	5245236	CHEMBL1685879	Inhibition of Tie2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	123.0	CHEMBL4128	Homo sapiens	INH	%	123.0
	5246066	CHEMBL1686095	Inhibition of Tie2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	27.0	CHEMBL4128	Homo sapiens	INH	%	27.0
	5293876	CHEMBL1697125	Inhibition of TIE2 after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	67800.0	CHEMBL4128	Homo sapiens	IC50	uM	67.8
	5312990	CHEMBL1694383	Inhibition of recombinant human Tie2 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	Cc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689369	=	Activity	%	70.0	CHEMBL4128	Homo sapiens	Activity	%	70.0
	5312998	CHEMBL1694383	Inhibition of recombinant human Tie2 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	CCOc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689372	=	Activity	%	76.0	CHEMBL4128	Homo sapiens	Activity	%	76.0
Not Active	6149658	CHEMBL1764706	Inhibition of Tie2	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	6157890	CHEMBL1764785	Inhibition of Tie2	B	COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC		CHEMBL1760035	=	IC50	nM	746.0	CHEMBL4128	Homo sapiens	IC50	uM	0.746
	6157891	CHEMBL1764785	Inhibition of Tie2	B	c1ccc2ncc(Nc3ccnc(Nc4ccc(OCCCN5CCCCC5)cc4)n3)cc2c1		CHEMBL1760057	=	IC50	nM	4130.0	CHEMBL4128	Homo sapiens	IC50	uM	4.13
	6167681	CHEMBL1769222	Inhibition of TIE2	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL4128	Homo sapiens	Ki	uM	1.0
	6172480	CHEMBL1767803	Inhibition of Tie2 assessed as residual activity at 25 uM after 20 mins using TK substrate 2 substrate for [gamma-33P]ATP incorporation by liquid scintillation counting	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	Activity	%	84.0	CHEMBL4128	Homo sapiens	Activity	%	84.0
	6210050	CHEMBL1781226	Inhibition of TIE2 at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	14.0	CHEMBL4128	Homo sapiens	INH	%	14.0
	6219909	CHEMBL1785337	Inhibition of human Tie2/TEK using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	2.2	CHEMBL4128	Homo sapiens	IC50	nM	2.2
Not Active	6230346	CHEMBL1785293	Inhibition of human TIE2	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	6262770	CHEMBL1798993	Inhibition of Tie2	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	6265580	CHEMBL1798289	Inhibition of Tie2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4128	Homo sapiens	INH	%	65.0
	6265684	CHEMBL1798289	Inhibition of Tie2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL4128	Homo sapiens	INH	%	65.0
	6339918	CHEMBL1826216	Activity of TIE2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	71.0	CHEMBL4128	Homo sapiens	Activity	%	71.0
	6350154	CHEMBL1825365	Inhibition of TIE2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Inhibition	%	97.0	CHEMBL4128	Homo sapiens	INH	%	97.0
	6350155	CHEMBL1825366	Inhibition of TIE2	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
	6387482	CHEMBL1839932	Inhibition of TIE2-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2051.0	CHEMBL4128	Homo sapiens	IC50	nM	2051.0
	7567193	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	140.0	CHEMBL4128	Homo sapiens	Kd	nM	140.0
	7567652	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7568123	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7568591	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	6700.0	CHEMBL4128	Homo sapiens	Kd	nM	6700.0
	7569166	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7569626	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	270.0	CHEMBL4128	Homo sapiens	Kd	nM	270.0
	7570098	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7570546	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7571142	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7571599	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7572096	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7572512	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	46.0	CHEMBL4128	Homo sapiens	Kd	nM	46.0
	7573123	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1400.0	CHEMBL4128	Homo sapiens	Kd	nM	1400.0
	7573580	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7573614	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7574083	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	7574491	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7575101	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7575591	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7576056	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7576464	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	7577092	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.1	CHEMBL4128	Homo sapiens	Kd	nM	3.1
	7577570	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1100.0	CHEMBL4128	Homo sapiens	Kd	nM	1100.0
	7578040	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2200.0	CHEMBL4128	Homo sapiens	Kd	nM	2200.0
	7578445	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1000.0	CHEMBL4128	Homo sapiens	Kd	nM	1000.0
	7578641	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7579015	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	20.0	CHEMBL4128	Homo sapiens	Kd	nM	20.0
	7579465	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7579939	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7580408	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7580811	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	450.0	CHEMBL4128	Homo sapiens	Kd	nM	450.0
	7580999	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7581384	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7581829	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7582300	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7582764	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	310.0	CHEMBL4128	Homo sapiens	Kd	nM	310.0
	7583164	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7583345	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	450.0	CHEMBL4128	Homo sapiens	Kd	nM	450.0
	7583742	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7584187	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7584658	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7585120	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7585675	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7586083	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	440.0	CHEMBL4128	Homo sapiens	Kd	nM	440.0
	7586529	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7587000	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7587636	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	310.0	CHEMBL4128	Homo sapiens	Kd	nM	310.0
	7588055	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	630.0	CHEMBL4128	Homo sapiens	Kd	nM	630.0
	7588508	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7588988	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7589601	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7590025	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7590524	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7590975	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7591574	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	19.0	CHEMBL4128	Homo sapiens	Kd	nM	19.0
	7591996	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1300.0	CHEMBL4128	Homo sapiens	Kd	nM	1300.0
	7592026	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7592499	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	300.0	CHEMBL4128	Homo sapiens	Kd	nM	300.0
	7592952	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3900.0	CHEMBL4128	Homo sapiens	Kd	nM	3900.0
	7593541	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7594006	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7594479	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1000.0	CHEMBL4128	Homo sapiens	Kd	nM	1000.0
	7594931	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2100.0	CHEMBL4128	Homo sapiens	Kd	nM	2100.0
	7595511	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7595985	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7596456	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	3300.0	CHEMBL4128	Homo sapiens	Kd	nM	3300.0
	7596903	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	140.0	CHEMBL4128	Homo sapiens	Kd	nM	140.0
	7597039	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1900.0	CHEMBL4128	Homo sapiens	Kd	nM	1900.0
	7597492	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7597965	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	3000.0	CHEMBL4128	Homo sapiens	Kd	nM	3000.0
	7598435	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	280.0	CHEMBL4128	Homo sapiens	Kd	nM	280.0
	7598877	CHEMBL1908496	Binding constant for TIE2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4128	Homo sapiens	Kd	nM	10000.0
	7922732	CHEMBL1919413	Inhibition of human recombinant TIE2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	-8.0	CHEMBL4128	Homo sapiens	INH	%	-8.0
	7925726	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926616	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926624	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926632	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926640	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926648	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926656	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926664	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926672	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926680	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926688	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926696	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926704	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926712	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926720	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926728	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926736	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926744	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926752	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926760	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926825	CHEMBL1920515	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7926830	CHEMBL1920331	Inhibition of Tie-2 using Tyr 05 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	7931138	CHEMBL1919475	Inhibition of TEK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	13.0	CHEMBL4128	Homo sapiens	INH	%	13.0
	7956225	CHEMBL1924888	Inhibition of N-terminus flag-tagged TIE2 expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	7961167	CHEMBL1931565	Inhibition of TIE2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	50000.0	CHEMBL4128	Homo sapiens	IC50	uM	50.0
	7961168	CHEMBL1931565	Inhibition of TIE2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	25.0	CHEMBL4128	Homo sapiens	IC50	uM	0.025
	7969805	CHEMBL1930377	Inhibition of TIE2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	65.0	CHEMBL4128	Homo sapiens	Activity	%	65.0
	7991161	CHEMBL1937313	Inhibition of Tie2	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	7992222	CHEMBL1936094	Inhibition of Tie2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	90.0	CHEMBL4128	Homo sapiens	INH	%	90.0
	7996731	CHEMBL1944383	Inhibition of TIE2 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	96.0	CHEMBL4128	Homo sapiens	INH	%	96.0
	8002128	CHEMBL1942192	Inhibition of TEK at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	8002129	CHEMBL1942192	Inhibition of TEK at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	19.0	CHEMBL4128	Homo sapiens	INH	%	19.0
	8002130	CHEMBL1942192	Inhibition of TEK at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
Not Active	8012283	CHEMBL1941708	Inhibition of TIE2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	8012284	CHEMBL1941708	Inhibition of TIE2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	8012285	CHEMBL1941708	Inhibition of TIE2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	8012286	CHEMBL1941708	Inhibition of TIE2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	8018918	CHEMBL1949068	Inhibition of Tie2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	86.0	CHEMBL4128	Homo sapiens	Activity	%	86.0
	8018919	CHEMBL1949068	Inhibition of Tie2 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	85.0	CHEMBL4128	Homo sapiens	Activity	%	85.0
	8018920	CHEMBL1949068	Inhibition of Tie2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	83.0	CHEMBL4128	Homo sapiens	Activity	%	83.0
	8045869	CHEMBL1959348	Inhibition of human GST-tagged Tie2 using biotin-(6-amino caproic acid)-LEARLVAYEGWVAGKKK-NH2 after 2 hrs by homogenous time-resolved fluorescence method	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	8047178	CHEMBL1959407	Inhibition of TIE2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	8059500	CHEMBL1958979	Inhibition of Tie2	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	200.0	CHEMBL4128	Homo sapiens	Ki	uM	0.2
	8060137	CHEMBL1961236	Inhibition of human recombinant TIE2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL4128	Homo sapiens	IC50	uM	35.0
	8060138	CHEMBL1961236	Inhibition of human recombinant TIE2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	260.0	CHEMBL4128	Homo sapiens	IC50	uM	0.26
	8061378	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.65	CHEMBL4128	Homo sapiens	Inhibition	%	3.65
	8061602	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	31.69	CHEMBL4128	Homo sapiens	Inhibition	%	31.69
	8061709	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.95	CHEMBL4128	Homo sapiens	Inhibition	%	2.95
	8062124	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.82	CHEMBL4128	Homo sapiens	Inhibition	%	2.82
	8062240	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.29	CHEMBL4128	Homo sapiens	Inhibition	%	5.29
	8062464	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.46	CHEMBL4128	Homo sapiens	Inhibition	%	1.46
	8062626	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.84	CHEMBL4128	Homo sapiens	Inhibition	%	7.84
	8062948	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.72	CHEMBL4128	Homo sapiens	Inhibition	%	2.72
	8063080	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.33	CHEMBL4128	Homo sapiens	Inhibition	%	4.33
	8063471	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.94	CHEMBL4128	Homo sapiens	Inhibition	%	4.94
	8063579	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.52	CHEMBL4128	Homo sapiens	Inhibition	%	4.52
	8063803	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.33	CHEMBL4128	Homo sapiens	Inhibition	%	5.33
	8063985	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.24	CHEMBL4128	Homo sapiens	Inhibition	%	5.24
	8064324	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.07	CHEMBL4128	Homo sapiens	Inhibition	%	2.07
	8064534	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.52	CHEMBL4128	Homo sapiens	Inhibition	%	1.52
	8064672	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	21.03	CHEMBL4128	Homo sapiens	Inhibition	%	21.03
	8064896	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.1	CHEMBL4128	Homo sapiens	Inhibition	%	2.1
	8065062	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.42	CHEMBL4128	Homo sapiens	Inhibition	%	4.42
	8065402	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.38	CHEMBL4128	Homo sapiens	Inhibition	%	5.38
	8065577	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.09	CHEMBL4128	Homo sapiens	Inhibition	%	4.09
	8065916	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.52	CHEMBL4128	Homo sapiens	Inhibition	%	2.52
	8066126	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.73	CHEMBL4128	Homo sapiens	Inhibition	%	4.73
	8066486	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	8.87	CHEMBL4128	Homo sapiens	Inhibition	%	8.87
	8066652	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.75	CHEMBL4128	Homo sapiens	Inhibition	%	2.75
	8067000	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	31.28	CHEMBL4128	Homo sapiens	Inhibition	%	31.28
	8067175	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	10.55	CHEMBL4128	Homo sapiens	Inhibition	%	10.55
	8067399	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.47	CHEMBL4128	Homo sapiens	Inhibition	%	5.47
	8067520	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.62	CHEMBL4128	Homo sapiens	Inhibition	%	4.62
	8067730	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.53	CHEMBL4128	Homo sapiens	Inhibition	%	2.53
	8067954	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.08	CHEMBL4128	Homo sapiens	Inhibition	%	5.08
	8068089	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	7.05	CHEMBL4128	Homo sapiens	Inhibition	%	7.05
	8068253	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.88	CHEMBL4128	Homo sapiens	Inhibition	%	5.88
	8068477	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.48	CHEMBL4128	Homo sapiens	Inhibition	%	0.48
	8068602	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	54.01	CHEMBL4128	Homo sapiens	Inhibition	%	54.01
	8069000	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	10.93	CHEMBL4128	Homo sapiens	Inhibition	%	10.93
	8069125	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.2	CHEMBL4128	Homo sapiens	Inhibition	%	3.2
	8069420	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	39.57	CHEMBL4128	Homo sapiens	Inhibition	%	39.57
	8069805	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.45	CHEMBL4128	Homo sapiens	Inhibition	%	2.45
	8069931	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.49	CHEMBL4128	Homo sapiens	Inhibition	%	1.49
	8070155	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.44	CHEMBL4128	Homo sapiens	Inhibition	%	2.44
	8070327	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	53.31	CHEMBL4128	Homo sapiens	Inhibition	%	53.31
	8070452	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.76	CHEMBL4128	Homo sapiens	Inhibition	%	4.76
	8070676	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.71	CHEMBL4128	Homo sapiens	Inhibition	%	4.71
	8070750	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.96	CHEMBL4128	Homo sapiens	Inhibition	%	3.96
	8070974	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	31.09	CHEMBL4128	Homo sapiens	Inhibition	%	31.09
	8071131	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.08	CHEMBL4128	Homo sapiens	Inhibition	%	2.08
	8071481	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.2	CHEMBL4128	Homo sapiens	Inhibition	%	1.2
	8071654	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	83.18	CHEMBL4128	Homo sapiens	Inhibition	%	83.18
	8072003	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	6.64	CHEMBL4128	Homo sapiens	Inhibition	%	6.64
	8072317	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.09	CHEMBL4128	Homo sapiens	Inhibition	%	1.09
	8072474	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.32	CHEMBL4128	Homo sapiens	Inhibition	%	2.32
	8072823	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.33	CHEMBL4128	Homo sapiens	Inhibition	%	3.33
	8072990	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	7.26	CHEMBL4128	Homo sapiens	Inhibition	%	7.26
	8073339	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	50.76	CHEMBL4128	Homo sapiens	Inhibition	%	50.76
	8073682	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.15	CHEMBL4128	Homo sapiens	Inhibition	%	-0.15
	8073915	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	5.44	CHEMBL4128	Homo sapiens	Inhibition	%	5.44
	8074067	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	5.37	CHEMBL4128	Homo sapiens	Inhibition	%	5.37
	8074291	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	9.24	CHEMBL4128	Homo sapiens	Inhibition	%	9.24
	8074421	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.94	CHEMBL4128	Homo sapiens	Inhibition	%	1.94
	8074578	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	13.68	CHEMBL4128	Homo sapiens	Inhibition	%	13.68
	8074802	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.62	CHEMBL4128	Homo sapiens	Inhibition	%	3.62
	8074929	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	77.97	CHEMBL4128	Homo sapiens	Inhibition	%	77.97
	8075264	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.63	CHEMBL4128	Homo sapiens	Inhibition	%	2.63
	8075501	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.79	CHEMBL4128	Homo sapiens	Inhibition	%	2.79
	8075866	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.75	CHEMBL4128	Homo sapiens	Inhibition	%	1.75
	8076008	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.94	CHEMBL4128	Homo sapiens	Inhibition	%	3.94
	8076380	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.3	CHEMBL4128	Homo sapiens	Inhibition	%	4.3
	8076514	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.15	CHEMBL4128	Homo sapiens	Inhibition	%	3.15
	8076738	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	7.32	CHEMBL4128	Homo sapiens	Inhibition	%	7.32
	8076840	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.37	CHEMBL4128	Homo sapiens	Inhibition	%	1.37
	8077087	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.96	CHEMBL4128	Homo sapiens	Inhibition	%	3.96
	8077439	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.22	CHEMBL4128	Homo sapiens	Inhibition	%	4.22
	8077590	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.94	CHEMBL4128	Homo sapiens	Inhibition	%	1.94
	8077814	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.83	CHEMBL4128	Homo sapiens	Inhibition	%	4.83
	8077957	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.5	CHEMBL4128	Homo sapiens	Inhibition	%	3.5
	8078320	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.97	CHEMBL4128	Homo sapiens	Inhibition	%	2.97
	8078422	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.99	CHEMBL4128	Homo sapiens	Inhibition	%	1.99
	8078646	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.37	CHEMBL4128	Homo sapiens	Inhibition	%	1.37
	8078672	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.63	CHEMBL4128	Homo sapiens	Inhibition	%	2.63
	8078896	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	11.39	CHEMBL4128	Homo sapiens	Inhibition	%	11.39
	8079012	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.65	CHEMBL4128	Homo sapiens	Inhibition	%	3.65
	8079394	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.55	CHEMBL4128	Homo sapiens	Inhibition	%	2.55
	8079536	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	14.92	CHEMBL4128	Homo sapiens	Inhibition	%	14.92
	8079899	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	21.74	CHEMBL4128	Homo sapiens	Inhibition	%	21.74
	8080228	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.77	CHEMBL4128	Homo sapiens	Inhibition	%	1.77
	8080480	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.75	CHEMBL4128	Homo sapiens	Inhibition	%	0.75
	8080595	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.45	CHEMBL4128	Homo sapiens	Inhibition	%	5.45
	8080819	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.79	CHEMBL4128	Homo sapiens	Inhibition	%	2.79
	8080983	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	14.57	CHEMBL4128	Homo sapiens	Inhibition	%	14.57
	8081118	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.18	CHEMBL4128	Homo sapiens	Inhibition	%	2.18
	8081342	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.24	CHEMBL4128	Homo sapiens	Inhibition	%	2.24
	8081486	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.84	CHEMBL4128	Homo sapiens	Inhibition	%	2.84
	8081813	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.54	CHEMBL4128	Homo sapiens	Inhibition	%	1.54
	8082065	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	7.91	CHEMBL4128	Homo sapiens	Inhibition	%	7.91
	8082402	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.45	CHEMBL4128	Homo sapiens	Inhibition	%	5.45
	8082575	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.35	CHEMBL4128	Homo sapiens	Inhibition	%	-0.35
	8082922	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.59	CHEMBL4128	Homo sapiens	Inhibition	%	2.59
	8083078	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.59	CHEMBL4128	Homo sapiens	Inhibition	%	4.59
	8083401	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.61	CHEMBL4128	Homo sapiens	Inhibition	%	3.61
	8083655	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.78	CHEMBL4128	Homo sapiens	Inhibition	%	1.78
	8083989	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.13	CHEMBL4128	Homo sapiens	Inhibition	%	3.13
	8084174	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.51	CHEMBL4128	Homo sapiens	Inhibition	%	1.51
	8084516	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.2	CHEMBL4128	Homo sapiens	Inhibition	%	1.2
	8084677	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.3	CHEMBL4128	Homo sapiens	Inhibition	%	2.3
	8084901	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.99	CHEMBL4128	Homo sapiens	Inhibition	%	5.99
	8084999	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.52	CHEMBL4128	Homo sapiens	Inhibition	%	1.52
	8085255	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.18	CHEMBL4128	Homo sapiens	Inhibition	%	3.18
	8085587	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.56	CHEMBL4128	Homo sapiens	Inhibition	%	2.56
	8085776	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	5.02	CHEMBL4128	Homo sapiens	Inhibition	%	5.02
	8086000	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	11.49	CHEMBL4128	Homo sapiens	Inhibition	%	11.49
	8086115	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.74	CHEMBL4128	Homo sapiens	Inhibition	%	2.74
	8086501	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.01	CHEMBL4128	Homo sapiens	Inhibition	%	3.01
	8086600	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	7.04	CHEMBL4128	Homo sapiens	Inhibition	%	7.04
	8086824	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.16	CHEMBL4128	Homo sapiens	Inhibition	%	2.16
	8087035	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.91	CHEMBL4128	Homo sapiens	Inhibition	%	5.91
	8087193	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.99	CHEMBL4128	Homo sapiens	Inhibition	%	3.99
	8087531	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	46.28	CHEMBL4128	Homo sapiens	Inhibition	%	46.28
	8087893	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	16.74	CHEMBL4128	Homo sapiens	Inhibition	%	16.74
	8088035	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.61	CHEMBL4128	Homo sapiens	Inhibition	%	6.61
	8088407	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.34	CHEMBL4128	Homo sapiens	Inhibition	%	0.34
	8088535	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.24	CHEMBL4128	Homo sapiens	Inhibition	%	7.24
	8088759	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.95	CHEMBL4128	Homo sapiens	Inhibition	%	4.95
	8088852	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.56	CHEMBL4128	Homo sapiens	Inhibition	%	0.56
	8089204	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.02	CHEMBL4128	Homo sapiens	Inhibition	%	4.02
	8089352	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.32	CHEMBL4128	Homo sapiens	Inhibition	%	2.32
	8089576	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.37	CHEMBL4128	Homo sapiens	Inhibition	%	0.37
	8089696	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	7.88	CHEMBL4128	Homo sapiens	Inhibition	%	7.88
	8089876	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.2	CHEMBL4128	Homo sapiens	Inhibition	%	1.2
	8090100	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.87	CHEMBL4128	Homo sapiens	Inhibition	%	3.87
	8090265	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.46	CHEMBL4128	Homo sapiens	Inhibition	%	4.46
	8090432	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.65	CHEMBL4128	Homo sapiens	Inhibition	%	6.65
	8090656	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.19	CHEMBL4128	Homo sapiens	Inhibition	%	4.19
	8090795	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.44	CHEMBL4128	Homo sapiens	Inhibition	%	7.44
	8091000	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	9.2	CHEMBL4128	Homo sapiens	Inhibition	%	9.2
	8091224	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.24	CHEMBL4128	Homo sapiens	Inhibition	%	1.24
	8091361	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.57	CHEMBL4128	Homo sapiens	Inhibition	%	3.57
	8091516	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.73	CHEMBL4128	Homo sapiens	Inhibition	%	4.73
	8091740	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.22	CHEMBL4128	Homo sapiens	Inhibition	%	6.22
	8091856	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.33	CHEMBL4128	Homo sapiens	Inhibition	%	0.33
	8092217	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.49	CHEMBL4128	Homo sapiens	Inhibition	%	-0.49
	8092368	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.14	CHEMBL4128	Homo sapiens	Inhibition	%	5.14
	8092592	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.64	CHEMBL4128	Homo sapiens	Inhibition	%	8.64
	8092740	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.58	CHEMBL4128	Homo sapiens	Inhibition	%	0.58
	8093093	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	24.2	CHEMBL4128	Homo sapiens	Inhibition	%	24.2
	8093181	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.01	CHEMBL4128	Homo sapiens	Inhibition	%	-0.01
	8093405	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.38	CHEMBL4128	Homo sapiens	Inhibition	%	2.38
	8093545	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	10.1	CHEMBL4128	Homo sapiens	Inhibition	%	10.1
	8093908	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.74	CHEMBL4128	Homo sapiens	Inhibition	%	3.74
	8094028	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.48	CHEMBL4128	Homo sapiens	Inhibition	%	0.48
	8094432	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.4	CHEMBL4128	Homo sapiens	Inhibition	%	2.4
	8094607	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.66	CHEMBL4128	Homo sapiens	Inhibition	%	2.66
	8094987	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.74	CHEMBL4128	Homo sapiens	Inhibition	%	5.74
	8095127	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	36.03	CHEMBL4128	Homo sapiens	Inhibition	%	36.03
	8095554	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.15	CHEMBL4128	Homo sapiens	Inhibition	%	4.15
	8095695	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.32	CHEMBL4128	Homo sapiens	Inhibition	%	3.32
	8096067	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.78	CHEMBL4128	Homo sapiens	Inhibition	%	4.78
	8096184	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.44	CHEMBL4128	Homo sapiens	Inhibition	%	6.44
	8096408	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.42	CHEMBL4128	Homo sapiens	Inhibition	%	1.42
	8096547	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.7	CHEMBL4128	Homo sapiens	Inhibition	%	1.7
	8096927	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	10.7	CHEMBL4128	Homo sapiens	Inhibition	%	10.7
	8097074	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.07	CHEMBL4128	Homo sapiens	Inhibition	%	1.07
	8097385	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	7.48	CHEMBL4128	Homo sapiens	Inhibition	%	7.48
	8097605	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.06	CHEMBL4128	Homo sapiens	Inhibition	%	5.06
	8097755	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.25	CHEMBL4128	Homo sapiens	Inhibition	%	1.25
	8098112	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.97	CHEMBL4128	Homo sapiens	Inhibition	%	1.97
	8098232	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	7.52	CHEMBL4128	Homo sapiens	Inhibition	%	7.52
	8098456	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.48	CHEMBL4128	Homo sapiens	Inhibition	%	-1.48
	8098636	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	5.27	CHEMBL4128	Homo sapiens	Inhibition	%	5.27
	8098821	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.35	CHEMBL4128	Homo sapiens	Inhibition	%	4.35
	8099189	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.15	CHEMBL4128	Homo sapiens	Inhibition	%	3.15
	8099331	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	79.25	CHEMBL4128	Homo sapiens	Inhibition	%	79.25
	8099555	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.54	CHEMBL4128	Homo sapiens	Inhibition	%	1.54
	8099749	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.54	CHEMBL4128	Homo sapiens	Inhibition	%	1.54
	8099896	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.76	CHEMBL4128	Homo sapiens	Inhibition	%	3.76
	8100120	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.38	CHEMBL4128	Homo sapiens	Inhibition	%	4.38
	8100266	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	10.15	CHEMBL4128	Homo sapiens	Inhibition	%	10.15
	8100606	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.06	CHEMBL4128	Homo sapiens	Inhibition	%	6.06
	8100746	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.37	CHEMBL4128	Homo sapiens	Inhibition	%	0.37
	8101130	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.23	CHEMBL4128	Homo sapiens	Inhibition	%	5.23
	8101272	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.01	CHEMBL4128	Homo sapiens	Inhibition	%	2.01
	8101496	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.66	CHEMBL4128	Homo sapiens	Inhibition	%	0.66
	8101681	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.72	CHEMBL4128	Homo sapiens	Inhibition	%	1.72
	8101934	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.98	CHEMBL4128	Homo sapiens	Inhibition	%	4.98
	8102089	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	10.36	CHEMBL4128	Homo sapiens	Inhibition	%	10.36
	8102313	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	9.12	CHEMBL4128	Homo sapiens	Inhibition	%	9.12
	8102444	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	7.16	CHEMBL4128	Homo sapiens	Inhibition	%	7.16
	8102788	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.47	CHEMBL4128	Homo sapiens	Inhibition	%	3.47
	8102966	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.64	CHEMBL4128	Homo sapiens	Inhibition	%	2.64
	8103162	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.7	CHEMBL4128	Homo sapiens	Inhibition	%	3.7
	8103386	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.91	CHEMBL4128	Homo sapiens	Inhibition	%	5.91
	8103524	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.19	CHEMBL4128	Homo sapiens	Inhibition	%	4.19
	8103898	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	8.41	CHEMBL4128	Homo sapiens	Inhibition	%	8.41
	8104083	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.72	CHEMBL4128	Homo sapiens	Inhibition	%	3.72
	8104455	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.1	CHEMBL4128	Homo sapiens	Inhibition	%	5.1
	8104601	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.92	CHEMBL4128	Homo sapiens	Inhibition	%	3.92
	8104939	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.13	CHEMBL4128	Homo sapiens	Inhibition	%	3.13
	8105079	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.08	CHEMBL4128	Homo sapiens	Inhibition	%	1.08
	8105303	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.53	CHEMBL4128	Homo sapiens	Inhibition	%	-0.53
	8105469	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.4	CHEMBL4128	Homo sapiens	Inhibition	%	6.4
	8105831	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.14	CHEMBL4128	Homo sapiens	Inhibition	%	5.14
	8106111	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.44	CHEMBL4128	Homo sapiens	Inhibition	%	1.44
	8106276	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	27.53	CHEMBL4128	Homo sapiens	Inhibition	%	27.53
	8106656	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	47.5	CHEMBL4128	Homo sapiens	Inhibition	%	47.5
	8106785	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.38	CHEMBL4128	Homo sapiens	Inhibition	%	4.38
	8107130	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.17	CHEMBL4128	Homo sapiens	Inhibition	%	-0.17
	8107302	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.4	CHEMBL4128	Homo sapiens	Inhibition	%	3.4
	8107526	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.07	CHEMBL4128	Homo sapiens	Inhibition	%	2.07
	8107727	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.74	CHEMBL4128	Homo sapiens	Inhibition	%	6.74
	8107862	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.74	CHEMBL4128	Homo sapiens	Inhibition	%	1.74
	8108086	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	10.14	CHEMBL4128	Homo sapiens	Inhibition	%	10.14
	8108244	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.19	CHEMBL4128	Homo sapiens	Inhibition	%	2.19
	8108419	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	17.06	CHEMBL4128	Homo sapiens	Inhibition	%	17.06
	8108790	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.83	CHEMBL4128	Homo sapiens	Inhibition	%	4.83
	8108932	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.65	CHEMBL4128	Homo sapiens	Inhibition	%	4.65
	8109156	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.25	CHEMBL4128	Homo sapiens	Inhibition	%	3.25
	8109270	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	8.62	CHEMBL4128	Homo sapiens	Inhibition	%	8.62
	8109624	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.87	CHEMBL4128	Homo sapiens	Inhibition	%	0.87
	8109795	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.19	CHEMBL4128	Homo sapiens	Inhibition	%	7.19
	8110151	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.94	CHEMBL4128	Homo sapiens	Inhibition	%	3.94
	8110430	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	7.33	CHEMBL4128	Homo sapiens	Inhibition	%	7.33
	8110596	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.61	CHEMBL4128	Homo sapiens	Inhibition	%	5.61
	8110820	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	9.58	CHEMBL4128	Homo sapiens	Inhibition	%	9.58
	8110978	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.84	CHEMBL4128	Homo sapiens	Inhibition	%	0.84
	8111101	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	14.0	CHEMBL4128	Homo sapiens	Inhibition	%	14.0
	8111325	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	46.17	CHEMBL4128	Homo sapiens	Inhibition	%	46.17
	8111452	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	6.2	CHEMBL4128	Homo sapiens	Inhibition	%	6.2
	8111842	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.72	CHEMBL4128	Homo sapiens	Inhibition	%	3.72
	8112047	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.06	CHEMBL4128	Homo sapiens	Inhibition	%	5.06
	8112408	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.73	CHEMBL4128	Homo sapiens	Inhibition	%	0.73
	8112576	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.86	CHEMBL4128	Homo sapiens	Inhibition	%	9.86
	8112748	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	44.67	CHEMBL4128	Homo sapiens	Inhibition	%	44.67
	8112972	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.86	CHEMBL4128	Homo sapiens	Inhibition	%	1.86
	8113124	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	19.78	CHEMBL4128	Homo sapiens	Inhibition	%	19.78
	8113484	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.48	CHEMBL4128	Homo sapiens	Inhibition	%	2.48
	8113608	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.14	CHEMBL4128	Homo sapiens	Inhibition	%	-0.14
	8113948	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.84	CHEMBL4128	Homo sapiens	Inhibition	%	-0.84
	8114124	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	11.9	CHEMBL4128	Homo sapiens	Inhibition	%	11.9
	8114348	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.37	CHEMBL4128	Homo sapiens	Inhibition	%	3.37
	8114480	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.85	CHEMBL4128	Homo sapiens	Inhibition	%	7.85
	8114756	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.79	CHEMBL4128	Homo sapiens	Inhibition	%	1.79
	8115146	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	63.7	CHEMBL4128	Homo sapiens	Inhibition	%	63.7
	8115311	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.39	CHEMBL4128	Homo sapiens	Inhibition	%	-0.39
	8115655	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	55.68	CHEMBL4128	Homo sapiens	Inhibition	%	55.68
	8115788	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.35	CHEMBL4128	Homo sapiens	Inhibition	%	-0.35
	8116012	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	4.39	CHEMBL4128	Homo sapiens	Inhibition	%	4.39
	8116171	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.74	CHEMBL4128	Homo sapiens	Inhibition	%	-0.74
	8116374	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.9	CHEMBL4128	Homo sapiens	Inhibition	%	4.9
	8116732	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.25	CHEMBL4128	Homo sapiens	Inhibition	%	2.25
	8116904	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.99	CHEMBL4128	Homo sapiens	Inhibition	%	2.99
	8117299	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.86	CHEMBL4128	Homo sapiens	Inhibition	%	4.86
	8117457	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.67	CHEMBL4128	Homo sapiens	Inhibition	%	2.67
	8117811	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	7.47	CHEMBL4128	Homo sapiens	Inhibition	%	7.47
	8117949	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.85	CHEMBL4128	Homo sapiens	Inhibition	%	4.85
	8118173	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.38	CHEMBL4128	Homo sapiens	Inhibition	%	0.38
	8118289	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.36	CHEMBL4128	Homo sapiens	Inhibition	%	1.36
	8118685	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.84	CHEMBL4128	Homo sapiens	Inhibition	%	4.84
	8118821	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.1	CHEMBL4128	Homo sapiens	Inhibition	%	4.1
	8119092	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.17	CHEMBL4128	Homo sapiens	Inhibition	%	4.17
	8119475	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	79.02	CHEMBL4128	Homo sapiens	Inhibition	%	79.02
	8119642	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.08	CHEMBL4128	Homo sapiens	Inhibition	%	-1.08
	8119985	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	7.71	CHEMBL4128	Homo sapiens	Inhibition	%	7.71
	8120348	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.68	CHEMBL4128	Homo sapiens	Inhibition	%	-0.68
	8120508	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.79	CHEMBL4128	Homo sapiens	Inhibition	%	0.79
	8120709	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.81	CHEMBL4128	Homo sapiens	Inhibition	%	4.81
	8120933	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.95	CHEMBL4128	Homo sapiens	Inhibition	%	7.95
	8121061	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.55	CHEMBL4128	Homo sapiens	Inhibition	%	1.55
	8121233	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	11.08	CHEMBL4128	Homo sapiens	Inhibition	%	11.08
	8121457	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.43	CHEMBL4128	Homo sapiens	Inhibition	%	-0.43
	8121624	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.8	CHEMBL4128	Homo sapiens	Inhibition	%	0.8
	8121787	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.8	CHEMBL4128	Homo sapiens	Inhibition	%	6.8
	8122011	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	Inhibition	%	2.0
	8122132	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.67	CHEMBL4128	Homo sapiens	Inhibition	%	9.67
	8122494	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.09	CHEMBL4128	Homo sapiens	Inhibition	%	3.09
	8122614	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.29	CHEMBL4128	Homo sapiens	Inhibition	%	5.29
	8122838	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.54	CHEMBL4128	Homo sapiens	Inhibition	%	7.54
	8123005	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.23	CHEMBL4128	Homo sapiens	Inhibition	%	3.23
	8123147	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.76	CHEMBL4128	Homo sapiens	Inhibition	%	6.76
	8123371	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.11	CHEMBL4128	Homo sapiens	Inhibition	%	6.11
	8123425	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.55	CHEMBL4128	Homo sapiens	Inhibition	%	0.55
	8123649	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.17	CHEMBL4128	Homo sapiens	Inhibition	%	0.17
	8123799	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	12.96	CHEMBL4128	Homo sapiens	Inhibition	%	12.96
	8123966	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.93	CHEMBL4128	Homo sapiens	Inhibition	%	2.93
	8124190	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.9	CHEMBL4128	Homo sapiens	Inhibition	%	-0.9
	8124309	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.89	CHEMBL4128	Homo sapiens	Inhibition	%	5.89
	8124672	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	6.26	CHEMBL4128	Homo sapiens	Inhibition	%	6.26
	8124837	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.41	CHEMBL4128	Homo sapiens	Inhibition	%	0.41
	8125262	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.66	CHEMBL4128	Homo sapiens	Inhibition	%	3.66
	8125392	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.02	CHEMBL4128	Homo sapiens	Inhibition	%	3.02
	8125784	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.3	CHEMBL4128	Homo sapiens	Inhibition	%	2.3
	8125948	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.33	CHEMBL4128	Homo sapiens	Inhibition	%	3.33
	8126336	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.42	CHEMBL4128	Homo sapiens	Inhibition	%	6.42
	8126451	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	59.35	CHEMBL4128	Homo sapiens	Inhibition	%	59.35
	8126675	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	80.61	CHEMBL4128	Homo sapiens	Inhibition	%	80.61
	8126811	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	0.38	CHEMBL4128	Homo sapiens	Inhibition	%	0.38
	8127157	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.79	CHEMBL4128	Homo sapiens	Inhibition	%	3.79
	8127324	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.78	CHEMBL4128	Homo sapiens	Inhibition	%	5.78
	8127690	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	20.9	CHEMBL4128	Homo sapiens	Inhibition	%	20.9
	8127978	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.33	CHEMBL4128	Homo sapiens	Inhibition	%	1.33
	8128130	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	52.35	CHEMBL4128	Homo sapiens	Inhibition	%	52.35
	8128521	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	9.67	CHEMBL4128	Homo sapiens	Inhibition	%	9.67
	8128640	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	5.94	CHEMBL4128	Homo sapiens	Inhibition	%	5.94
	8128864	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	21.32	CHEMBL4128	Homo sapiens	Inhibition	%	21.32
	8129001	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%		CHEMBL4128	Homo sapiens	Inhibition	%	
	8129172	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	5.18	CHEMBL4128	Homo sapiens	Inhibition	%	5.18
	8129396	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.77	CHEMBL4128	Homo sapiens	Inhibition	%	0.77
	8129585	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.41	CHEMBL4128	Homo sapiens	Inhibition	%	4.41
	8129724	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.38	CHEMBL4128	Homo sapiens	Inhibition	%	1.38
	8129948	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.88	CHEMBL4128	Homo sapiens	Inhibition	%	1.88
	8130109	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.95	CHEMBL4128	Homo sapiens	Inhibition	%	1.95
	8130281	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.84	CHEMBL4128	Homo sapiens	Inhibition	%	1.84
	8130505	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.91	CHEMBL4128	Homo sapiens	Inhibition	%	2.91
	8130665	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.9	CHEMBL4128	Homo sapiens	Inhibition	%	3.9
	8131005	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.55	CHEMBL4128	Homo sapiens	Inhibition	%	1.55
	8131144	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	10.44	CHEMBL4128	Homo sapiens	Inhibition	%	10.44
	8131488	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.32	CHEMBL4128	Homo sapiens	Inhibition	%	4.32
	8131655	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.21	CHEMBL4128	Homo sapiens	Inhibition	%	4.21
	8131879	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	14.09	CHEMBL4128	Homo sapiens	Inhibition	%	14.09
	8132020	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	56.35	CHEMBL4128	Homo sapiens	Inhibition	%	56.35
	8132306	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.09	CHEMBL4128	Homo sapiens	Inhibition	%	3.09
	8132453	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.65	CHEMBL4128	Homo sapiens	Inhibition	%	5.65
	8132677	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	10.67	CHEMBL4128	Homo sapiens	Inhibition	%	10.67
	8132845	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.85	CHEMBL4128	Homo sapiens	Inhibition	%	-0.85
	8133190	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.58	CHEMBL4128	Homo sapiens	Inhibition	%	0.58
	8133328	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.76	CHEMBL4128	Homo sapiens	Inhibition	%	4.76
	8133724	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	11.55	CHEMBL4128	Homo sapiens	Inhibition	%	11.55
	8133904	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	33.17	CHEMBL4128	Homo sapiens	Inhibition	%	33.17
	8134276	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.49	CHEMBL4128	Homo sapiens	Inhibition	%	2.49
	8134436	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.61	CHEMBL4128	Homo sapiens	Inhibition	%	3.61
	8134844	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.36	CHEMBL4128	Homo sapiens	Inhibition	%	0.36
	8135004	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	12.18	CHEMBL4128	Homo sapiens	Inhibition	%	12.18
	8135343	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.73	CHEMBL4128	Homo sapiens	Inhibition	%	4.73
	8135484	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.74	CHEMBL4128	Homo sapiens	Inhibition	%	0.74
	8135708	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.82	CHEMBL4128	Homo sapiens	Inhibition	%	5.82
	8135829	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.93	CHEMBL4128	Homo sapiens	Inhibition	%	4.93
	8136221	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.3	CHEMBL4128	Homo sapiens	Inhibition	%	5.3
	8136365	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	74.38	CHEMBL4128	Homo sapiens	Inhibition	%	74.38
	8136655	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.26	CHEMBL4128	Homo sapiens	Inhibition	%	0.26
	8137014	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.31	CHEMBL4128	Homo sapiens	Inhibition	%	2.31
	8137177	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.09	CHEMBL4128	Homo sapiens	Inhibition	%	4.09
	8137521	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.03	CHEMBL4128	Homo sapiens	Inhibition	%	4.03
	8137669	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.5	CHEMBL4128	Homo sapiens	Inhibition	%	1.5
	8137893	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	10.28	CHEMBL4128	Homo sapiens	Inhibition	%	10.28
	8138059	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.22	CHEMBL4128	Homo sapiens	Inhibition	%	-1.22
	8138238	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	67.11	CHEMBL4128	Homo sapiens	Inhibition	%	67.11
	8138462	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.84	CHEMBL4128	Homo sapiens	Inhibition	%	5.84
	8138610	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.73	CHEMBL4128	Homo sapiens	Inhibition	%	2.73
	8138768	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.56	CHEMBL4128	Homo sapiens	Inhibition	%	1.56
	8138992	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.38	CHEMBL4128	Homo sapiens	Inhibition	%	3.38
	8139177	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.36	CHEMBL4128	Homo sapiens	Inhibition	%	2.36
	8139336	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.01	CHEMBL4128	Homo sapiens	Inhibition	%	2.01
	8139560	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	8.32	CHEMBL4128	Homo sapiens	Inhibition	%	8.32
	8139674	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.1	CHEMBL4128	Homo sapiens	Inhibition	%	0.1
	8140039	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.66	CHEMBL4128	Homo sapiens	Inhibition	%	3.66
	8140162	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.93	CHEMBL4128	Homo sapiens	Inhibition	%	3.93
	8140386	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.07	CHEMBL4128	Homo sapiens	Inhibition	%	4.07
	8140545	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.37	CHEMBL4128	Homo sapiens	Inhibition	%	4.37
	8140688	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.45	CHEMBL4128	Homo sapiens	Inhibition	%	7.45
	8140912	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.33	CHEMBL4128	Homo sapiens	Inhibition	%	12.33
	8140990	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.24	CHEMBL4128	Homo sapiens	Inhibition	%	2.24
	8141344	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.81	CHEMBL4128	Homo sapiens	Inhibition	%	4.81
	8141504	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	8.93	CHEMBL4128	Homo sapiens	Inhibition	%	8.93
	8141728	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	36.19	CHEMBL4128	Homo sapiens	Inhibition	%	36.19
	8141847	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.16	CHEMBL4128	Homo sapiens	Inhibition	%	-0.16
	8142232	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.07	CHEMBL4128	Homo sapiens	Inhibition	%	8.07
	8142400	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.44	CHEMBL4128	Homo sapiens	Inhibition	%	3.44
	8142800	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.51	CHEMBL4128	Homo sapiens	Inhibition	%	6.51
	8142949	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.76	CHEMBL4128	Homo sapiens	Inhibition	%	-0.76
	8143328	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.84	CHEMBL4128	Homo sapiens	Inhibition	%	1.84
	8143515	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.71	CHEMBL4128	Homo sapiens	Inhibition	%	4.71
	8143898	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.55	CHEMBL4128	Homo sapiens	Inhibition	%	3.55
	8144012	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.31	CHEMBL4128	Homo sapiens	Inhibition	%	4.31
	8144375	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.42	CHEMBL4128	Homo sapiens	Inhibition	%	5.42
	8144729	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.55	CHEMBL4128	Homo sapiens	Inhibition	%	2.55
	8144882	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.3	CHEMBL4128	Homo sapiens	Inhibition	%	2.3
	8145243	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.73	CHEMBL4128	Homo sapiens	Inhibition	%	5.73
	8145332	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.77	CHEMBL4128	Homo sapiens	Inhibition	%	-0.77
	8145556	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.37	CHEMBL4128	Homo sapiens	Inhibition	%	1.37
	8145680	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.28	CHEMBL4128	Homo sapiens	Inhibition	%	5.28
	8146065	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	64.25	CHEMBL4128	Homo sapiens	Inhibition	%	64.25
	8146185	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.69	CHEMBL4128	Homo sapiens	Inhibition	%	7.69
	8146409	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	21.09	CHEMBL4128	Homo sapiens	Inhibition	%	21.09
	8146569	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	45.88	CHEMBL4128	Homo sapiens	Inhibition	%	45.88
	8146736	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	5.78	CHEMBL4128	Homo sapiens	Inhibition	%	5.78
	8147129	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.98	CHEMBL4128	Homo sapiens	Inhibition	%	5.98
	8147271	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.28	CHEMBL4128	Homo sapiens	Inhibition	%	-0.28
	8147495	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.12	CHEMBL4128	Homo sapiens	Inhibition	%	0.12
	8147648	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.47	CHEMBL4128	Homo sapiens	Inhibition	%	3.47
	8147835	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.55	CHEMBL4128	Homo sapiens	Inhibition	%	5.55
	8148217	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.11	CHEMBL4128	Homo sapiens	Inhibition	%	8.11
	8148331	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.77	CHEMBL4128	Homo sapiens	Inhibition	%	0.77
	8148555	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.68	CHEMBL4128	Homo sapiens	Inhibition	%	4.68
	8148694	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.87	CHEMBL4128	Homo sapiens	Inhibition	%	2.87
	8149056	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.16	CHEMBL4128	Homo sapiens	Inhibition	%	5.16
	8149215	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.3	CHEMBL4128	Homo sapiens	Inhibition	%	2.3
	8149573	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.7	CHEMBL4128	Homo sapiens	Inhibition	%	8.7
	8149895	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-0.08	CHEMBL4128	Homo sapiens	Inhibition	%	-0.08
	8150020	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	10.43	CHEMBL4128	Homo sapiens	Inhibition	%	10.43
	8150244	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	49.4	CHEMBL4128	Homo sapiens	Inhibition	%	49.4
	8150404	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	72.13	CHEMBL4128	Homo sapiens	Inhibition	%	72.13
	8150748	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	70.71	CHEMBL4128	Homo sapiens	Inhibition	%	70.71
	8150913	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.04	CHEMBL4128	Homo sapiens	Inhibition	%	6.04
	8151076	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	32.42	CHEMBL4128	Homo sapiens	Inhibition	%	32.42
	8151300	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.34	CHEMBL4128	Homo sapiens	Inhibition	%	0.34
	8151477	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	7.69	CHEMBL4128	Homo sapiens	Inhibition	%	7.69
	8151839	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.87	CHEMBL4128	Homo sapiens	Inhibition	%	4.87
	8151993	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.11	CHEMBL4128	Homo sapiens	Inhibition	%	2.11
	8152181	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.09	CHEMBL4128	Homo sapiens	Inhibition	%	3.09
	8152405	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.01	CHEMBL4128	Homo sapiens	Inhibition	%	3.01
	8152563	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.52	CHEMBL4128	Homo sapiens	Inhibition	%	3.52
	8152901	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.69	CHEMBL4128	Homo sapiens	Inhibition	%	6.69
	8153040	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.69	CHEMBL4128	Homo sapiens	Inhibition	%	4.69
	8153264	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.14	CHEMBL4128	Homo sapiens	Inhibition	%	4.14
	8153401	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.4	CHEMBL4128	Homo sapiens	Inhibition	%	6.4
	8153558	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.27	CHEMBL4128	Homo sapiens	Inhibition	%	2.27
	8153782	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.84	CHEMBL4128	Homo sapiens	Inhibition	%	1.84
	8153915	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.54	CHEMBL4128	Homo sapiens	Inhibition	%	5.54
	8154236	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.57	CHEMBL4128	Homo sapiens	Inhibition	%	3.57
	8154586	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	82.43	CHEMBL4128	Homo sapiens	Inhibition	%	82.43
	8154745	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.1	CHEMBL4128	Homo sapiens	Inhibition	%	-0.1
	8155089	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.56	CHEMBL4128	Homo sapiens	Inhibition	%	1.56
	8155265	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.53	CHEMBL4128	Homo sapiens	Inhibition	%	10.53
	8155650	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	3.3	CHEMBL4128	Homo sapiens	Inhibition	%	3.3
	8155828	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.14	CHEMBL4128	Homo sapiens	Inhibition	%	4.14
	8156190	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.3	CHEMBL4128	Homo sapiens	Inhibition	%	1.3
	8156402	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.5	CHEMBL4128	Homo sapiens	Inhibition	%	3.5
	8156776	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	9.26	CHEMBL4128	Homo sapiens	Inhibition	%	9.26
	8156919	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.1	CHEMBL4128	Homo sapiens	Inhibition	%	2.1
	8157263	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.71	CHEMBL4128	Homo sapiens	Inhibition	%	1.71
	8157404	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	86.09	CHEMBL4128	Homo sapiens	Inhibition	%	86.09
	8157628	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.15	CHEMBL4128	Homo sapiens	Inhibition	%	2.15
	8157758	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	60.52	CHEMBL4128	Homo sapiens	Inhibition	%	60.52
	8158143	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.78	CHEMBL4128	Homo sapiens	Inhibition	%	8.78
	8158393	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	78.74	CHEMBL4128	Homo sapiens	Inhibition	%	78.74
	8158551	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.03	CHEMBL4128	Homo sapiens	Inhibition	%	1.03
	8158775	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.42	CHEMBL4128	Homo sapiens	Inhibition	%	5.42
	8158944	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.35	CHEMBL4128	Homo sapiens	Inhibition	%	3.35
	8159079	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.83	CHEMBL4128	Homo sapiens	Inhibition	%	3.83
	8159303	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.8	CHEMBL4128	Homo sapiens	Inhibition	%	2.8
	8159423	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.04	CHEMBL4128	Homo sapiens	Inhibition	%	5.04
	8159778	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.13	CHEMBL4128	Homo sapiens	Inhibition	%	3.13
	8159919	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.12	CHEMBL4128	Homo sapiens	Inhibition	%	-0.12
	8160280	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.61	CHEMBL4128	Homo sapiens	Inhibition	%	2.61
	8160430	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.25	CHEMBL4128	Homo sapiens	Inhibition	%	1.25
	8160654	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.11	CHEMBL4128	Homo sapiens	Inhibition	%	-0.11
	8160724	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.09	CHEMBL4128	Homo sapiens	Inhibition	%	3.09
	8160948	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.4	CHEMBL4128	Homo sapiens	Inhibition	%	4.4
	8161098	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.99	CHEMBL4128	Homo sapiens	Inhibition	%	3.99
	8161241	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.98	CHEMBL4128	Homo sapiens	Inhibition	%	2.98
	8161465	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.72	CHEMBL4128	Homo sapiens	Inhibition	%	3.72
	8161590	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.96	CHEMBL4128	Homo sapiens	Inhibition	%	6.96
	8161952	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.29	CHEMBL4128	Homo sapiens	Inhibition	%	6.29
	8162082	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.63	CHEMBL4128	Homo sapiens	Inhibition	%	2.63
	8162306	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	10.51	CHEMBL4128	Homo sapiens	Inhibition	%	10.51
	8162466	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	9.94	CHEMBL4128	Homo sapiens	Inhibition	%	9.94
	8162719	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	11.29	CHEMBL4128	Homo sapiens	Inhibition	%	11.29
	8163091	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	1.88	CHEMBL4128	Homo sapiens	Inhibition	%	1.88
	8163260	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	9.26	CHEMBL4128	Homo sapiens	Inhibition	%	9.26
	8163618	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.75	CHEMBL4128	Homo sapiens	Inhibition	%	7.75
	8163741	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.27	CHEMBL4128	Homo sapiens	Inhibition	%	2.27
	8163965	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.78	CHEMBL4128	Homo sapiens	Inhibition	%	4.78
	8164099	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	Inhibition	%	4.0
	8164239	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.12	CHEMBL4128	Homo sapiens	Inhibition	%	1.12
	8164463	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.61	CHEMBL4128	Homo sapiens	Inhibition	%	1.61
	8164618	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.26	CHEMBL4128	Homo sapiens	Inhibition	%	4.26
	8164986	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	4.5	CHEMBL4128	Homo sapiens	Inhibition	%	4.5
	8165280	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.81	CHEMBL4128	Homo sapiens	Inhibition	%	1.81
	8165421	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	29.34	CHEMBL4128	Homo sapiens	Inhibition	%	29.34
	8165788	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	20.52	CHEMBL4128	Homo sapiens	Inhibition	%	20.52
	8165914	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.47	CHEMBL4128	Homo sapiens	Inhibition	%	1.47
	8166138	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.97	CHEMBL4128	Homo sapiens	Inhibition	%	5.97
	8166276	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.52	CHEMBL4128	Homo sapiens	Inhibition	%	0.52
	8166630	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.23	CHEMBL4128	Homo sapiens	Inhibition	%	3.23
	8166731	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	8.4	CHEMBL4128	Homo sapiens	Inhibition	%	8.4
	8166955	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	49.76	CHEMBL4128	Homo sapiens	Inhibition	%	49.76
	8167043	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	11.37	CHEMBL4128	Homo sapiens	Inhibition	%	11.37
	8167408	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	19.55	CHEMBL4128	Homo sapiens	Inhibition	%	19.55
	8167572	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.34	CHEMBL4128	Homo sapiens	Inhibition	%	2.34
	8167929	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.7	CHEMBL4128	Homo sapiens	Inhibition	%	2.7
	8168277	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.66	CHEMBL4128	Homo sapiens	Inhibition	%	0.66
	8168418	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.28	CHEMBL4128	Homo sapiens	Inhibition	%	4.28
	8168778	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.96	CHEMBL4128	Homo sapiens	Inhibition	%	3.96
	8168942	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.66	CHEMBL4128	Homo sapiens	Inhibition	%	3.66
	8169308	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.18	CHEMBL4128	Homo sapiens	Inhibition	%	2.18
	8169612	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-0.04	CHEMBL4128	Homo sapiens	Inhibition	%	-0.04
	8169746	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.11	CHEMBL4128	Homo sapiens	Inhibition	%	2.11
	8169970	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.62	CHEMBL4128	Homo sapiens	Inhibition	%	2.62
	8170115	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	29.14	CHEMBL4128	Homo sapiens	Inhibition	%	29.14
	8170464	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.65	CHEMBL4128	Homo sapiens	Inhibition	%	1.65
	8170604	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.79	CHEMBL4128	Homo sapiens	Inhibition	%	4.79
	8170963	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	15.74	CHEMBL4128	Homo sapiens	Inhibition	%	15.74
	8171160	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	53.81	CHEMBL4128	Homo sapiens	Inhibition	%	53.81
	8171377	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.75	CHEMBL4128	Homo sapiens	Inhibition	%	3.75
	8171601	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.59	CHEMBL4128	Homo sapiens	Inhibition	%	6.59
	8171742	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.06	CHEMBL4128	Homo sapiens	Inhibition	%	1.06
	8171895	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.02	CHEMBL4128	Homo sapiens	Inhibition	%	6.02
	8172119	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.49	CHEMBL4128	Homo sapiens	Inhibition	%	1.49
	8172251	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.79	CHEMBL4128	Homo sapiens	Inhibition	%	1.79
	8172603	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.1	CHEMBL4128	Homo sapiens	Inhibition	%	3.1
	8172745	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.27	CHEMBL4128	Homo sapiens	Inhibition	%	5.27
	8172969	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.83	CHEMBL4128	Homo sapiens	Inhibition	%	6.83
	8173105	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.65	CHEMBL4128	Homo sapiens	Inhibition	%	1.65
	8173270	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	18.65	CHEMBL4128	Homo sapiens	Inhibition	%	18.65
	8173494	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.02	CHEMBL4128	Homo sapiens	Inhibition	%	6.02
	8173635	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	10.93	CHEMBL4128	Homo sapiens	Inhibition	%	10.93
	8173946	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.64	CHEMBL4128	Homo sapiens	Inhibition	%	1.64
	8174302	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	Inhibition	%	1.0
	8174450	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	77.46	CHEMBL4128	Homo sapiens	Inhibition	%	77.46
	8174796	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.24	CHEMBL4128	Homo sapiens	Inhibition	%	1.24
	8174939	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.65	CHEMBL4128	Homo sapiens	Inhibition	%	0.65
	8175163	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.85	CHEMBL4128	Homo sapiens	Inhibition	%	3.85
	8175299	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.92	CHEMBL4128	Homo sapiens	Inhibition	%	2.92
	8175555	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.76	CHEMBL4128	Homo sapiens	Inhibition	%	0.76
	8175942	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	10.59	CHEMBL4128	Homo sapiens	Inhibition	%	10.59
	8176095	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.63	CHEMBL4128	Homo sapiens	Inhibition	%	3.63
	8176468	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	9.0	CHEMBL4128	Homo sapiens	Inhibition	%	9.0
	8176600	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.76	CHEMBL4128	Homo sapiens	Inhibition	%	5.76
	8176824	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.19	CHEMBL4128	Homo sapiens	Inhibition	%	9.19
	8176954	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.28	CHEMBL4128	Homo sapiens	Inhibition	%	0.28
	8177320	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	Inhibition	%	4.0
	8177458	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.55	CHEMBL4128	Homo sapiens	Inhibition	%	3.55
	8177846	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	37.53	CHEMBL4128	Homo sapiens	Inhibition	%	37.53
	8177986	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.2	CHEMBL4128	Homo sapiens	Inhibition	%	1.2
	8178210	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.63	CHEMBL4128	Homo sapiens	Inhibition	%	2.63
	8178298	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.16	CHEMBL4128	Homo sapiens	Inhibition	%	3.16
	8178649	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.3	CHEMBL4128	Homo sapiens	Inhibition	%	1.3
	8178798	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.21	CHEMBL4128	Homo sapiens	Inhibition	%	2.21
	8179022	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.47	CHEMBL4128	Homo sapiens	Inhibition	%	6.47
	8179145	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.23	CHEMBL4128	Homo sapiens	Inhibition	%	1.23
	8179513	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-0.94	CHEMBL4128	Homo sapiens	Inhibition	%	-0.94
	8179650	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.32	CHEMBL4128	Homo sapiens	Inhibition	%	4.32
	8179907	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.4	CHEMBL4128	Homo sapiens	Inhibition	%	4.4
	8180285	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	52.48	CHEMBL4128	Homo sapiens	Inhibition	%	52.48
	8180441	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.68	CHEMBL4128	Homo sapiens	Inhibition	%	2.68
	8180665	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.28	CHEMBL4128	Homo sapiens	Inhibition	%	3.28
	8180813	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.03	CHEMBL4128	Homo sapiens	Inhibition	%	1.03
	8181170	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	27.11	CHEMBL4128	Homo sapiens	Inhibition	%	27.11
	8181301	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.93	CHEMBL4128	Homo sapiens	Inhibition	%	3.93
	8181665	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.4	CHEMBL4128	Homo sapiens	Inhibition	%	4.4
	8181804	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.36	CHEMBL4128	Homo sapiens	Inhibition	%	1.36
	8182028	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	Inhibition	%	5.0
	8182191	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.26	CHEMBL4128	Homo sapiens	Inhibition	%	1.26
	8182555	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.72	CHEMBL4128	Homo sapiens	Inhibition	%	1.72
	8182647	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.98	CHEMBL4128	Homo sapiens	Inhibition	%	2.98
	8182871	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.32	CHEMBL4128	Homo sapiens	Inhibition	%	5.32
	8182993	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.18	CHEMBL4128	Homo sapiens	Inhibition	%	2.18
	8183366	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.35	CHEMBL4128	Homo sapiens	Inhibition	%	3.35
	8183495	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.88	CHEMBL4128	Homo sapiens	Inhibition	%	3.88
	8183861	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.16	CHEMBL4128	Homo sapiens	Inhibition	%	1.16
	8183997	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.56	CHEMBL4128	Homo sapiens	Inhibition	%	1.56
	8184221	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.25	CHEMBL4128	Homo sapiens	Inhibition	%	6.25
	8184263	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.55	CHEMBL4128	Homo sapiens	Inhibition	%	2.55
	8184487	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.0	CHEMBL4128	Homo sapiens	Inhibition	%	7.0
	8184634	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.27	CHEMBL4128	Homo sapiens	Inhibition	%	2.27
	8185015	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	6.26	CHEMBL4128	Homo sapiens	Inhibition	%	6.26
	8185164	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.59	CHEMBL4128	Homo sapiens	Inhibition	%	5.59
	8185519	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	70.53	CHEMBL4128	Homo sapiens	Inhibition	%	70.53
	8185650	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.44	CHEMBL4128	Homo sapiens	Inhibition	%	0.44
	8185874	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.44	CHEMBL4128	Homo sapiens	Inhibition	%	2.44
	8186013	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.86	CHEMBL4128	Homo sapiens	Inhibition	%	1.86
	8186378	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.17	CHEMBL4128	Homo sapiens	Inhibition	%	3.17
	8186542	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.32	CHEMBL4128	Homo sapiens	Inhibition	%	4.32
	8186905	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.95	CHEMBL4128	Homo sapiens	Inhibition	%	1.95
	8187227	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.45	CHEMBL4128	Homo sapiens	Inhibition	%	2.45
	8187351	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.99	CHEMBL4128	Homo sapiens	Inhibition	%	5.99
	8187723	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	16.09	CHEMBL4128	Homo sapiens	Inhibition	%	16.09
	8187852	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.11	CHEMBL4128	Homo sapiens	Inhibition	%	9.11
	8188076	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	33.81	CHEMBL4128	Homo sapiens	Inhibition	%	33.81
	8188219	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.79	CHEMBL4128	Homo sapiens	Inhibition	%	0.79
	8188578	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	7.64	CHEMBL4128	Homo sapiens	Inhibition	%	7.64
	8188852	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.04	CHEMBL4128	Homo sapiens	Inhibition	%	4.04
	8189000	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	8.54	CHEMBL4128	Homo sapiens	Inhibition	%	8.54
	8189224	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.88	CHEMBL4128	Homo sapiens	Inhibition	%	0.88
	8189380	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	23.4	CHEMBL4128	Homo sapiens	Inhibition	%	23.4
	8189529	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.95	CHEMBL4128	Homo sapiens	Inhibition	%	0.95
	8189753	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	4.38	CHEMBL4128	Homo sapiens	Inhibition	%	4.38
	8189885	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.13	CHEMBL4128	Homo sapiens	Inhibition	%	5.13
	8190241	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.42	CHEMBL4128	Homo sapiens	Inhibition	%	4.42
	8190381	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.48	CHEMBL4128	Homo sapiens	Inhibition	%	3.48
	8190742	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.31	CHEMBL4128	Homo sapiens	Inhibition	%	7.31
	8190906	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.29	CHEMBL4128	Homo sapiens	Inhibition	%	2.29
	8191130	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.07	CHEMBL4128	Homo sapiens	Inhibition	%	3.07
	8191268	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.91	CHEMBL4128	Homo sapiens	Inhibition	%	2.91
	8191588	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.29	CHEMBL4128	Homo sapiens	Inhibition	%	5.29
	8191710	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.4	CHEMBL4128	Homo sapiens	Inhibition	%	1.4
	8191934	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.58	CHEMBL4128	Homo sapiens	Inhibition	%	4.58
	8192083	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.3	CHEMBL4128	Homo sapiens	Inhibition	%	1.3
	8192436	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.37	CHEMBL4128	Homo sapiens	Inhibition	%	3.37
	8192580	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.42	CHEMBL4128	Homo sapiens	Inhibition	%	3.42
	8192804	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.59	CHEMBL4128	Homo sapiens	Inhibition	%	1.59
	8192940	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	31.43	CHEMBL4128	Homo sapiens	Inhibition	%	31.43
	8193212	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	17.84	CHEMBL4128	Homo sapiens	Inhibition	%	17.84
	8193581	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	12.23	CHEMBL4128	Homo sapiens	Inhibition	%	12.23
	8193738	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.12	CHEMBL4128	Homo sapiens	Inhibition	%	4.12
	8194111	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.7	CHEMBL4128	Homo sapiens	Inhibition	%	0.7
	8194242	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	12.49	CHEMBL4128	Homo sapiens	Inhibition	%	12.49
	8194597	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.14	CHEMBL4128	Homo sapiens	Inhibition	%	6.14
	8194740	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.02	CHEMBL4128	Homo sapiens	Inhibition	%	3.02
	8194964	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.28	CHEMBL4128	Homo sapiens	Inhibition	%	6.28
	8195097	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.8	CHEMBL4128	Homo sapiens	Inhibition	%	1.8
	8195485	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.1	CHEMBL4128	Homo sapiens	Inhibition	%	2.1
	8195624	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	12.61	CHEMBL4128	Homo sapiens	Inhibition	%	12.61
	8195946	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.65	CHEMBL4128	Homo sapiens	Inhibition	%	2.65
	8196287	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.5	CHEMBL4128	Homo sapiens	Inhibition	%	2.5
	8196437	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.17	CHEMBL4128	Homo sapiens	Inhibition	%	3.17
	8196661	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.44	CHEMBL4128	Homo sapiens	Inhibition	%	3.44
	8196789	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	8.26	CHEMBL4128	Homo sapiens	Inhibition	%	8.26
	8197154	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-0.24	CHEMBL4128	Homo sapiens	Inhibition	%	-0.24
	8197291	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	7.37	CHEMBL4128	Homo sapiens	Inhibition	%	7.37
	8197566	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.39	CHEMBL4128	Homo sapiens	Inhibition	%	4.39
	8197930	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.11	CHEMBL4128	Homo sapiens	Inhibition	%	3.11
	8198087	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	8.33	CHEMBL4128	Homo sapiens	Inhibition	%	8.33
	8198449	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.05	CHEMBL4128	Homo sapiens	Inhibition	%	0.05
	8198579	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.58	CHEMBL4128	Homo sapiens	Inhibition	%	3.58
	8198803	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	17.68	CHEMBL4128	Homo sapiens	Inhibition	%	17.68
	8198934	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.59	CHEMBL4128	Homo sapiens	Inhibition	%	5.59
	8199306	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.86	CHEMBL4128	Homo sapiens	Inhibition	%	3.86
	8199440	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.36	CHEMBL4128	Homo sapiens	Inhibition	%	3.36
	8199664	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.87	CHEMBL4128	Homo sapiens	Inhibition	%	1.87
	8199827	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.01	CHEMBL4128	Homo sapiens	Inhibition	%	3.01
	8199965	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.48	CHEMBL4128	Homo sapiens	Inhibition	%	2.48
	8200189	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.23	CHEMBL4128	Homo sapiens	Inhibition	%	6.23
	8200293	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.49	CHEMBL4128	Homo sapiens	Inhibition	%	2.49
	8200632	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.58	CHEMBL4128	Homo sapiens	Inhibition	%	5.58
	8201006	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	17.51	CHEMBL4128	Homo sapiens	Inhibition	%	17.51
	8201136	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.44	CHEMBL4128	Homo sapiens	Inhibition	%	4.44
	8201495	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.38	CHEMBL4128	Homo sapiens	Inhibition	%	1.38
	8201628	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	13.53	CHEMBL4128	Homo sapiens	Inhibition	%	13.53
	8201852	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	76.87	CHEMBL4128	Homo sapiens	Inhibition	%	76.87
	8201907	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.08	CHEMBL4128	Homo sapiens	Inhibition	%	3.08
	8202131	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.55	CHEMBL4128	Homo sapiens	Inhibition	%	4.55
	8202271	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	26.95	CHEMBL4128	Homo sapiens	Inhibition	%	26.95
	8202438	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.17	CHEMBL4128	Homo sapiens	Inhibition	%	3.17
	8202662	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.76	CHEMBL4128	Homo sapiens	Inhibition	%	5.76
	8202787	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.32	CHEMBL4128	Homo sapiens	Inhibition	%	2.32
	8203141	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.8	CHEMBL4128	Homo sapiens	Inhibition	%	3.8
	8203272	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.86	CHEMBL4128	Homo sapiens	Inhibition	%	8.86
	8203496	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	12.43	CHEMBL4128	Homo sapiens	Inhibition	%	12.43
	8203642	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.47	CHEMBL4128	Homo sapiens	Inhibition	%	4.47
	8204000	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.11	CHEMBL4128	Homo sapiens	Inhibition	%	2.11
	8204166	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.09	CHEMBL4128	Homo sapiens	Inhibition	%	2.09
	8204527	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	7.91	CHEMBL4128	Homo sapiens	Inhibition	%	7.91
	8204632	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.84	CHEMBL4128	Homo sapiens	Inhibition	%	3.84
	8204856	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	18.5	CHEMBL4128	Homo sapiens	Inhibition	%	18.5
	8204971	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.16	CHEMBL4128	Homo sapiens	Inhibition	%	2.16
	8205344	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.4	CHEMBL4128	Homo sapiens	Inhibition	%	0.4
	8205480	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	27.3	CHEMBL4128	Homo sapiens	Inhibition	%	27.3
	8205704	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.25	CHEMBL4128	Homo sapiens	Inhibition	%	2.25
	8205843	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.06	CHEMBL4128	Homo sapiens	Inhibition	%	3.06
	8206199	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	82.16	CHEMBL4128	Homo sapiens	Inhibition	%	82.16
	8206475	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.67	CHEMBL4128	Homo sapiens	Inhibition	%	5.67
	8206618	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.24	CHEMBL4128	Homo sapiens	Inhibition	%	-0.24
	8207022	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.92	CHEMBL4128	Homo sapiens	Inhibition	%	0.92
	8207148	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.49	CHEMBL4128	Homo sapiens	Inhibition	%	2.49
	8207372	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.2	CHEMBL4128	Homo sapiens	Inhibition	%	4.2
	8207502	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.38	CHEMBL4128	Homo sapiens	Inhibition	%	9.38
	8207858	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	52.96	CHEMBL4128	Homo sapiens	Inhibition	%	52.96
	8208003	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.79	CHEMBL4128	Homo sapiens	Inhibition	%	2.79
	8208359	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.18	CHEMBL4128	Homo sapiens	Inhibition	%	2.18
	8208525	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.67	CHEMBL4128	Homo sapiens	Inhibition	%	3.67
	8208749	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.02	CHEMBL4128	Homo sapiens	Inhibition	%	3.02
	8208882	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	48.18	CHEMBL4128	Homo sapiens	Inhibition	%	48.18
	8209211	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.06	CHEMBL4128	Homo sapiens	Inhibition	%	3.06
	8209327	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	9.2	CHEMBL4128	Homo sapiens	Inhibition	%	9.2
	8209551	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.07	CHEMBL4128	Homo sapiens	Inhibition	%	2.07
	8209701	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.76	CHEMBL4128	Homo sapiens	Inhibition	%	5.76
	8210061	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	8.59	CHEMBL4128	Homo sapiens	Inhibition	%	8.59
	8210202	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.75	CHEMBL4128	Homo sapiens	Inhibition	%	2.75
	8210562	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	9.68	CHEMBL4128	Homo sapiens	Inhibition	%	9.68
	8210821	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.45	CHEMBL4128	Homo sapiens	Inhibition	%	4.45
	8210965	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	3.72	CHEMBL4128	Homo sapiens	Inhibition	%	3.72
	8211189	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.13	CHEMBL4128	Homo sapiens	Inhibition	%	4.13
	8211359	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.59	CHEMBL4128	Homo sapiens	Inhibition	%	1.59
	8211706	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.76	CHEMBL4128	Homo sapiens	Inhibition	%	5.76
	8211835	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.98	CHEMBL4128	Homo sapiens	Inhibition	%	5.98
	8212191	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.31	CHEMBL4128	Homo sapiens	Inhibition	%	4.31
	8212332	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.09	CHEMBL4128	Homo sapiens	Inhibition	%	3.09
	8212556	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.89	CHEMBL4128	Homo sapiens	Inhibition	%	1.89
	8212689	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.66	CHEMBL4128	Homo sapiens	Inhibition	%	2.66
	8213083	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.68	CHEMBL4128	Homo sapiens	Inhibition	%	8.68
	8213212	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.33	CHEMBL4128	Homo sapiens	Inhibition	%	1.33
	8213540	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	19.02	CHEMBL4128	Homo sapiens	Inhibition	%	19.02
	8213877	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.68	CHEMBL4128	Homo sapiens	Inhibition	%	1.68
	8214024	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.08	CHEMBL4128	Homo sapiens	Inhibition	%	1.08
	8214385	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	12.74	CHEMBL4128	Homo sapiens	Inhibition	%	12.74
	8214519	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.74	CHEMBL4128	Homo sapiens	Inhibition	%	6.74
	8214743	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.56	CHEMBL4128	Homo sapiens	Inhibition	%	4.56
	8214895	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	11.14	CHEMBL4128	Homo sapiens	Inhibition	%	11.14
	8215146	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.89	CHEMBL4128	Homo sapiens	Inhibition	%	6.89
	8215523	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	14.3	CHEMBL4128	Homo sapiens	Inhibition	%	14.3
	8215687	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.18	CHEMBL4128	Homo sapiens	Inhibition	%	3.18
	8216030	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.59	CHEMBL4128	Homo sapiens	Inhibition	%	2.59
	8216149	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	26.21	CHEMBL4128	Homo sapiens	Inhibition	%	26.21
	8216373	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.27	CHEMBL4128	Homo sapiens	Inhibition	%	2.27
	8216509	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.65	CHEMBL4128	Homo sapiens	Inhibition	%	7.65
	8216871	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.64	CHEMBL4128	Homo sapiens	Inhibition	%	6.64
	8217005	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.51	CHEMBL4128	Homo sapiens	Inhibition	%	2.51
	8217229	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.87	CHEMBL4128	Homo sapiens	Inhibition	%	2.87
	8217403	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.12	CHEMBL4128	Homo sapiens	Inhibition	%	0.12
	8217534	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.19	CHEMBL4128	Homo sapiens	Inhibition	%	5.19
	8217758	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.63	CHEMBL4128	Homo sapiens	Inhibition	%	5.63
	8217859	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.19	CHEMBL4128	Homo sapiens	Inhibition	%	-0.19
	8218198	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.29	CHEMBL4128	Homo sapiens	Inhibition	%	2.29
	8218325	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.97	CHEMBL4128	Homo sapiens	Inhibition	%	6.97
	8218549	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.62	CHEMBL4128	Homo sapiens	Inhibition	%	8.62
	8218692	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	41.71	CHEMBL4128	Homo sapiens	Inhibition	%	41.71
	8219047	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	39.73	CHEMBL4128	Homo sapiens	Inhibition	%	39.73
	8219207	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.66	CHEMBL4128	Homo sapiens	Inhibition	%	4.66
	8219457	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.3	CHEMBL4128	Homo sapiens	Inhibition	%	8.3
	8219681	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.42	CHEMBL4128	Homo sapiens	Inhibition	%	8.42
	8219842	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.58	CHEMBL4128	Homo sapiens	Inhibition	%	2.58
	8220011	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	10.83	CHEMBL4128	Homo sapiens	Inhibition	%	10.83
	8220235	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.85	CHEMBL4128	Homo sapiens	Inhibition	%	2.85
	8220364	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.08	CHEMBL4128	Homo sapiens	Inhibition	%	6.08
	8220702	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.55	CHEMBL4128	Homo sapiens	Inhibition	%	3.55
	8220840	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.53	CHEMBL4128	Homo sapiens	Inhibition	%	4.53
	8221200	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.27	CHEMBL4128	Homo sapiens	Inhibition	%	1.27
	8221557	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.04	CHEMBL4128	Homo sapiens	Inhibition	%	2.04
	8221722	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.44	CHEMBL4128	Homo sapiens	Inhibition	%	1.44
	8222077	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	14.61	CHEMBL4128	Homo sapiens	Inhibition	%	14.61
	8222175	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.01	CHEMBL4128	Homo sapiens	Inhibition	%	3.01
	8222399	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.09	CHEMBL4128	Homo sapiens	Inhibition	%	2.09
	8222533	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	11.89	CHEMBL4128	Homo sapiens	Inhibition	%	11.89
	8222875	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	46.37	CHEMBL4128	Homo sapiens	Inhibition	%	46.37
	8223019	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	79.33	CHEMBL4128	Homo sapiens	Inhibition	%	79.33
	8223372	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	9.81	CHEMBL4128	Homo sapiens	Inhibition	%	9.81
	8223533	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.13	CHEMBL4128	Homo sapiens	Inhibition	%	7.13
	8223757	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.2	CHEMBL4128	Homo sapiens	Inhibition	%	2.2
	8224007	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	75.0	CHEMBL4128	Homo sapiens	Inhibition	%	75.0
	8224169	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.38	CHEMBL4128	Homo sapiens	Inhibition	%	7.38
	8224563	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.15	CHEMBL4128	Homo sapiens	Inhibition	%	3.15
	8224698	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.36	CHEMBL4128	Homo sapiens	Inhibition	%	2.36
	8225036	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.83	CHEMBL4128	Homo sapiens	Inhibition	%	4.83
	8225170	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.58	CHEMBL4128	Homo sapiens	Inhibition	%	7.58
	8225394	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.05	CHEMBL4128	Homo sapiens	Inhibition	%	4.05
	8225532	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.75	CHEMBL4128	Homo sapiens	Inhibition	%	4.75
	8225891	CHEMBL1962179	GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.53	CHEMBL4128	Homo sapiens	Inhibition	%	5.53
	8226049	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.75	CHEMBL4128	Homo sapiens	Inhibition	%	2.75
	8226398	CHEMBL1962178	GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.38	CHEMBL4128	Homo sapiens	Inhibition	%	4.38
	10838633	CHEMBL2014511	Inhibition of TIE2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	10839553	CHEMBL2015819	Inhibition of TIE2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	5.0	CHEMBL4128	Homo sapiens	Activity	%	5.0
	10839597	CHEMBL2014710	Inhibition of TIE2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	18.0	CHEMBL4128	Homo sapiens	Activity	%	18.0
Active	10842634	CHEMBL2016085	Displacement of angiopoietin 1 from human recombinant Tie2 at 25 to 100 uM	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		Activity			CHEMBL4128	Homo sapiens	Activity		
Active	10842635	CHEMBL2016086	Displacement of angiopoietin 2 from human recombinant Tie2 at 25 to 100 uM	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		Activity			CHEMBL4128	Homo sapiens	Activity		
	10842636	CHEMBL2016084	Binding affinity to human recombinant Tie2 by SPR assay	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841	=	Kd	nM	5900.0	CHEMBL4128	Homo sapiens	Kd	uM	5.9
	10842637	CHEMBL2016084	Binding affinity to human recombinant Tie2 by SPR assay	B	O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1		CHEMBL1000	=	Kd	nM	90000.0	CHEMBL4128	Homo sapiens	Kd	10'-5M	9.0
	10842638	CHEMBL2016084	Binding affinity to human recombinant Tie2 by SPR assay	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174	=	Kd	nM	82000.0	CHEMBL4128	Homo sapiens	Kd	10'-5M	8.2
	10842639	CHEMBL2016084	Binding affinity to human recombinant Tie2 by SPR assay	B	O=C(N[C@H](Cc1ccccc1F)C(=O)O)OCC1c2ccccc2-c2ccccc21	Outside typical range	CHEMBL2012790	=	Kd	nM	120000.0	CHEMBL4128	Homo sapiens	Kd	10'-4M	1.2
Active	10842640	CHEMBL2016087	Displacement of angiopoietin 1 from human recombinant Tie2 at 50 to 100 uM	B	O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1		CHEMBL1000		Activity			CHEMBL4128	Homo sapiens	Activity		
Active	10842641	CHEMBL2016087	Displacement of angiopoietin 1 from human recombinant Tie2 at 50 to 100 uM	B	O=C(N[C@H](Cc1ccccc1F)C(=O)O)OCC1c2ccccc2-c2ccccc21		CHEMBL2012790		Activity			CHEMBL4128	Homo sapiens	Activity		
Active	10842642	CHEMBL2016087	Displacement of angiopoietin 1 from human recombinant Tie2 at 50 to 100 uM	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		Activity			CHEMBL4128	Homo sapiens	Activity		
Not Active	10843571	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	10843572	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	10843573	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	10843574	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	10843575	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	10843576	CHEMBL2016357	Inhibition of Tie2 at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	10843898	CHEMBL2015675	Inhibition of human Tie2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	50.0	CHEMBL4128	Homo sapiens	IC50	nM	50.0
	10843911	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)n1c2ccc(Nc3ccncc3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010878	>	IC50	nM	3000.0	CHEMBL4128	Homo sapiens	IC50	nM	3000.0
	10843912	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)Cn1c2ccc(Nc3nccc(C(F)(F)F)n3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010876	>	IC50	nM	3000.0	CHEMBL4128	Homo sapiens	IC50	nM	3000.0
	10843913	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	Cc1cc(C)nc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)n1		CHEMBL2010874	>	IC50	nM	3000.0	CHEMBL4128	Homo sapiens	IC50	nM	3000.0
	10843914	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	COc1ccnc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)n1		CHEMBL2010875	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	10843915	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1c-4cnn1C)C(=O)NC3		CHEMBL2011061	=	IC50	nM	241.0	CHEMBL4128	Homo sapiens	IC50	nM	241.0
	10843916	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)n1c2ccc(Nc3cccnn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010877	=	IC50	nM	166.0	CHEMBL4128	Homo sapiens	IC50	nM	166.0
	10843917	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)n1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010870	=	IC50	nM	76.0	CHEMBL4128	Homo sapiens	IC50	nM	76.0
	10843918	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CCCn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010871	=	IC50	nM	27.0	CHEMBL4128	Homo sapiens	IC50	nM	27.0
	10843919	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	nM	22.0
	10843920	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	10843921	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CCc1cnc(Nc2ccc3c(c2)c2c4c(c5c(c2n3CC(C)C)CCc2nn(C)cc2-5)C(=O)NC4)nc1		CHEMBL2010873	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
	10843922	CHEMBL2015673	Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis	B	CCCn1c2ccc(Nc3ncc(CC)cn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010869	=	IC50	nM	4.0	CHEMBL4128	Homo sapiens	IC50	nM	4.0
	10867548	CHEMBL2027438	Inhibition of Tie2 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	10889052	CHEMBL2032463	Inhibition of TIE2	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	10889079	CHEMBL2032463	Inhibition of TIE2	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	100.0	CHEMBL4128	Homo sapiens	IC50	uM	0.1
	10934991	CHEMBL2051527	Inhibition of TIE2 at 10 uM	B	O=C(Nc1ccc(Oc2ccnc(-c3ncc(C(F)(F)F)[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2047981	=	Inhibition	%	27.5	CHEMBL4128	Homo sapiens	INH	%	27.5
	10949781	CHEMBL2050661	Inhibition of TIE2 using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	3200.0	CHEMBL4128	Homo sapiens	IC50	nM	3200.0
Active	10990932	CHEMBL2071857	Binding affinity to human TIE2	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Activity			CHEMBL4128	Homo sapiens	Activity		
	10993503	CHEMBL2073079	Inhibition of Tek at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	6.0	CHEMBL4128	Homo sapiens	INH	%	6.0
	11003684	CHEMBL2090812	Inhibition of TIE2	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)[nH]c3ncnc(NCC4SCCS4)c23)cc1		CHEMBL2087875	=	Ki	nM	200.0	CHEMBL4128	Homo sapiens	Ki	nM	200.0
	12036426	CHEMBL2150261	Inhibition of TIE2 after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	12047361	CHEMBL2157714	Inhibition of Tie2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-2.9	CHEMBL4128	Homo sapiens	INH	%	-2.9
	12081885	CHEMBL2166779	Inhibition of TIE2	B	Oc1ccc2oc3ncc(O)c(-c4ccccc4)c3c2c1	Outside typical range	CHEMBL2163772	>	Ki	nM	1000000.0	CHEMBL4128	Homo sapiens	Ki	uM	1000.0
Active	12136258	CHEMBL2185472	Inhibition of TIE2 at 10 uM in presence of ATP at Km level by kinase profiler method	B	COc1ccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)cc1		CHEMBL2180561		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	12145251	CHEMBL2182675	Inhibition of TIE2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL4128	Homo sapiens	INH	%	25.0
	12145252	CHEMBL2182675	Inhibition of TIE2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL4128	Homo sapiens	INH	%	25.0
	12152495	CHEMBL2182399	Inhibition of TIE2 assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	Activity	%	116.0	CHEMBL4128	Homo sapiens	Activity	%	116.0
	12152510	CHEMBL2182399	Inhibition of TIE2 assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	=	Activity	%	77.0	CHEMBL4128	Homo sapiens	Activity	%	77.0
	12170724	CHEMBL2214632	Inhibition of TIE2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	119.0	CHEMBL4128	Homo sapiens	Activity	%	119.0
	12170855	CHEMBL2212721	Inhibition of TIE2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	133.0	CHEMBL4128	Homo sapiens	Activity	%	133.0
	12172180	CHEMBL2209259	Inhibition of TIE2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	92.0	CHEMBL4128	Homo sapiens	Activity	%	92.0
	12175195	CHEMBL2210720	Inhibition of TIE2	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	840.0	CHEMBL4128	Homo sapiens	IC50	nM	840.0
	12191208	CHEMBL2215703	Inhibition of Tie-2 by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	5100.0	CHEMBL4128	Homo sapiens	IC50	nM	5100.0
	12261758	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	114.0	CHEMBL4128	Homo sapiens	Residual Activity	%	114.0
	12261759	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	77.0	CHEMBL4128	Homo sapiens	Residual Activity	%	77.0
	12261760	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	60.0	CHEMBL4128	Homo sapiens	Residual Activity	%	60.0
	12261761	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12261762	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12261763	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	73.0	CHEMBL4128	Homo sapiens	Residual Activity	%	73.0
	12261764	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12261765	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261766	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	81.0	CHEMBL4128	Homo sapiens	Residual Activity	%	81.0
	12261767	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12261768	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	52.0	CHEMBL4128	Homo sapiens	Residual Activity	%	52.0
	12261769	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12261770	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	81.0	CHEMBL4128	Homo sapiens	Residual Activity	%	81.0
	12261771	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12261772	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	100.0	CHEMBL4128	Homo sapiens	Residual Activity	%	100.0
	12261773	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	108.0	CHEMBL4128	Homo sapiens	Residual Activity	%	108.0
	12261774	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL4128	Homo sapiens	Residual Activity	%	103.0
	12261775	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	12.0	CHEMBL4128	Homo sapiens	Residual Activity	%	12.0
	12261776	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12261777	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12261778	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12261779	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12261780	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12261781	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	112.0	CHEMBL4128	Homo sapiens	Residual Activity	%	112.0
	12261782	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261783	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	48.0	CHEMBL4128	Homo sapiens	Residual Activity	%	48.0
	12261784	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	67.0	CHEMBL4128	Homo sapiens	Residual Activity	%	67.0
	12261785	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	61.0	CHEMBL4128	Homo sapiens	Residual Activity	%	61.0
	12261786	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	69.0	CHEMBL4128	Homo sapiens	Residual Activity	%	69.0
	12261787	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	55.0	CHEMBL4128	Homo sapiens	Residual Activity	%	55.0
	12261788	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL4128	Homo sapiens	Residual Activity	%	91.0
	12261789	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	3.0	CHEMBL4128	Homo sapiens	Residual Activity	%	3.0
	12261790	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12261791	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	81.0	CHEMBL4128	Homo sapiens	Residual Activity	%	81.0
	12261792	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12261793	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12261794	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12261795	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12261796	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261797	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	110.0	CHEMBL4128	Homo sapiens	Residual Activity	%	110.0
	12261798	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	105.0	CHEMBL4128	Homo sapiens	Residual Activity	%	105.0
	12261799	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12261800	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	54.0	CHEMBL4128	Homo sapiens	Residual Activity	%	54.0
	12261801	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	34.0	CHEMBL4128	Homo sapiens	Residual Activity	%	34.0
	12261802	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	33.0	CHEMBL4128	Homo sapiens	Residual Activity	%	33.0
	12261803	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	77.0	CHEMBL4128	Homo sapiens	Residual Activity	%	77.0
	12261804	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL4128	Homo sapiens	Residual Activity	%	95.0
	12261805	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12261806	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	75.0	CHEMBL4128	Homo sapiens	Residual Activity	%	75.0
	12261807	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12261808	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12261809	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	12.0	CHEMBL4128	Homo sapiens	Residual Activity	%	12.0
	12261810	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	67.0	CHEMBL4128	Homo sapiens	Residual Activity	%	67.0
	12261811	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12261812	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12261813	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	107.0	CHEMBL4128	Homo sapiens	Residual Activity	%	107.0
	12261814	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	115.0	CHEMBL4128	Homo sapiens	Residual Activity	%	115.0
	12261815	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12261816	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261817	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12261818	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL4128	Homo sapiens	Residual Activity	%	75.0
	12261819	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	133.0	CHEMBL4128	Homo sapiens	Residual Activity	%	133.0
	12261820	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	84.0	CHEMBL4128	Homo sapiens	Residual Activity	%	84.0
	12261821	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12261822	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL4128	Homo sapiens	Residual Activity	%	105.0
	12261823	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261824	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	84.0	CHEMBL4128	Homo sapiens	Residual Activity	%	84.0
	12261825	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	69.0	CHEMBL4128	Homo sapiens	Residual Activity	%	69.0
	12261826	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	75.0	CHEMBL4128	Homo sapiens	Residual Activity	%	75.0
	12261827	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	67.0	CHEMBL4128	Homo sapiens	Residual Activity	%	67.0
	12261828	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	98.0	CHEMBL4128	Homo sapiens	Residual Activity	%	98.0
	12261829	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	136.0	CHEMBL4128	Homo sapiens	Residual Activity	%	136.0
	12261830	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	120.0	CHEMBL4128	Homo sapiens	Residual Activity	%	120.0
	12261831	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL4128	Homo sapiens	Residual Activity	%	106.0
	12261832	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	114.0	CHEMBL4128	Homo sapiens	Residual Activity	%	114.0
	12261833	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	43.0	CHEMBL4128	Homo sapiens	Residual Activity	%	43.0
	12261834	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12261835	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	56.0	CHEMBL4128	Homo sapiens	Residual Activity	%	56.0
	12261836	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261837	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4128	Homo sapiens	Residual Activity	%	0.0
	12261838	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12261839	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	36.0	CHEMBL4128	Homo sapiens	Residual Activity	%	36.0
	12261840	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12261841	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	84.0	CHEMBL4128	Homo sapiens	Residual Activity	%	84.0
	12261842	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	45.0	CHEMBL4128	Homo sapiens	Residual Activity	%	45.0
	12261843	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261844	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	91.0	CHEMBL4128	Homo sapiens	Residual Activity	%	91.0
	12261845	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	102.0	CHEMBL4128	Homo sapiens	Residual Activity	%	102.0
	12261846	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261847	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	103.0	CHEMBL4128	Homo sapiens	Residual Activity	%	103.0
	12261848	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12261849	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12261850	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	77.0	CHEMBL4128	Homo sapiens	Residual Activity	%	77.0
	12261851	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	109.0	CHEMBL4128	Homo sapiens	Residual Activity	%	109.0
	12261852	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4128	Homo sapiens	Residual Activity	%	103.0
	12261853	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL4128	Homo sapiens	Residual Activity	%	107.0
	12261854	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	117.0	CHEMBL4128	Homo sapiens	Residual Activity	%	117.0
	12261855	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	115.0	CHEMBL4128	Homo sapiens	Residual Activity	%	115.0
	12261856	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	100.0	CHEMBL4128	Homo sapiens	Residual Activity	%	100.0
	12261857	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	97.0	CHEMBL4128	Homo sapiens	Residual Activity	%	97.0
	12261858	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	98.0	CHEMBL4128	Homo sapiens	Residual Activity	%	98.0
	12261859	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	20.0	CHEMBL4128	Homo sapiens	Residual Activity	%	20.0
	12261860	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL4128	Homo sapiens	Residual Activity	%	108.0
	12261861	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	97.0	CHEMBL4128	Homo sapiens	Residual Activity	%	97.0
	12261862	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	98.0	CHEMBL4128	Homo sapiens	Residual Activity	%	98.0
	12261863	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12261864	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	85.0	CHEMBL4128	Homo sapiens	Residual Activity	%	85.0
	12261865	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12261866	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	93.0	CHEMBL4128	Homo sapiens	Residual Activity	%	93.0
	12261867	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	98.0	CHEMBL4128	Homo sapiens	Residual Activity	%	98.0
	12261868	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	98.0	CHEMBL4128	Homo sapiens	Residual Activity	%	98.0
	12261869	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	100.0	CHEMBL4128	Homo sapiens	Residual Activity	%	100.0
	12261870	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12261871	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	97.0	CHEMBL4128	Homo sapiens	Residual Activity	%	97.0
	12261872	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	109.0	CHEMBL4128	Homo sapiens	Residual Activity	%	109.0
	12261873	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261874	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	82.0	CHEMBL4128	Homo sapiens	Residual Activity	%	82.0
	12261875	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	118.0	CHEMBL4128	Homo sapiens	Residual Activity	%	118.0
	12261876	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	113.0	CHEMBL4128	Homo sapiens	Residual Activity	%	113.0
	12261877	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	128.0	CHEMBL4128	Homo sapiens	Residual Activity	%	128.0
	12261878	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261879	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261880	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	91.0	CHEMBL4128	Homo sapiens	Residual Activity	%	91.0
	12261881	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12261882	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	92.0	CHEMBL4128	Homo sapiens	Residual Activity	%	92.0
	12261883	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12261884	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12261885	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL4128	Homo sapiens	Residual Activity	%	113.0
	12261886	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	105.0	CHEMBL4128	Homo sapiens	Residual Activity	%	105.0
	12261887	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL4128	Homo sapiens	Residual Activity	%	-1.0
	12261888	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261889	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL4128	Homo sapiens	Residual Activity	%	100.0
	12261890	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	95.0	CHEMBL4128	Homo sapiens	Residual Activity	%	95.0
	12261891	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL4128	Homo sapiens	Residual Activity	%	96.0
	12261892	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	18.0	CHEMBL4128	Homo sapiens	Residual Activity	%	18.0
	12261893	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	100.0	CHEMBL4128	Homo sapiens	Residual Activity	%	100.0
	12261894	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	110.0	CHEMBL4128	Homo sapiens	Residual Activity	%	110.0
	12261895	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261896	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	67.0	CHEMBL4128	Homo sapiens	Residual Activity	%	67.0
	12261897	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12261898	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261899	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	97.0	CHEMBL4128	Homo sapiens	Residual Activity	%	97.0
	12261900	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	106.0	CHEMBL4128	Homo sapiens	Residual Activity	%	106.0
	12261901	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12261902	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261903	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	114.0	CHEMBL4128	Homo sapiens	Residual Activity	%	114.0
	12261904	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12261905	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	92.0	CHEMBL4128	Homo sapiens	Residual Activity	%	92.0
	12261906	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12261907	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261908	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	102.0	CHEMBL4128	Homo sapiens	Residual Activity	%	102.0
	12261909	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12261910	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12261911	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL4128	Homo sapiens	Residual Activity	%	95.0
	12261912	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	115.0	CHEMBL4128	Homo sapiens	Residual Activity	%	115.0
	12261913	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	114.0	CHEMBL4128	Homo sapiens	Residual Activity	%	114.0
	12261914	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	109.0	CHEMBL4128	Homo sapiens	Residual Activity	%	109.0
	12261915	CHEMBL2219313	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12261916	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12261917	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	91.0	CHEMBL4128	Homo sapiens	Residual Activity	%	91.0
	12261918	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12261919	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL4128	Homo sapiens	Residual Activity	%	106.0
	12261920	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12261921	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	102.0	CHEMBL4128	Homo sapiens	Residual Activity	%	102.0
	12261922	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	73.0	CHEMBL4128	Homo sapiens	Residual Activity	%	73.0
	12261923	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12261924	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	61.0	CHEMBL4128	Homo sapiens	Residual Activity	%	61.0
	12261925	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	34.0	CHEMBL4128	Homo sapiens	Residual Activity	%	34.0
	12261926	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	57.0	CHEMBL4128	Homo sapiens	Residual Activity	%	57.0
	12261927	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	40.0	CHEMBL4128	Homo sapiens	Residual Activity	%	40.0
	12261928	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12261929	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	28.0	CHEMBL4128	Homo sapiens	Residual Activity	%	28.0
	12261930	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	49.0	CHEMBL4128	Homo sapiens	Residual Activity	%	49.0
	12261931	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	76.0	CHEMBL4128	Homo sapiens	Residual Activity	%	76.0
	12261932	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	30.0	CHEMBL4128	Homo sapiens	Residual Activity	%	30.0
	12261933	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	3.0	CHEMBL4128	Homo sapiens	Residual Activity	%	3.0
	12261934	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	59.0	CHEMBL4128	Homo sapiens	Residual Activity	%	59.0
	12261935	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	64.0	CHEMBL4128	Homo sapiens	Residual Activity	%	64.0
	12261936	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	49.0	CHEMBL4128	Homo sapiens	Residual Activity	%	49.0
	12261937	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	44.0	CHEMBL4128	Homo sapiens	Residual Activity	%	44.0
	12261938	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	60.0	CHEMBL4128	Homo sapiens	Residual Activity	%	60.0
	12261939	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12261940	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12261941	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	46.0	CHEMBL4128	Homo sapiens	Residual Activity	%	46.0
	12261942	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	75.0	CHEMBL4128	Homo sapiens	Residual Activity	%	75.0
	12261943	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	53.0	CHEMBL4128	Homo sapiens	Residual Activity	%	53.0
	12261944	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	69.0	CHEMBL4128	Homo sapiens	Residual Activity	%	69.0
	12261945	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	32.0	CHEMBL4128	Homo sapiens	Residual Activity	%	32.0
	12261946	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12261947	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL4128	Homo sapiens	Residual Activity	%	1.0
	12261948	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	37.0	CHEMBL4128	Homo sapiens	Residual Activity	%	37.0
	12261949	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	97.0	CHEMBL4128	Homo sapiens	Residual Activity	%	97.0
	12261950	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12261951	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	117.0	CHEMBL4128	Homo sapiens	Residual Activity	%	117.0
	12261952	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12263599	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL4128	Homo sapiens	Residual Activity	%	96.0
	12263600	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12263601	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL4128	Homo sapiens	Residual Activity	%	91.0
	12263602	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12263603	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12263604	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	68.0	CHEMBL4128	Homo sapiens	Residual Activity	%	68.0
	12263605	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL4128	Homo sapiens	Residual Activity	%	10.0
	12263606	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	13.0	CHEMBL4128	Homo sapiens	Residual Activity	%	13.0
	12263607	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	88.0	CHEMBL4128	Homo sapiens	Residual Activity	%	88.0
	12263608	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12263609	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	82.0	CHEMBL4128	Homo sapiens	Residual Activity	%	82.0
	12263610	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	20.0	CHEMBL4128	Homo sapiens	Residual Activity	%	20.0
	12263611	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	59.0	CHEMBL4128	Homo sapiens	Residual Activity	%	59.0
	12263612	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	36.0	CHEMBL4128	Homo sapiens	Residual Activity	%	36.0
	12263613	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	3.0	CHEMBL4128	Homo sapiens	Residual Activity	%	3.0
	12263614	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	22.0	CHEMBL4128	Homo sapiens	Residual Activity	%	22.0
	12263615	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	40.0	CHEMBL4128	Homo sapiens	Residual Activity	%	40.0
	12263616	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12263617	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	76.0	CHEMBL4128	Homo sapiens	Residual Activity	%	76.0
	12263618	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	65.0	CHEMBL4128	Homo sapiens	Residual Activity	%	65.0
	12263619	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	59.0	CHEMBL4128	Homo sapiens	Residual Activity	%	59.0
	12263620	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	58.0	CHEMBL4128	Homo sapiens	Residual Activity	%	58.0
	12263621	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	64.0	CHEMBL4128	Homo sapiens	Residual Activity	%	64.0
	12263622	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	51.0	CHEMBL4128	Homo sapiens	Residual Activity	%	51.0
	12263623	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	73.0	CHEMBL4128	Homo sapiens	Residual Activity	%	73.0
	12263624	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	74.0	CHEMBL4128	Homo sapiens	Residual Activity	%	74.0
	12263625	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12263626	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL4128	Homo sapiens	Residual Activity	%	95.0
	12263627	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12263628	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	76.0	CHEMBL4128	Homo sapiens	Residual Activity	%	76.0
	12263629	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12263630	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	83.0	CHEMBL4128	Homo sapiens	Residual Activity	%	83.0
	12263631	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	62.0	CHEMBL4128	Homo sapiens	Residual Activity	%	62.0
	12263632	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12263633	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12263634	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	60.0	CHEMBL4128	Homo sapiens	Residual Activity	%	60.0
	12263635	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12263636	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	60.0	CHEMBL4128	Homo sapiens	Residual Activity	%	60.0
	12263637	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	43.0	CHEMBL4128	Homo sapiens	Residual Activity	%	43.0
	12263638	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL4128	Homo sapiens	Residual Activity	%	85.0
	12263639	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	19.0	CHEMBL4128	Homo sapiens	Residual Activity	%	19.0
	12263640	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12263641	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL4128	Homo sapiens	Residual Activity	%	-1.0
	12263642	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	72.0	CHEMBL4128	Homo sapiens	Residual Activity	%	72.0
	12263643	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	0.0	CHEMBL4128	Homo sapiens	Residual Activity	%	0.0
	12263644	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	81.0	CHEMBL4128	Homo sapiens	Residual Activity	%	81.0
	12263645	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12263646	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	51.0	CHEMBL4128	Homo sapiens	Residual Activity	%	51.0
	12263647	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL4128	Homo sapiens	Residual Activity	%	96.0
	12263648	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	41.0	CHEMBL4128	Homo sapiens	Residual Activity	%	41.0
	12263649	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	62.0	CHEMBL4128	Homo sapiens	Residual Activity	%	62.0
	12263650	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	61.0	CHEMBL4128	Homo sapiens	Residual Activity	%	61.0
	12263651	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	41.0	CHEMBL4128	Homo sapiens	Residual Activity	%	41.0
	12263652	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12263653	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	72.0	CHEMBL4128	Homo sapiens	Residual Activity	%	72.0
	12263654	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	6.0	CHEMBL4128	Homo sapiens	Residual Activity	%	6.0
	12263655	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL4128	Homo sapiens	Residual Activity	%	90.0
	12263656	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	75.0	CHEMBL4128	Homo sapiens	Residual Activity	%	75.0
	12263657	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	111.0	CHEMBL4128	Homo sapiens	Residual Activity	%	111.0
	12263658	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	82.0	CHEMBL4128	Homo sapiens	Residual Activity	%	82.0
	12263659	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	118.0	CHEMBL4128	Homo sapiens	Residual Activity	%	118.0
	12263660	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12263661	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	93.0	CHEMBL4128	Homo sapiens	Residual Activity	%	93.0
	12263662	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12263663	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL4128	Homo sapiens	Residual Activity	%	3.0
	12263664	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL4128	Homo sapiens	Residual Activity	%	106.0
	12263665	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL4128	Homo sapiens	Residual Activity	%	105.0
	12263666	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	125.0	CHEMBL4128	Homo sapiens	Residual Activity	%	125.0
	12263667	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12263668	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL4128	Homo sapiens	Residual Activity	%	81.0
	12263669	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	78.0	CHEMBL4128	Homo sapiens	Residual Activity	%	78.0
	12263670	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	59.0	CHEMBL4128	Homo sapiens	Residual Activity	%	59.0
	12263671	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	104.0	CHEMBL4128	Homo sapiens	Residual Activity	%	104.0
	12263672	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12263673	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	122.0	CHEMBL4128	Homo sapiens	Residual Activity	%	122.0
	12263674	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	46.0	CHEMBL4128	Homo sapiens	Residual Activity	%	46.0
	12263675	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	47.0	CHEMBL4128	Homo sapiens	Residual Activity	%	47.0
	12263676	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	131.0	CHEMBL4128	Homo sapiens	Residual Activity	%	131.0
	12263677	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	103.0	CHEMBL4128	Homo sapiens	Residual Activity	%	103.0
	12263678	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	21.0	CHEMBL4128	Homo sapiens	Residual Activity	%	21.0
	12263679	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	66.0	CHEMBL4128	Homo sapiens	Residual Activity	%	66.0
	12263680	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12263681	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	124.0	CHEMBL4128	Homo sapiens	Residual Activity	%	124.0
	12263682	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	95.0	CHEMBL4128	Homo sapiens	Residual Activity	%	95.0
	12263683	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	42.0	CHEMBL4128	Homo sapiens	Residual Activity	%	42.0
	12263684	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12263685	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	84.0	CHEMBL4128	Homo sapiens	Residual Activity	%	84.0
	12263686	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	34.0	CHEMBL4128	Homo sapiens	Residual Activity	%	34.0
	12263687	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12263688	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	59.0	CHEMBL4128	Homo sapiens	Residual Activity	%	59.0
	12263689	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	131.0	CHEMBL4128	Homo sapiens	Residual Activity	%	131.0
	12263690	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	82.0	CHEMBL4128	Homo sapiens	Residual Activity	%	82.0
	12263691	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4128	Homo sapiens	Residual Activity	%	-2.0
	12263692	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	80.0	CHEMBL4128	Homo sapiens	Residual Activity	%	80.0
	12263693	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL4128	Homo sapiens	Residual Activity	%	93.0
	12263694	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	63.0	CHEMBL4128	Homo sapiens	Residual Activity	%	63.0
	12263695	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12263696	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	1.0	CHEMBL4128	Homo sapiens	Residual Activity	%	1.0
	12263697	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	52.0	CHEMBL4128	Homo sapiens	Residual Activity	%	52.0
	12263698	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12263699	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	8.0	CHEMBL4128	Homo sapiens	Residual Activity	%	8.0
	12263700	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12263701	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12263702	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12263703	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	69.0	CHEMBL4128	Homo sapiens	Residual Activity	%	69.0
	12263704	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	99.0	CHEMBL4128	Homo sapiens	Residual Activity	%	99.0
	12263705	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	44.0	CHEMBL4128	Homo sapiens	Residual Activity	%	44.0
	12263706	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	72.0	CHEMBL4128	Homo sapiens	Residual Activity	%	72.0
	12263707	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL4128	Homo sapiens	Residual Activity	%	86.0
	12263708	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	87.0	CHEMBL4128	Homo sapiens	Residual Activity	%	87.0
	12263709	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	70.0	CHEMBL4128	Homo sapiens	Residual Activity	%	70.0
	12263710	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	79.0	CHEMBL4128	Homo sapiens	Residual Activity	%	79.0
	12263711	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL4128	Homo sapiens	Residual Activity	%	106.0
	12263712	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	71.0	CHEMBL4128	Homo sapiens	Residual Activity	%	71.0
	12263713	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	89.0	CHEMBL4128	Homo sapiens	Residual Activity	%	89.0
	12263714	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	92.0	CHEMBL4128	Homo sapiens	Residual Activity	%	92.0
	12263715	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL4128	Homo sapiens	Residual Activity	%	94.0
	12263716	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	101.0	CHEMBL4128	Homo sapiens	Residual Activity	%	101.0
	12263717	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	66.0	CHEMBL4128	Homo sapiens	Residual Activity	%	66.0
	12263718	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	49.0	CHEMBL4128	Homo sapiens	Residual Activity	%	49.0
	12263719	CHEMBL2219314	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	117.0	CHEMBL4128	Homo sapiens	Residual Activity	%	117.0
Not Active	12623294	CHEMBL2318774	Binding affinity to TIE2 (unknown origin) at 10 nM after 2 hrs by FRET assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1		CHEMBL2316582		Activity			CHEMBL4128	Homo sapiens	Activity		
	12626664	CHEMBL2317113	Inhibition of TIE2 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	12672879	CHEMBL2341141	Inhibition of recombinant TIE2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	40.0	CHEMBL4128	Homo sapiens	Activity	%	40.0
	12672880	CHEMBL2341141	Inhibition of recombinant TIE2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	39.0	CHEMBL4128	Homo sapiens	Activity	%	39.0
	12674102	CHEMBL2345554	Inhibition of TIE2 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	600.0	CHEMBL4128	Homo sapiens	IC50	uM	0.6
	12674103	CHEMBL2345554	Inhibition of TIE2 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	800.0	CHEMBL4128	Homo sapiens	IC50	uM	0.8
	12674104	CHEMBL2345554	Inhibition of TIE2 (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	1800.0	CHEMBL4128	Homo sapiens	IC50	uM	1.8
	12679728	CHEMBL2345838	Inhibition of TEK (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	5.75	CHEMBL4128	Homo sapiens	INH	%	5.75
	12685256	CHEMBL2342045	Inhibition of TIE2 (unknown origin) assessed as residual activity at 100 nM after 1 hr by competitive binding assay relative to control	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Activity	%	31.0	CHEMBL4128	Homo sapiens	Activity	%	31.0
	12700142	CHEMBL2342680	Inhibition of recombinant TEK (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	51.0	CHEMBL4128	Homo sapiens	INH	%	51.0
	12721794	CHEMBL2351850	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL4128	Homo sapiens	INH	%	100.0
	12727640	CHEMBL2351103	Inhibition of TIE2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	95.0	CHEMBL4128	Homo sapiens	Activity	%	95.0
	12728085	CHEMBL2351300	Inhibition of TIE2 (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	12728925	CHEMBL2352824	Inhibition of TIE2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	91.0	CHEMBL4128	Homo sapiens	Activity	%	91.0
	12729811	CHEMBL2352143	Inhibition of TIE2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL4128	Homo sapiens	Activity	%	91.0
	12730068	CHEMBL2351103	Inhibition of TIE2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	12731140	CHEMBL2352232	Inhibition of human Tie2 using TK substrate 2 as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349212	=	Activity	%	44.0	CHEMBL4128	Homo sapiens	Activity	%	44.0
	12731141	CHEMBL2352232	Inhibition of human Tie2 using TK substrate 2 as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349206	=	Activity	%	46.0	CHEMBL4128	Homo sapiens	Activity	%	46.0
	12731142	CHEMBL2352232	Inhibition of human Tie2 using TK substrate 2 as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349205	=	Activity	%	28.0	CHEMBL4128	Homo sapiens	Activity	%	28.0
	12731143	CHEMBL2352232	Inhibition of human Tie2 using TK substrate 2 as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	Activity	%	29.0	CHEMBL4128	Homo sapiens	Activity	%	29.0
	12731144	CHEMBL2352232	Inhibition of human Tie2 using TK substrate 2 as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348833	=	Activity	%	22.0	CHEMBL4128	Homo sapiens	Activity	%	22.0
	13327632	CHEMBL2389810	Inhibition of TEK (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	83.0	CHEMBL4128	Homo sapiens	INH	%	83.0
	13327633	CHEMBL2389810	Inhibition of TEK (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	90.0	CHEMBL4128	Homo sapiens	INH	%	90.0
Not Active	13328746	CHEMBL2387908	Inhibition of Tie2 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Determined	13330030	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1cccc(NC(=O)Nc3ccc(Cl)cc3Cl)c1)cn2C1CCCC1		CHEMBL2386999		IC50			CHEMBL4128	Homo sapiens	IC50		
	13330035	CHEMBL2389550	Inhibition of TIE2 (unknown origin)	B	COc1cc(-c2cn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)c1ccccc1		CHEMBL2387003	=	IC50	nM	137.0	CHEMBL4128	Homo sapiens	IC50	nM	137.0
	13330036	CHEMBL2389549	Inhibition of TIE2 (unknown origin) by HTRF assay	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
	13330090	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	COc1ccc(C)cc1NC(=O)Nc1cccc(C(=O)c2cn(C3CCCC3)c3ncnc(N)c23)c1		CHEMBL2387001	=	IC50	nM	8.8	CHEMBL4128	Homo sapiens	IC50	nM	8.8
	13330091	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Cc1ccc(F)c(NC(=O)Nc2cccc(C(=O)c3cn(C4CCCC4)c4ncnc(N)c34)c2)c1		CHEMBL2387000	=	IC50	nM	12.0	CHEMBL4128	Homo sapiens	IC50	nM	12.0
	13330092	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1cccc(NC(=O)Nc3ccc(Cl)cc3)c1)cn2C1CCCC1		CHEMBL2386998	=	IC50	nM	45.0	CHEMBL4128	Homo sapiens	IC50	nM	45.0
	13330093	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(Cc1cccc(NS(=O)(=O)c3c(F)cccc3F)c1)cn2C1CCCC1		CHEMBL2386997	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	13330094	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1ccc(NC(=O)Nc3c(F)cccc3F)cc1)cn2C1CCCC1		CHEMBL2386996	=	IC50	nM	345.0	CHEMBL4128	Homo sapiens	IC50	nM	345.0
	13330095	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1ccc(NS(=O)(=O)c3c(F)cccc3F)cc1)cn2C1CCCC1		CHEMBL2386995	=	IC50	nM	745.0	CHEMBL4128	Homo sapiens	IC50	nM	745.0
	13330096	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1cccc(NC(=O)Nc3c(F)cccc3F)c1)cn2C1CCCC1		CHEMBL2386994	=	IC50	nM	361.0	CHEMBL4128	Homo sapiens	IC50	nM	361.0
	13330097	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(C(=O)c1cccc(NS(=O)(=O)c3c(F)cccc3F)c1)cn2C1CCCC1		CHEMBL2386993	=	IC50	nM	423.0	CHEMBL4128	Homo sapiens	IC50	nM	423.0
	13330098	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(-c1nc3ccc(NC(=O)Nc4c(F)cccc4F)cc3[nH]1)cn2C1CCCC1		CHEMBL2387005	=	IC50	nM	241.0	CHEMBL4128	Homo sapiens	IC50	nM	241.0
	13330099	CHEMBL2387820	Inhibition of GST-fused TIE2 (unknown origin) using poly[Glu:Tyr] as substrate assessed as phosphotyrosine level by ELISA	B	Nc1ncnc2c1c(-c1nc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3[nH]1)cn2C1CCCC1		CHEMBL2387004	=	IC50	nM	568.0	CHEMBL4128	Homo sapiens	IC50	nM	568.0
	13374323	CHEMBL2405487	Inhibition of TEK (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	7.0	CHEMBL4128	Homo sapiens	INH	%	7.0
	13389891	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
	13389946	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1		CHEMBL2409790	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	13389947	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1		CHEMBL2409781	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	13389948	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1		CHEMBL2409779	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	13389949	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1		CHEMBL2409775	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	13389950	CHEMBL2410837	Inhibition of Tie-2 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1		CHEMBL2348996	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	13439921	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13445427	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13448486	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13448616	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13451411	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13454602	CHEMBL2429299	Competitive binding affinity to TIE2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	13503622	CHEMBL2447748	Inhibition of TIE2 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)ccc1O		CHEMBL2442531	=	Activity	%	85.0	CHEMBL4128	Homo sapiens	Activity	%	85.0
	13503623	CHEMBL2447748	Inhibition of TIE2 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)cc(Cl)c1O		CHEMBL2442530	=	Activity	%	36.0	CHEMBL4128	Homo sapiens	Activity	%	36.0
	13503624	CHEMBL2447748	Inhibition of TIE2 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(C)c3o2)ccc1O		CHEMBL2442529	=	Activity	%	112.0	CHEMBL4128	Homo sapiens	Activity	%	112.0
	13503625	CHEMBL2447748	Inhibition of TIE2 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(Cl)c3o2)ccc1O		CHEMBL2442424	=	Activity	%	93.0	CHEMBL4128	Homo sapiens	Activity	%	93.0
	13871731	CHEMBL3100766	Inhibition of human Tie2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	117.0	CHEMBL4128	Homo sapiens	Activity	%	117.0
	13948208	CHEMBL3132615	Inhibition of TIE2 receptor (unknown origin) using biotinylated poly-Glu-Tyr (4:1) as substrate preincubated for 5 mins measured after 12 hrs	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	740.0	CHEMBL4128	Homo sapiens	IC50	nmol/L	740.0
	14544025	CHEMBL3226035	Inhibition of TIE2 (unknown origin) at 10 uM	B	CC1(C)C(=O)Nc2cc3nccc(Oc4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4Cl)c3cc21		CHEMBL3218350	=	Inhibition	%	22.3	CHEMBL4128	Homo sapiens	INH	%	22.3
Not Active	14545567	CHEMBL3225613	Binding affinity to human Tie-2 (amino acid residues A23 to K745) at 0.125 to 2 uM by surface plasmon resonance assay	B	CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]		CHEMBL3219622		Activity			CHEMBL4128	Homo sapiens	Activity		
	14585347	CHEMBL3240764	Inhibition of human Tie2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	118.0	CHEMBL4128	Homo sapiens	Activity	%	118.0
	14659389	CHEMBL3267960	Inhibition of TIE2 (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	14659390	CHEMBL3267960	Inhibition of TIE2 (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	14664344	CHEMBL3271274	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	67.0	CHEMBL4128	Homo sapiens	INH	%	67.0
	14664345	CHEMBL3271274	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	82.0	CHEMBL4128	Homo sapiens	INH	%	82.0
	14664346	CHEMBL3271274	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	99.0	CHEMBL4128	Homo sapiens	INH	%	99.0
	14984405	CHEMBL3384386	Inhibition of Tie2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	INH	%	4.0
	14984526	CHEMBL3377045	Inhibition of Tie2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	15018703	CHEMBL3369203	Inhibition of TIE2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	10.1	CHEMBL4128	Homo sapiens	INH	%	10.1
	15022507	CHEMBL3374445	Inhibition of TEK/Tie-2 (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	32.0	CHEMBL4128	Homo sapiens	INH	%	32.0
	15025418	CHEMBL3365920	Inhibition of Tie2 (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	7.3	CHEMBL4128	Homo sapiens	INH	%	7.3
	15055342	CHEMBL3380478	Inhibition of human recombinant TIE2 using poly(Glu,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
Not Active	15071576	CHEMBL3381567	Inhibition of Tie2 (unknown origin) at 10 uM	B	CCN(CC)CCO/N=C(\c1ccc(SC)cc1)c1cccc2ccccc12.O=C(O)C(=O)O		CHEMBL3356484		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	15072598	CHEMBL3382658	Inhibition of TIE2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	105.0	CHEMBL4128	Homo sapiens	Activity	%	105.0
	15152443	CHEMBL3395872	Inhibition of TIE-2 (unknown origin)	B	O=C1CNCC2=C1C(c1ccccc1F)c1c[nH]nc1N2		CHEMBL3393455	>	IC50	nM	20000.0	CHEMBL4128	Homo sapiens	IC50	uM	20.0
	15181154	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		CHEMBL3402508	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	15181155	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)cc1		CHEMBL3402507	=	Activity	%	68.4	CHEMBL4128	Homo sapiens	Activity	%	68.4
	15181156	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402506	=	Activity	%	59.9	CHEMBL4128	Homo sapiens	Activity	%	59.9
	15181157	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402505	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	15181158	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402503	=	Activity	%	94.23	CHEMBL4128	Homo sapiens	Activity	%	94.23
	15181159	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1OCC		CHEMBL3402502	=	Activity	%	78.83	CHEMBL4128	Homo sapiens	Activity	%	78.83
	15181160	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CC(C)(C)c1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402501	=	Activity	%	92.46	CHEMBL4128	Homo sapiens	Activity	%	92.46
	15181161	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402500	=	Activity	%	99.2	CHEMBL4128	Homo sapiens	Activity	%	99.2
	15181162	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)cc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402493	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	15181163	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402491	=	Activity	%	62.79	CHEMBL4128	Homo sapiens	Activity	%	62.79
	15181164	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1cccs1		CHEMBL3402489	=	Activity	%	63.51	CHEMBL4128	Homo sapiens	Activity	%	63.51
	15181165	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4cccs4)C3c3ccc(C)cc3)sc2c1		CHEMBL3400173	=	Activity	%	83.16	CHEMBL4128	Homo sapiens	Activity	%	83.16
	15181166	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)o1		CHEMBL3402485	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	15181167	CHEMBL3405548	Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate	B	COc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3400828	=	Activity	%	66.4	CHEMBL4128	Homo sapiens	Activity	%	66.4
	15186232	CHEMBL3405645	Inhibition of Tie-2 (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401781	=	Activity	%	38.7	CHEMBL4128	Homo sapiens	Activity	%	38.7
	15186233	CHEMBL3405645	Inhibition of Tie-2 (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3sc(-c4ccccc4)cc23)c1		CHEMBL3401782	=	Activity	%	35.8	CHEMBL4128	Homo sapiens	Activity	%	35.8
	15193020	CHEMBL3411674	Inhibition of TIE2 (unknown origin) by FRET analysis	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	IC50	nM	22.0	CHEMBL4128	Homo sapiens	IC50	nM	22.0
	15193026	CHEMBL3411680	Inhibition of TIE2 (unknown origin) by cell-based assay	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	117.0	CHEMBL4128	Homo sapiens	EC50	nM	117.0
	15211851	CHEMBL3420209	Inhibition of TIE2/TEK (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	117.0	CHEMBL4128	Homo sapiens	EC50	nM	117.0
	15250017	CHEMBL3428992	Inhibition of human TIE2/TEK using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	32.0	CHEMBL4128	Homo sapiens	INH	%	32.0
	15648974	CHEMBL3594870	Inhibition of TIE2 (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	15650140	CHEMBL3595406	Inhibition of human TEK at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	61.0	CHEMBL4128	Homo sapiens	INH	%	61.0
	15665874	CHEMBL3603011	Inhibition of recombinant TIE2 (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
Not Active	15723467	CHEMBL3620320	Inhibition of TIE2 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	15754271	CHEMBL3631697	Inhibition of Tie2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	1.8	CHEMBL4128	Homo sapiens	INH	%	1.8
	15755935	CHEMBL3631586	Inhibition of TIE2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	74.0	CHEMBL4128	Homo sapiens	Activity	%	74.0
	15756789	CHEMBL3631497	Inhibition of TIE2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	69.17	CHEMBL4128	Homo sapiens	INH	%	69.17
	15757934	CHEMBL3631497	Inhibition of TIE2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	96.99	CHEMBL4128	Homo sapiens	INH	%	96.99
	15758913	CHEMBL3631497	Inhibition of TIE2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	4.75	CHEMBL4128	Homo sapiens	INH	%	4.75
273867	16277341	CHEMBL3707700	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 M. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 M. Reactions were carried out in 10 M ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
254323	16294816	CHEMBL3707796	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	57.0	CHEMBL4128	Homo sapiens	Kd	nM	57.0
273899	16310090	CHEMBL3707700	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 M. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 M. Reactions were carried out in 10 M ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	719.8	CHEMBL4128	Homo sapiens	IC50	nM	719.8
	16379633	CHEMBL3738545	Inhibition of TIE2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16379634	CHEMBL3738545	Inhibition of TIE2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	0.8	CHEMBL4128	Homo sapiens	INH	%	0.8
	16417331	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	16417332	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	16417333	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16417334	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	16417335	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16417336	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	3.0	CHEMBL4128	Homo sapiens	INH	%	3.0
	16417337	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16417338	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	4.0	CHEMBL4128	Homo sapiens	INH	%	4.0
	16417339	CHEMBL3750777	Inhibition of TIE2 (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16425353	CHEMBL3751239	Inhibition of Tie2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	7.4	CHEMBL4128	Homo sapiens	INH	%	7.4
	16429074	CHEMBL3750812	Inhibition of TIE2 (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	16432029	CHEMBL3750183	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	16451634	CHEMBL3761276	Inhibition of TIE2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-0.1	CHEMBL4128	Homo sapiens	INH	%	-0.1
	16458680	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	16458681	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	3.0	CHEMBL4128	Homo sapiens	INH	%	3.0
	16458682	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	9.0	CHEMBL4128	Homo sapiens	INH	%	9.0
	16458683	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	7.0	CHEMBL4128	Homo sapiens	INH	%	7.0
	16458684	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-3.0	CHEMBL4128	Homo sapiens	INH	%	-3.0
	16458685	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	16458686	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	13.0	CHEMBL4128	Homo sapiens	INH	%	13.0
	16458687	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	16458688	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-1.0	CHEMBL4128	Homo sapiens	INH	%	-1.0
	16458689	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	INH	%	11.0
	16458690	CHEMBL3761606	Inhibition of TEK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	16465575	CHEMBL3766483	Inhibition of human TIE2 using poly(Glu, Tyr) as substrate by [33P]-phosphoryl transfer assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	14.3	CHEMBL4128	Homo sapiens	IC50	nM	14.3
	16474712	CHEMBL3767332	Inhibition of TIE2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	57.5	CHEMBL4128	Homo sapiens	INH	%	57.5
	16486394	CHEMBL3772128	Inhibition of human recombinant TIE2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	16495243	CHEMBL3779052	Inhibition of N-terminal His6-tagged recombinant human TIE2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL4128	Homo sapiens	Activity	%	3.0
	16495244	CHEMBL3779053	Inhibition of N-terminal His6-tagged recombinant human TIE2 R849W mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-3.0	CHEMBL4128	Homo sapiens	Activity	%	-3.0
	16495245	CHEMBL3779054	Inhibition of N-terminal His6-tagged recombinant human TIE2 Y897S mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-12.0	CHEMBL4128	Homo sapiens	Activity	%	-12.0
	16496162	CHEMBL3779052	Inhibition of N-terminal His6-tagged recombinant human TIE2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-9.0	CHEMBL4128	Homo sapiens	Activity	%	-9.0
	16496163	CHEMBL3779053	Inhibition of N-terminal His6-tagged recombinant human TIE2 R849W mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL4128	Homo sapiens	Activity	%	-4.0
	16496164	CHEMBL3779054	Inhibition of N-terminal His6-tagged recombinant human TIE2 Y897S mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL4128	Homo sapiens	Activity	%	-4.0
	16508952	CHEMBL3779052	Inhibition of N-terminal His6-tagged recombinant human TIE2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-6.0	CHEMBL4128	Homo sapiens	Activity	%	-6.0
	16508953	CHEMBL3779053	Inhibition of N-terminal His6-tagged recombinant human TIE2 R849W mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-10.0	CHEMBL4128	Homo sapiens	Activity	%	-10.0
	16508954	CHEMBL3779054	Inhibition of N-terminal His6-tagged recombinant human TIE2 Y897S mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	31.0	CHEMBL4128	Homo sapiens	Activity	%	31.0
	16509790	CHEMBL3782936	Inhibition of N-terminal His6-tagged recombinant human Tie2 residues 771-end expressed in baculovirus infected insect Sf21 cells assessed as residual activity at 10 uM	B	Cc1ccc2nc(C3=C(N)N(c4cccc(O)c4)CC3=O)[nH]c2c1		CHEMBL3781980	=	Activity	%	92.7	CHEMBL4128	Homo sapiens	Activity	%	92.7
	16509791	CHEMBL3782936	Inhibition of N-terminal His6-tagged recombinant human Tie2 residues 771-end expressed in baculovirus infected insect Sf21 cells assessed as residual activity at 10 uM	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(O)c1		CHEMBL3781511	=	Activity	%	84.7	CHEMBL4128	Homo sapiens	Activity	%	84.7
Not Active	16515659	CHEMBL3782400	Inhibition of partial length human TIE2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	16556370	CHEMBL3796371	Inhibition of N-terminal His6-tagged recombinant human Tie2 (771 to end residues ) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1-c1ccccc1		CHEMBL3792965	=	Activity	%	84.2	CHEMBL4128	Homo sapiens	Activity	%	84.2
	16556371	CHEMBL3796371	Inhibition of N-terminal His6-tagged recombinant human Tie2 (771 to end residues ) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	O=C(O)c1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL1719248	=	Activity	%	119.7	CHEMBL4128	Homo sapiens	Activity	%	119.7
	16556372	CHEMBL3796371	Inhibition of N-terminal His6-tagged recombinant human Tie2 (771 to end residues ) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(C(=O)O)c4)c23)cc1		CHEMBL3401764	=	Activity	%	109.0	CHEMBL4128	Homo sapiens	Activity	%	109.0
	16559667	CHEMBL3794821	Inhibition of human N-terminal GST-tagged TIE2 receptor cytoplasmic domain (771 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	3.0	CHEMBL4128	Homo sapiens	INH	%	3.0
	16559668	CHEMBL3794821	Inhibition of human N-terminal GST-tagged TIE2 receptor cytoplasmic domain (771 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-2.0	CHEMBL4128	Homo sapiens	INH	%	-2.0
	16559669	CHEMBL3794821	Inhibition of human N-terminal GST-tagged TIE2 receptor cytoplasmic domain (771 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-2.5	CHEMBL4128	Homo sapiens	INH	%	-2.5
	16578324	CHEMBL3804378	Inhibition of partial length wild type human TIE2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	63.0	CHEMBL4128	Homo sapiens	Activity	%	63.0
	16593528	CHEMBL3811535	Inhibition of GST-tagged human recombinant TIE2 (817 to 1101 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	16594835	CHEMBL3812902	Inhibition of human TIE2 (804 to 1112 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	89.0	CHEMBL4128	Homo sapiens	Activity	%	89.0
	16612748	CHEMBL3815743	Inhibition of human TIE2 (771 to 1124 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	19.0	CHEMBL4128	Homo sapiens	Activity	%	19.0
	16614648	CHEMBL3816864	Inhibition of human TIE2 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	13.0	CHEMBL4128	Homo sapiens	INH	%	13.0
	16618669	CHEMBL3816092	Inhibition of recombinant human GST-tagged cytoplasmic TIE2 (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	16621536	CHEMBL3820675	Inhibition of TIE2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4128	Homo sapiens	IC50	nM	30000.0
	16622243	CHEMBL3820675	Inhibition of TIE2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	213.2	CHEMBL4128	Homo sapiens	IC50	nM	213.2
	16654246	CHEMBL3829780	Inhibition of human TIE2 (771 to 1124 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	80.0	CHEMBL4128	Homo sapiens	Activity	%	80.0
	16737975	CHEMBL3856692	Inhibition of human TIE2 assessed as remaining activity at 10 uM preincubated for 15 mins followed by substrate addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3sc(C)c(C)c23)C1=O		CHEMBL3904118	=	Activity	%	32.0	CHEMBL4128	Homo sapiens	Activity	%	32.0
	16737976	CHEMBL3856692	Inhibition of human TIE2 assessed as remaining activity at 10 uM preincubated for 15 mins followed by substrate addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3sc(-c4ccc(OC5CCNC5)cc4)c(C)c23)C1=O.Cl		CHEMBL3954358	=	Activity	%	25.0	CHEMBL4128	Homo sapiens	Activity	%	25.0
	16737977	CHEMBL3856692	Inhibition of human TIE2 assessed as remaining activity at 10 uM preincubated for 15 mins followed by substrate addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	16.0	CHEMBL4128	Homo sapiens	Activity	%	16.0
	16737981	CHEMBL3856696	Inhibition of human TIE2 preincubated for 15 mins followed by substrate addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	IC50	nM	9750.0	CHEMBL4128	Homo sapiens	IC50	uM	9.75
	16739546	CHEMBL3857081	Inhibition of GST tagged recombinant human Tie2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	9.0	CHEMBL4128	Homo sapiens	INH	%	9.0
	16739547	CHEMBL3857081	Inhibition of GST tagged recombinant human Tie2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	16739548	CHEMBL3857081	Inhibition of GST tagged recombinant human Tie2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	16742585	CHEMBL3857925	Inhibition of TIE-2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 2 hrs in presence of [33P]-gamma-ATP by microbeta scintillation counting	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	1.1	CHEMBL4128	Homo sapiens	IC50	nM	1.1
	16742595	CHEMBL3857915	Inhibition of TIE-2 (unknown origin)	B	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1		CHEMBL3545365	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	nM	8.0
	16742596	CHEMBL3857915	Inhibition of TIE-2 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	14.3	CHEMBL4128	Homo sapiens	IC50	nM	14.3
	16815469	CHEMBL3871630	Inhibition of human recombinant GST-tagged TEK cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	48.0	CHEMBL4128	Homo sapiens	INH	%	48.0
	16837398	CHEMBL3876056	Inhibition of human recombinant GST-tagged TEK cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	1040.0	CHEMBL4128	Homo sapiens	IC50	nM	1040.0
	16883050	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4cc(OC)c(OC)c(OC)c4)n[nH]c3c2)ccc1O		CHEMBL3947303		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	16883051	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1ccccc1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3975705	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	16883052	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Brc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3980816	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	16883053	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3961315	=	Inhibition	%	69.0	CHEMBL4128	Homo sapiens	INH	%	69.0
	16883054	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(NC(C)=O)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3927752	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	16883055	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(N)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3930504	=	Inhibition	%	27.0	CHEMBL4128	Homo sapiens	INH	%	27.0
	16883056	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(N)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3939894	=	Inhibition	%	40.0	CHEMBL4128	Homo sapiens	INH	%	40.0
	16883057	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3915043		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	16883058	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(NC(=O)c2ncc(C)s2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3914057	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	16883059	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3944307	=	Inhibition	%	29.0	CHEMBL4128	Homo sapiens	INH	%	29.0
	16883060	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(N(C)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3953791		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	16883061	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3983004	=	Inhibition	%	18.0	CHEMBL4128	Homo sapiens	INH	%	18.0
	16883062	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)OCc1ccccc1		CHEMBL3944638		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	16883063	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(NC(=O)OCc2ccccc2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3930218	=	Inhibition	%	17.0	CHEMBL4128	Homo sapiens	INH	%	17.0
	16883064	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1		CHEMBL3948411	=	Inhibition	%	15.0	CHEMBL4128	Homo sapiens	INH	%	15.0
	16883065	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1		CHEMBL3898789	=	Inhibition	%	44.0	CHEMBL4128	Homo sapiens	INH	%	44.0
	16883066	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccc4c(c3)OCO4)n[nH]c2c1		CHEMBL3889841	=	Inhibition	%	10.0	CHEMBL4128	Homo sapiens	INH	%	10.0
	16883067	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cccc(C(=O)Nc2cccc(N(C)c3ccc4c(/C=C/c5ccc6c(c5)OCO6)n[nH]c4c3)c2)c1		CHEMBL3951790	=	Inhibition	%	52.0	CHEMBL4128	Homo sapiens	INH	%	52.0
	16883068	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4cccs4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3959522	=	Inhibition	%	19.0	CHEMBL4128	Homo sapiens	INH	%	19.0
	16883069	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Inhibition	%	35.0	CHEMBL4128	Homo sapiens	INH	%	35.0
	16883070	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3915607	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	16883071	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n(C)n1		CHEMBL3891895	=	Inhibition	%	49.0	CHEMBL4128	Homo sapiens	INH	%	49.0
	16883072	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3953227	=	Inhibition	%	46.0	CHEMBL4128	Homo sapiens	INH	%	46.0
	16883073	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)ONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3955019	=	Inhibition	%	55.0	CHEMBL4128	Homo sapiens	INH	%	55.0
	16883074	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)ccc1C		CHEMBL3930485	=	Inhibition	%	41.0	CHEMBL4128	Homo sapiens	INH	%	41.0
	16883075	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3901827	=	Inhibition	%	56.0	CHEMBL4128	Homo sapiens	INH	%	56.0
	16883076	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C#CCNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3965277	=	Inhibition	%	47.0	CHEMBL4128	Homo sapiens	INH	%	47.0
	16883077	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3963146	=	Inhibition	%	48.0	CHEMBL4128	Homo sapiens	INH	%	48.0
	16883078	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(Nc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c(F)cc1C		CHEMBL3982880	=	Inhibition	%	52.0	CHEMBL4128	Homo sapiens	INH	%	52.0
	16883079	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NNc1ccccn1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3931953	=	Inhibition	%	82.0	CHEMBL4128	Homo sapiens	INH	%	82.0
	16883080	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3904168	=	Inhibition	%	51.0	CHEMBL4128	Homo sapiens	INH	%	51.0
	16883081	CHEMBL3881063	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 1 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(O)c(Cl)cc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3924544	=	Inhibition	%	94.0	CHEMBL4128	Homo sapiens	INH	%	94.0
	16883097	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(/C=C/c4ccc(OC)c(OC)c4)n[nH]c3c2)ccc1O		CHEMBL3923888	=	Inhibition	%	95.0	CHEMBL4128	Homo sapiens	INH	%	95.0
	16883098	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4cc5ccccc5[nH]4)n[nH]c3c2)ccc1O		CHEMBL3891392	=	Inhibition	%	90.0	CHEMBL4128	Homo sapiens	INH	%	90.0
	16883099	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C(=C/c1n[nH]c2cc(Oc3ccccc3)ccc12)\c1ccccc1		CHEMBL3975092	=	Inhibition	%	55.0	CHEMBL4128	Homo sapiens	INH	%	55.0
	16883100	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C(=C/c1n[nH]c2cc(Sc3ccccc3)ccc12)\c1ccccc1		CHEMBL3915562	=	Inhibition	%	31.0	CHEMBL4128	Homo sapiens	INH	%	31.0
	16883101	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Oc1ccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)cc1		CHEMBL3946793	=	Inhibition	%	88.0	CHEMBL4128	Homo sapiens	INH	%	88.0
	16883102	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1ccccc1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3901866	=	Inhibition	%	20.0	CHEMBL4128	Homo sapiens	INH	%	20.0
	16883103	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c(C)cc1O		CHEMBL3937879	=	Inhibition	%	91.0	CHEMBL4128	Homo sapiens	INH	%	91.0
	16883104	CHEMBL3881108	Inhibition of N-terminal truncated form of phosphorylated TIE2 R774M mutant (unknown origin) expressed in insect cells assessed as reduction in NADH oxidation at 10 uM using poly(Glu4Tyr) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL538361	=	Inhibition	%	92.0	CHEMBL4128	Homo sapiens	INH	%	92.0
412052	17776767	CHEMBL3888695	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	2430.0	CHEMBL4128	Homo sapiens	IC50	nM	2430.0
418011	17781254	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115787	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418012	17781255	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115788	=	IC50	nM	6.0	CHEMBL4128	Homo sapiens	IC50	nM	6.0
418013	17781256	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115789	=	IC50	nM	1.2	CHEMBL4128	Homo sapiens	IC50	nM	1.2
418014	17781257	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115790	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418015	17781258	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3972985	=	IC50	nM	380.0	CHEMBL4128	Homo sapiens	IC50	nM	380.0
418016	17781259	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3943444	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
418017	17781260	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3967647	=	IC50	nM	105.0	CHEMBL4128	Homo sapiens	IC50	nM	105.0
418018	17781261	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3906358	=	IC50	nM	1.9	CHEMBL4128	Homo sapiens	IC50	nM	1.9
418019	17781262	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(CN3CCCC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3931060	=	IC50	nM	6.7	CHEMBL4128	Homo sapiens	IC50	nM	6.7
418020	17781263	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115791	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418021	17781264	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115792	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418022	17781265	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115793	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418023	17781266	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115794	=	IC50	nM	1.3	CHEMBL4128	Homo sapiens	IC50	nM	1.3
418024	17781267	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(F)(F)F)c2)cc1-n1cc(C)n2nc(-c3cn[nH]c3)cc12		CHEMBL3978122	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418025	17781268	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115795	=	IC50	nM	24.0	CHEMBL4128	Homo sapiens	IC50	nM	24.0
418026	17781269	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115796	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418027	17781270	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115797	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418028	17781271	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115798	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418029	17781272	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115799	=	IC50	nM	0.9	CHEMBL4128	Homo sapiens	IC50	nM	0.9
418030	17781273	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115800	=	IC50	nM	3.1	CHEMBL4128	Homo sapiens	IC50	nM	3.1
418031	17781274	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115801	=	IC50	nM	2.1	CHEMBL4128	Homo sapiens	IC50	nM	2.1
418032	17781275	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115802	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418033	17781276	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115803	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418034	17781277	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115804	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418035	17781278	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115805	=	IC50	nM	1.9	CHEMBL4128	Homo sapiens	IC50	nM	1.9
418036	17781279	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115806	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418037	17781280	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115807	=	IC50	nM	3.1	CHEMBL4128	Homo sapiens	IC50	nM	3.1
418038	17781281	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115808	=	IC50	nM	2.1	CHEMBL4128	Homo sapiens	IC50	nM	2.1
418039	17781282	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115809	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
418040	17781283	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115810	=	IC50	nM	2.0	CHEMBL4128	Homo sapiens	IC50	nM	2.0
418041	17781284	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115811	=	IC50	nM	1.1	CHEMBL4128	Homo sapiens	IC50	nM	1.1
418042	17781285	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115812	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418043	17781286	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115813	=	IC50	nM	2.5	CHEMBL4128	Homo sapiens	IC50	nM	2.5
418044	17781287	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115814	=	IC50	nM	2.1	CHEMBL4128	Homo sapiens	IC50	nM	2.1
418045	17781288	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115815	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418046	17781289	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115816	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418047	17781290	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115817	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418048	17781291	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C#N)cc(OC(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3963905	=	IC50	nM	15.0	CHEMBL4128	Homo sapiens	IC50	nM	15.0
418049	17781292	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3928395	=	IC50	nM	320.0	CHEMBL4128	Homo sapiens	IC50	nM	320.0
418050	17781293	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3959425	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418051	17781294	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3930956	=	IC50	nM	35.0	CHEMBL4128	Homo sapiens	IC50	nM	35.0
418052	17781295	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(N(C)CCCN(C)C)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3974502	=	IC50	nM	1.5	CHEMBL4128	Homo sapiens	IC50	nM	1.5
418053	17781296	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3924803	=	IC50	nM	56.0	CHEMBL4128	Homo sapiens	IC50	nM	56.0
418054	17781297	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C#N)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3956530	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	nM	130.0
418055	17781298	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccc(F)c(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3980186	=	IC50	nM	740.0	CHEMBL4128	Homo sapiens	IC50	nM	740.0
418056	17781299	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2F)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3951276	=	IC50	nM	980.0	CHEMBL4128	Homo sapiens	IC50	nM	980.0
418057	17781300	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3976004	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418058	17781301	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3950106	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418059	17781302	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)cc(C(C)(C)O)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3967492	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418060	17781303	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C#N)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3937870	=	IC50	nM	1.2	CHEMBL4128	Homo sapiens	IC50	nM	1.2
418061	17781304	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(CN3CCCC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3952341	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418062	17781305	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)cc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)c1		CHEMBL3921135	=	IC50	nM	230.0	CHEMBL4128	Homo sapiens	IC50	nM	230.0
418063	17781306	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C(C)C)ccc2O)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3892165	=	IC50	nM	340.0	CHEMBL4128	Homo sapiens	IC50	nM	340.0
418064	17781307	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(-c3cccc(C#N)c3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3966953	=	IC50	nM	670.0	CHEMBL4128	Homo sapiens	IC50	nM	670.0
418065	17781308	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(-n3cccn3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3952312	=	IC50	nM	275.0	CHEMBL4128	Homo sapiens	IC50	nM	275.0
418066	17781309	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(N3CCCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3905136	=	IC50	nM	52.0	CHEMBL4128	Homo sapiens	IC50	nM	52.0
418067	17781310	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(N3CCCC3)ccc2Cl)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3946991	=	IC50	nM	995.0	CHEMBL4128	Homo sapiens	IC50	nM	995.0
418068	17781311	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccc(Cl)c(N3CCCCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3915640	=	IC50	nM	330.0	CHEMBL4128	Homo sapiens	IC50	nM	330.0
418069	17781312	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3938204	=	IC50	nM	600.0	CHEMBL4128	Homo sapiens	IC50	nM	600.0
418070	17781313	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(OC(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3910280	=	IC50	nM	125.0	CHEMBL4128	Homo sapiens	IC50	nM	125.0
418071	17781314	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	CCCOc1cccc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)c1		CHEMBL3928007	=	IC50	nM	260.0	CHEMBL4128	Homo sapiens	IC50	nM	260.0
418072	17781315	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(OCC(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3903535	=	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
418073	17781316	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	COc1cc(OC)cc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)c1		CHEMBL3977173	=	IC50	nM	770.0	CHEMBL4128	Homo sapiens	IC50	nM	770.0
418074	17781317	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccnc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3906508	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
418075	17781318	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(Cl)nc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3953768	=	IC50	nM	57.0	CHEMBL4128	Homo sapiens	IC50	nM	57.0
418076	17781319	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	CNc1cc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)cc(C(C)(C)C)n1		CHEMBL3915487	=	IC50	nM	7.9	CHEMBL4128	Homo sapiens	IC50	nM	7.9
418077	17781320	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3910445	=	IC50	nM	57.0	CHEMBL4128	Homo sapiens	IC50	nM	57.0
418078	17781321	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3981291	=	IC50	nM	71.0	CHEMBL4128	Homo sapiens	IC50	nM	71.0
418079	17781322	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3933531	=	IC50	nM	580.0	CHEMBL4128	Homo sapiens	IC50	nM	580.0
418080	17781323	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115818	=	IC50	nM	105.0	CHEMBL4128	Homo sapiens	IC50	nM	105.0
418081	17781324	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115819	=	IC50	nM	34.0	CHEMBL4128	Homo sapiens	IC50	nM	34.0
418082	17781325	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115820	=	IC50	nM	350.0	CHEMBL4128	Homo sapiens	IC50	nM	350.0
418083	17781326	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115821	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418084	17781327	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115822	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418085	17781328	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115823	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418086	17781329	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115824	=	IC50	nM	82.0	CHEMBL4128	Homo sapiens	IC50	nM	82.0
418087	17781330	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115825	=	IC50	nM	13.0	CHEMBL4128	Homo sapiens	IC50	nM	13.0
418088	17781331	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(Br)cc(C(C)(C)C)c1		CHEMBL3920770	=	IC50	nM	115.0	CHEMBL4128	Homo sapiens	IC50	nM	115.0
418089	17781332	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(C(C)(C)C)c1		CHEMBL3929545	=	IC50	nM	26.0	CHEMBL4128	Homo sapiens	IC50	nM	26.0
418090	17781333	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115826	=	IC50	nM	725.0	CHEMBL4128	Homo sapiens	IC50	nM	725.0
418091	17781334	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115827	=	IC50	nM	435.0	CHEMBL4128	Homo sapiens	IC50	nM	435.0
418092	17781335	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115828	=	IC50	nM	250.0	CHEMBL4128	Homo sapiens	IC50	nM	250.0
418093	17781336	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115829	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
418094	17781337	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115830	=	IC50	nM	220.0	CHEMBL4128	Homo sapiens	IC50	nM	220.0
418095	17781338	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115831	=	IC50	nM	20.0	CHEMBL4128	Homo sapiens	IC50	nM	20.0
418096	17781339	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115832	=	IC50	nM	1.1	CHEMBL4128	Homo sapiens	IC50	nM	1.1
418097	17781340	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115833	=	IC50	nM	980.0	CHEMBL4128	Homo sapiens	IC50	nM	980.0
418098	17781341	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115834	=	IC50	nM	23.0	CHEMBL4128	Homo sapiens	IC50	nM	23.0
418099	17781342	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115835	=	IC50	nM	2.3	CHEMBL4128	Homo sapiens	IC50	nM	2.3
418100	17781343	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115836	=	IC50	nM	91.0	CHEMBL4128	Homo sapiens	IC50	nM	91.0
418101	17781344	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115837	=	IC50	nM	215.0	CHEMBL4128	Homo sapiens	IC50	nM	215.0
418102	17781345	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C#N)cc(C3(O)CCC3)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3904599	=	IC50	nM	29.0	CHEMBL4128	Homo sapiens	IC50	nM	29.0
418103	17781346	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C#N)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3937870	=	IC50	nM	19.0	CHEMBL4128	Homo sapiens	IC50	nM	19.0
418104	17781347	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115838	=	IC50	nM	350.0	CHEMBL4128	Homo sapiens	IC50	nM	350.0
418105	17781348	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115839	=	IC50	nM	47.0	CHEMBL4128	Homo sapiens	IC50	nM	47.0
418106	17781349	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115840	=	IC50	nM	9.2	CHEMBL4128	Homo sapiens	IC50	nM	9.2
418107	17781350	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115841	=	IC50	nM	595.0	CHEMBL4128	Homo sapiens	IC50	nM	595.0
418108	17781351	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115842	=	IC50	nM	240.0	CHEMBL4128	Homo sapiens	IC50	nM	240.0
418109	17781352	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115843	=	IC50	nM	175.0	CHEMBL4128	Homo sapiens	IC50	nM	175.0
418110	17781353	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115844	=	IC50	nM	19.0	CHEMBL4128	Homo sapiens	IC50	nM	19.0
418111	17781354	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115845	=	IC50	nM	130.0	CHEMBL4128	Homo sapiens	IC50	nM	130.0
418112	17781355	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115846	=	IC50	nM	39.0	CHEMBL4128	Homo sapiens	IC50	nM	39.0
418113	17781356	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115847	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
418114	17781357	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115848	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418115	17781358	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115849	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418116	17781359	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115850	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418117	17781360	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115851	=	IC50	nM	5.0	CHEMBL4128	Homo sapiens	IC50	nM	5.0
418118	17781361	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115852	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418119	17781362	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115853	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418120	17781363	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(Br)cc(C(C)(C)C)c1		CHEMBL3944654	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418121	17781364	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(C(C)(C)C)c1		CHEMBL3937186	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418122	17781365	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(Cl)nc(C(C)(C)C)c1		CHEMBL3957460	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418123	17781366	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)nc(C(C)(C)C)c1		CHEMBL3950414	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418124	17781367	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(F)c(NC(=O)c2cc(C#N)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3922694	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418125	17781368	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115854	=	IC50	nM	110.0	CHEMBL4128	Homo sapiens	IC50	nM	110.0
418126	17781369	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115855	=	IC50	nM	37.0	CHEMBL4128	Homo sapiens	IC50	nM	37.0
418127	17781370	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115856	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
418128	17781371	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)cc(S(N)(=O)=O)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3937098	=	IC50	nM	3.9	CHEMBL4128	Homo sapiens	IC50	nM	3.9
418129	17781372	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cccc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3975340	=	IC50	nM	56.0	CHEMBL4128	Homo sapiens	IC50	nM	56.0
418130	17781373	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)cc(S(N)(=O)=O)c1		CHEMBL3949425	=	IC50	nM	297.0	CHEMBL4128	Homo sapiens	IC50	nM	297.0
418131	17781374	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)ccn2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3984523	=	IC50	nM	280.0	CHEMBL4128	Homo sapiens	IC50	nM	280.0
418132	17781375	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(SC(F)(F)F)c1		CHEMBL3913891	=	IC50	nM	1.2	CHEMBL4128	Homo sapiens	IC50	nM	1.2
418133	17781376	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OC(F)(F)F)c1		CHEMBL3931577	=	IC50	nM	1.4	CHEMBL4128	Homo sapiens	IC50	nM	1.4
418134	17781377	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OC(F)F)c1		CHEMBL3927973	=	IC50	nM	43.0	CHEMBL4128	Homo sapiens	IC50	nM	43.0
418135	17781378	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OC(F)(F)C(F)F)c1		CHEMBL3891004	=	IC50	nM	3.2	CHEMBL4128	Homo sapiens	IC50	nM	3.2
418136	17781379	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OCC(F)(F)F)c1		CHEMBL3919064	=	IC50	nM	24.0	CHEMBL4128	Homo sapiens	IC50	nM	24.0
418137	17781380	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	COc1cccc(C(=O)Nc2cc(-n3ccn4nc(-c5cccnc5)cc34)c(C)cc2C)c1		CHEMBL3917971	=	IC50	nM	252.0	CHEMBL4128	Homo sapiens	IC50	nM	252.0
418138	17781381	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OC(C)C)c1		CHEMBL3942395	=	IC50	nM	4.6	CHEMBL4128	Homo sapiens	IC50	nM	4.6
418139	17781382	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OCC(C)C)c1		CHEMBL3905415	=	IC50	nM	53.0	CHEMBL4128	Homo sapiens	IC50	nM	53.0
418140	17781383	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OC(C)(C)C)c1		CHEMBL3933416	=	IC50	nM	55.0	CHEMBL4128	Homo sapiens	IC50	nM	55.0
418141	17781384	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	CCOCCOc1cccc(C(=O)Nc2cc(-n3ccn4nc(-c5cccnc5)cc34)c(C)cc2C)c1		CHEMBL3951546	=	IC50	nM	607.0	CHEMBL4128	Homo sapiens	IC50	nM	607.0
418142	17781385	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OCCO)c1		CHEMBL3900087	=	IC50	nM	687.0	CHEMBL4128	Homo sapiens	IC50	nM	687.0
418143	17781386	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(OCCN(C)C)c1		CHEMBL3964941	=	IC50	nM	409.0	CHEMBL4128	Homo sapiens	IC50	nM	409.0
418144	17781387	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(N2CCC(F)(F)CC2)c1		CHEMBL3979351	=	IC50	nM	65.0	CHEMBL4128	Homo sapiens	IC50	nM	65.0
418145	17781388	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(C(C)(C)C(F)(F)F)c1		CHEMBL3896522	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418146	17781389	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(C2(C)COC2)c1		CHEMBL3967691	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418147	17781390	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(C(C)(C)O)c1		CHEMBL3891050	=	IC50	nM	62.0	CHEMBL4128	Homo sapiens	IC50	nM	62.0
418148	17781391	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cccc(C(C)(C)F)c1		CHEMBL3928950	=	IC50	nM	0.9	CHEMBL4128	Homo sapiens	IC50	nM	0.9
418149	17781392	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115857	=	IC50	nM	1.3	CHEMBL4128	Homo sapiens	IC50	nM	1.3
418150	17781393	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115858	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418151	17781394	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115859	=	IC50	nM	0.9	CHEMBL4128	Homo sapiens	IC50	nM	0.9
418152	17781395	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115860	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418153	17781396	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115822	=	IC50	nM	0.2	CHEMBL4128	Homo sapiens	IC50	nM	0.2
418154	17781397	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115861	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418155	17781398	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115862	=	IC50	nM	2.3	CHEMBL4128	Homo sapiens	IC50	nM	2.3
418156	17781399	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115863	=	IC50	nM	2.4	CHEMBL4128	Homo sapiens	IC50	nM	2.4
418157	17781400	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115864	=	IC50	nM	6.1	CHEMBL4128	Homo sapiens	IC50	nM	6.1
418158	17781401	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115865	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418159	17781402	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115866	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418160	17781403	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115867	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418161	17781404	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115868	=	IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
418162	17781405	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115869	=	IC50	nM	5.9	CHEMBL4128	Homo sapiens	IC50	nM	5.9
418163	17781406	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115870	=	IC50	nM	0.5	CHEMBL4128	Homo sapiens	IC50	nM	0.5
418164	17781407	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115871	=	IC50	nM	58.0	CHEMBL4128	Homo sapiens	IC50	nM	58.0
418165	17781408	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115872	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	nM	10.0
418166	17781409	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115873	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
418167	17781410	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115874	=	IC50	nM	28.0	CHEMBL4128	Homo sapiens	IC50	nM	28.0
418168	17781411	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115875	=	IC50	nM	8.9	CHEMBL4128	Homo sapiens	IC50	nM	8.9
418169	17781412	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115876	=	IC50	nM	0.4	CHEMBL4128	Homo sapiens	IC50	nM	0.4
418170	17781413	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115877	=	IC50	nM	1.7	CHEMBL4128	Homo sapiens	IC50	nM	1.7
418171	17781414	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115878	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418172	17781415	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115879	=	IC50	nM	726.0	CHEMBL4128	Homo sapiens	IC50	nM	726.0
418173	17781416	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115880	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
418174	17781417	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115881	=	IC50	nM	1.2	CHEMBL4128	Homo sapiens	IC50	nM	1.2
418175	17781418	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115882	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
418176	17781419	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115883	=	IC50	nM	7.8	CHEMBL4128	Homo sapiens	IC50	nM	7.8
418177	17781420	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115884	=	IC50	nM	9.3	CHEMBL4128	Homo sapiens	IC50	nM	9.3
418178	17781421	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115885	=	IC50	nM	2.8	CHEMBL4128	Homo sapiens	IC50	nM	2.8
418179	17781422	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115886	=	IC50	nM	3.2	CHEMBL4128	Homo sapiens	IC50	nM	3.2
418180	17781423	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115887	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418181	17781424	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115888	=	IC50	nM	1.8	CHEMBL4128	Homo sapiens	IC50	nM	1.8
418182	17781425	CHEMBL3888827	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: For the assay, 50 nl of a 100-fold concentrated solution of the respective test substance in DMSO were pipetted into a black low-volume 384-well microtitre plate (Greiner Bio-One, Frickenhausen, Germany) 2 l of a solution of the Tie2 fusion protein in assay buffer [50 mM HEPES/HCl pH 7, mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.01% (v/v) Nonidet P-40, 0.1% (w/v) bovine serum albumin (BSA), 1 Complete EDTA-free protease inhibitor mixture (Roche)] were added, and the mixture was incubated for 15 min to allow pre-binding of the substance to the enzyme prior to the kinase reaction. The kinase reaction was then started by adding 3 l of a solution of adenosine triphosphate (ATP, 1.67 mMfinal concentration in 5 l assay volume=1 mM) and substrate (1.67 Mfinal concentration in 5 l assay volume=1 M) in assay buffer, and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of the Tie2 fusion protein was adapted to the respective activity of the enzyme and adjusted such that the assay was carried out in the linear range. Typical concentrations were in the range of 30 ng/ml. The reaction was stopped by addition of 5 l of a solution of TR-FRET detection reagents [200 nM streptavidin-XL665 and 2 nM PT66-Eu chelate, a europium chelate-labelled anti-phosphotyrosine antibody (Perkin-Elmer); alternatively, it is also possible to use PT66-Tb cryptate (Cisbio Bioassays, Codolet, France)] in aqueous EDTA solution [90 mM EDTA, 0.28% (w/v) bovine serum albumin (BSA) in 50 mM HEPES pH 7.5]. The resulting mixture was incubated at 22 C. for 1 h to allow formation of the complex of the biotinylated phosphorylated substrate and the detection reagents. The amount of phosphorylated substrate was then determined by measuring the resonance energy transfer from PT66-Eu chelate to streptavidin-XL665. To this end, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm were measured in a TR-FRET measuring instrument (for example Viewlux, Perkin-Elmer).	B			CHEMBL4115889	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418183	17781426	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115788	=	IC50	nM	7.6	CHEMBL4128	Homo sapiens	IC50	nM	7.6
418184	17781427	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115789	=	IC50	nM	3.4	CHEMBL4128	Homo sapiens	IC50	nM	3.4
418185	17781428	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115790	=	IC50	nM	4.7	CHEMBL4128	Homo sapiens	IC50	nM	4.7
418186	17781429	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cn[nH]c3)cc12		CHEMBL3943444	=	IC50	nM	17.0	CHEMBL4128	Homo sapiens	IC50	nM	17.0
418187	17781430	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115793	=	IC50	nM	4.7	CHEMBL4128	Homo sapiens	IC50	nM	4.7
418188	17781431	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115796	=	IC50	nM	3.2	CHEMBL4128	Homo sapiens	IC50	nM	3.2
418189	17781432	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115798	=	IC50	nM	11.0	CHEMBL4128	Homo sapiens	IC50	nM	11.0
418190	17781433	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115806	=	IC50	nM	3.0	CHEMBL4128	Homo sapiens	IC50	nM	3.0
418191	17781434	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115808	=	IC50	nM	3.6	CHEMBL4128	Homo sapiens	IC50	nM	3.6
418192	17781435	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115812	=	IC50	nM	2.1	CHEMBL4128	Homo sapiens	IC50	nM	2.1
418193	17781436	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	Cc1ccc(NC(=O)c2cc(-n3ccnc3C)cc(C(F)(F)F)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3959425	=	IC50	nM	2.3	CHEMBL4128	Homo sapiens	IC50	nM	2.3
418194	17781437	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3950106	=	IC50	nM	6.4	CHEMBL4128	Homo sapiens	IC50	nM	6.4
418195	17781438	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	Cc1ccc(NC(=O)c2cc(CN3CCCC3)cc(C(C)(C)C)c2)cc1-n1ccn2nc(-c3cccnc3)cc12		CHEMBL3952341	=	IC50	nM	8.8	CHEMBL4128	Homo sapiens	IC50	nM	8.8
418196	17781439	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	CNc1cc(C(=O)Nc2ccc(C)c(-n3ccn4nc(-c5cccnc5)cc34)c2)cc(C(C)(C)C)n1		CHEMBL3915487	=	IC50	nM	46.0	CHEMBL4128	Homo sapiens	IC50	nM	46.0
418197	17781440	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115821	=	IC50	nM	0.8	CHEMBL4128	Homo sapiens	IC50	nM	0.8
418198	17781441	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115822	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
418199	17781442	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115823	=	IC50	nM	1.7	CHEMBL4128	Homo sapiens	IC50	nM	1.7
418200	17781443	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115825	=	IC50	nM	8.8	CHEMBL4128	Homo sapiens	IC50	nM	8.8
418201	17781444	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115831	=	IC50	nM	44.0	CHEMBL4128	Homo sapiens	IC50	nM	44.0
418202	17781445	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115834	=	IC50	nM	41.0	CHEMBL4128	Homo sapiens	IC50	nM	41.0
418203	17781446	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115844	=	IC50	nM	18.0	CHEMBL4128	Homo sapiens	IC50	nM	18.0
418204	17781447	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115848	=	IC50	nM	0.9	CHEMBL4128	Homo sapiens	IC50	nM	0.9
418205	17781448	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115853	=	IC50	nM	1.4	CHEMBL4128	Homo sapiens	IC50	nM	1.4
418206	17781449	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)nc(C(C)(C)C)c1		CHEMBL3950414	=	IC50	nM	2.9	CHEMBL4128	Homo sapiens	IC50	nM	2.9
418207	17781450	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115870	=	IC50	nM	1.0	CHEMBL4128	Homo sapiens	IC50	nM	1.0
418208	17781451	CHEMBL3888828	Sandwich ELISA Assay: For measuring the autophosphorylation of the endogenous Tie2 receptor in the cell lysates prepared, a self-prepared anti-Tie2 antibody directed against the N-terminus of the Tie-2 receptor (1.09 mg/ml) and an HRP-coupled anti-phosphotyrosine antibody (Sigma, A4595, clone pY-20) were used. White 96-well ELISA plates (Lumitrac600, Greiner, #655074) were incubated with 100 l per well of a 1:1000 dilution of the anti-Tie2 antibody in coating buffer [15 mM Na2CO3, 35 mM NaHCO3, pH 9.6] with shaking at 4 C. overnight. The coated ELISA plates were washed three times with 250 l PBST buffer [0.1% Tween-20 in PBS], the wells were blocked with 250 l 3% BSA in PBST buffer with shaking at RT for 1-6 h and washed three more times with 250 l PBST buffer. From the cell lysate plates thawed in the fridge, in each case 100 l of lysate were transferred into the coated wells of the ELISA plates, and the plates were incubated with shaking at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST buffer, and 100 l of a 1:5000 dilution of the anti-phosphotyrosine HRP antibody in 3% Prionex (Calbiochem, #529600) in PBST were then pipetted into each well and the plates were incubated with shaking and protected from light at 4 C. overnight. The plates were washed three times with in each case 250 l of PBST, and 100 l of chemiluminescent substrate [BM Chemiluminescence ELISA Substrate (POD) Reagent A and B 1:100, Roche, #1582950] were then pipetted into each well, and after 3 min the plates were measured using a luminescence reader.	B			CHEMBL4115874	=	IC50	nM	8.9	CHEMBL4128	Homo sapiens	IC50	nM	8.9
431439	17791547	CHEMBL3889049	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	10.1	CHEMBL4128	Homo sapiens	IC50	nM	10.1
	17955659	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)cc3)c12		CHEMBL4086694	=	IC50	nM	13.22	CHEMBL4128	Homo sapiens	IC50	nM	13.22
	17955660	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5OC(F)(F)F)CC4)cc3)c12		CHEMBL4104599	=	IC50	nM	134.12	CHEMBL4128	Homo sapiens	IC50	nM	134.12
	17955661	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OC(F)(F)F)cc5Br)CC4)cc3)c12		CHEMBL4071731	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	17955662	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)cc3)c12		CHEMBL4092519	=	IC50	nM	6.05	CHEMBL4128	Homo sapiens	IC50	nM	6.05
	17955663	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(OC(F)(F)F)ccc5Br)CC4)cc3)c12		CHEMBL4093247	=	IC50	nM	904.52	CHEMBL4128	Homo sapiens	IC50	nM	904.52
	17955664	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)cc3)c12		CHEMBL4072514	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	17955665	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)c(F)c5)CC4)cc3)c12		CHEMBL4100979	=	IC50	nM	23.78	CHEMBL4128	Homo sapiens	IC50	nM	23.78
	17955666	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)cc3)c12		CHEMBL4083001	=	IC50	nM	3.49	CHEMBL4128	Homo sapiens	IC50	nM	3.49
	17955667	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)c12		CHEMBL4075266	=	IC50	nM	49.97	CHEMBL4128	Homo sapiens	IC50	nM	49.97
	17955668	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc6c(c5)OCO6)CC4)cc3)c12		CHEMBL4101918	=	IC50	nM	6.72	CHEMBL4128	Homo sapiens	IC50	nM	6.72
	17955669	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)c3)c12		CHEMBL4085495	=	IC50	nM	1.95	CHEMBL4128	Homo sapiens	IC50	nM	1.95
	17955670	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)c3)c12		CHEMBL4063920	=	IC50	nM	6.34	CHEMBL4128	Homo sapiens	IC50	nM	6.34
	17955671	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)c3)c12		CHEMBL4082005	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	17955672	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)c3)c12		CHEMBL4060113	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	17955673	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.83	CHEMBL4128	Homo sapiens	IC50	nM	0.83
	17955674	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(Br)cc(C(F)(F)F)c4)cc3)cc2n1		CHEMBL4069517	=	IC50	nM	2.47	CHEMBL4128	Homo sapiens	IC50	nM	2.47
	17955675	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Br)cc4OC(F)(F)F)cc3)cc2n1		CHEMBL4089043	=	IC50	nM	15.68	CHEMBL4128	Homo sapiens	IC50	nM	15.68
	17955676	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(OC(F)(F)F)cc4Br)cc3)cc2n1		CHEMBL4060841	=	IC50	nM	9.68	CHEMBL4128	Homo sapiens	IC50	nM	9.68
	17955677	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)cc2n1		CHEMBL4066813	=	IC50	nM	0.6	CHEMBL4128	Homo sapiens	IC50	nM	0.6
	17955678	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(OC(F)(F)F)ccc4Br)cc3)cc2n1		CHEMBL4088100	=	IC50	nM	87.38	CHEMBL4128	Homo sapiens	IC50	nM	87.38
	17955679	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)cc2n1		CHEMBL4104466	=	IC50	nM	164.35	CHEMBL4128	Homo sapiens	IC50	nM	164.35
	17955680	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(F)c(F)c4)cc3)cc2n1		CHEMBL4080224	=	IC50	nM	52.04	CHEMBL4128	Homo sapiens	IC50	nM	52.04
	17955681	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)c(Cl)c4)cc3)cc2n1		CHEMBL4085653	=	IC50	nM	1.14	CHEMBL4128	Homo sapiens	IC50	nM	1.14
	17955682	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)cc2n1		CHEMBL4103584	=	IC50	nM	0.16	CHEMBL4128	Homo sapiens	IC50	nM	0.16
	17955683	CHEMBL3993540	Inhibition of TIE-2 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc5c(c4)OCO5)cc3)cc2n1		CHEMBL4087541	=	IC50	nM	0.13	CHEMBL4128	Homo sapiens	IC50	nM	0.13
	17964956	CHEMBL3995062	Inhibition of human TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	27.0	CHEMBL4128	Homo sapiens	Activity	%	27.0
	17979276	CHEMBL3998080	Inhibition of recombinant human GST-tagged TIE2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	11.0	CHEMBL4128	Homo sapiens	INH	%	11.0
	18007234	CHEMBL4003442	Inhibition of human wild type C-terminal GST-His-tagged TIE2 expressed in Sf9 cells assessed as residual activity at 0.5 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1		CHEMBL4077018	=	Activity	%	30.0	CHEMBL4128	Homo sapiens	Activity	%	30.0
	18053049	CHEMBL4011896	Inhibition of TIE2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-9.2	CHEMBL4128	Homo sapiens	INH	%	-9.2
Not Determined	18066674	CHEMBL4014514	Inhibition of human TEK	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL4128	Homo sapiens	IC50		
	18066675	CHEMBL4014514	Inhibition of human TEK	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	=	IC50	nM	510.0	CHEMBL4128	Homo sapiens	IC50	uM	0.51
	18066676	CHEMBL4014514	Inhibition of human TEK	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	=	IC50	nM	950.0	CHEMBL4128	Homo sapiens	IC50	uM	0.95
	18066677	CHEMBL4014515	Inhibition of human TEK at 10 uM relative to control	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	18105915	CHEMBL4022693	Inhibition of human Tie2 using biotin-GGGGAPDLYKDFLT peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL3185148	>	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	uM	5.0
	18105916	CHEMBL4022693	Inhibition of human Tie2 using biotin-GGGGAPDLYKDFLT peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	>	IC50	nM	25000.0	CHEMBL4128	Homo sapiens	IC50	uM	25.0
	18105917	CHEMBL4022693	Inhibition of human Tie2 using biotin-GGGGAPDLYKDFLT peptide substrate after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	>	IC50	nM	5000.0	CHEMBL4128	Homo sapiens	IC50	uM	5.0
	18114882	CHEMBL4025412	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	18121156	CHEMBL4026808	Inhibition of human TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	4.9	CHEMBL4128	Homo sapiens	Activity	%	4.9
	18156555	CHEMBL4035090	Inhibition of TIE2/TEK (unknown origin)	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364	=	IC50	nM	1800.0	CHEMBL4128	Homo sapiens	IC50	uM	1.8
	18203936	CHEMBL4044223	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	26.0	CHEMBL4128	Homo sapiens	Activity	%	26.0
	18212115	CHEMBL4046133	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL4128	Homo sapiens	INH	%	20.0
	18232200	CHEMBL4050306	Inhibition of human TIE2 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	41.0	CHEMBL4128	Homo sapiens	Activity	%	41.0
	18253558	CHEMBL4055063	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	87.0	CHEMBL4128	Homo sapiens	Activity	%	87.0
	18253559	CHEMBL4055063	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	18282181	CHEMBL4120136	Inhibition of recombinant GST-tagged human Tie2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	13.7	CHEMBL4128	Homo sapiens	INH	%	13.7
	18282500	CHEMBL4120136	Inhibition of recombinant GST-tagged human Tie2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	4.6	CHEMBL4128	Homo sapiens	INH	%	4.6
	18309588	CHEMBL4131860	Inhibition of recombinant human full length TIE2 using poly (Glu, Tyr) as substrate by alpha screen assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	14.3	CHEMBL4128	Homo sapiens	IC50	nM	14.3
	18328434	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)cc3)cc2n1		CHEMBL4165234	=	IC50	nM	65.26	CHEMBL4128	Homo sapiens	IC50	nM	65.26
	18328435	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5OC(F)(F)F)CC4)cc3)cc2n1		CHEMBL4175857	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328436	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OC(F)(F)F)cc5Br)CC4)cc3)cc2n1		CHEMBL4166703	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328437	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)cc3)cc2n1		CHEMBL4177333	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328438	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(OC(F)(F)F)ccc5Br)CC4)cc3)cc2n1		CHEMBL4162947	=	IC50	nM	14.65	CHEMBL4128	Homo sapiens	IC50	nM	14.65
	18328439	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)cc3)cc2n1		CHEMBL4170879	=	IC50	nM	54.9	CHEMBL4128	Homo sapiens	IC50	nM	54.9
	18328440	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)c(F)c5)CC4)cc3)cc2n1		CHEMBL4166401	=	IC50	nM	14.49	CHEMBL4128	Homo sapiens	IC50	nM	14.49
	18328441	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)cc3)cc2n1		CHEMBL4174319	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328442	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)cc2n1		CHEMBL4174711	=	IC50	nM	21.2	CHEMBL4128	Homo sapiens	IC50	nM	21.2
	18328443	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OCCCN6CCOCC6)c(F)c5)CC4)cc3)cc2n1		CHEMBL4164062	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328444	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc6c(c5)OCO6)CC4)cc3)cc2n1		CHEMBL4159588	=	IC50	nM	432.35	CHEMBL4128	Homo sapiens	IC50	nM	432.35
	18328445	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	6.77	CHEMBL4128	Homo sapiens	IC50	nM	6.77
	18328446	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)cc2)cn1		CHEMBL4167913	=	IC50	nM	21.27	CHEMBL4128	Homo sapiens	IC50	nM	21.27
	18328447	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)cn1		CHEMBL4175773	=	IC50	nM	9.19	CHEMBL4128	Homo sapiens	IC50	nM	9.19
	18328448	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)cn1		CHEMBL4176454	=	IC50	nM	9.77	CHEMBL4128	Homo sapiens	IC50	nM	9.77
	18328449	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(C)c(Cl)c3)cc2)cn1		CHEMBL4168590	=	IC50	nM	14.2	CHEMBL4128	Homo sapiens	IC50	nM	14.2
	18328450	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cc2)cn1		CHEMBL4161345	=	IC50	nM	90.86	CHEMBL4128	Homo sapiens	IC50	nM	90.86
	18328451	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)cn1		CHEMBL4171943	=	IC50	nM	105.07	CHEMBL4128	Homo sapiens	IC50	nM	105.07
	18328452	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cn1		CHEMBL4169668	=	IC50	nM	3.59	CHEMBL4128	Homo sapiens	IC50	nM	3.59
	18328453	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)cn1		CHEMBL4161735	=	IC50	nM	7.97	CHEMBL4128	Homo sapiens	IC50	nM	7.97
	18328531	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1		CHEMBL4163581	=	IC50	nM	24.75	CHEMBL4128	Homo sapiens	IC50	nM	24.75
	18328532	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1ccc(F)c(F)c1		CHEMBL4174261	=	IC50	nM	16.55	CHEMBL4128	Homo sapiens	IC50	nM	16.55
	18328533	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL4167030	=	IC50	nM	12.81	CHEMBL4128	Homo sapiens	IC50	nM	12.81
	18328534	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4159125	=	IC50	nM	245.28	CHEMBL4128	Homo sapiens	IC50	nM	245.28
	18328535	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4163655	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328536	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	5.63	CHEMBL4128	Homo sapiens	IC50	nM	5.63
	18328537	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3c(C)cccc3C)cc2)cn1		CHEMBL4165168	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18328538	CHEMBL4135860	Inhibition of TIE-2 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)cn1		CHEMBL4173072	=	IC50	nM	59.93	CHEMBL4128	Homo sapiens	IC50	nM	59.93
	18355978	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	2.13	CHEMBL4128	Homo sapiens	IC50	nM	2.13
	18355979	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(OC(F)(F)F)ccc4Br)cc3)c12		CHEMBL4168788	=	IC50	nM	4.85	CHEMBL4128	Homo sapiens	IC50	nM	4.85
	18355980	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)c12		CHEMBL4175949	=	IC50	nM	19.8	CHEMBL4128	Homo sapiens	IC50	nM	19.8
	18355981	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(F)c(F)c4)cc3)c12		CHEMBL4167759	=	IC50	nM	28.32	CHEMBL4128	Homo sapiens	IC50	nM	28.32
	18355982	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(Cl)c(Cl)c4)cc3)c12		CHEMBL4175943	=	IC50	nM	16.7	CHEMBL4128	Homo sapiens	IC50	nM	16.7
	18355983	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)n1		CHEMBL4165320	=	IC50	nM	13.75	CHEMBL4128	Homo sapiens	IC50	nM	13.75
	18355984	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(C)c(Cl)c3)cc2)n1		CHEMBL4160813	=	IC50	nM	14.2	CHEMBL4128	Homo sapiens	IC50	nM	14.2
	18355985	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)n1		CHEMBL4168735	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18355986	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)cc2)n1		CHEMBL4164213	=	IC50	nM	68.68	CHEMBL4128	Homo sapiens	IC50	nM	68.68
	18355987	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)n1		CHEMBL4172089	=	IC50	nM	10.29	CHEMBL4128	Homo sapiens	IC50	nM	10.29
	18355988	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)n1		CHEMBL4167663	=	IC50	nM	97.74	CHEMBL4128	Homo sapiens	IC50	nM	97.74
	18355989	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4175530	=	IC50	nM	31.15	CHEMBL4128	Homo sapiens	IC50	nM	31.15
	18355990	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)n1		CHEMBL4171035	=	IC50	nM	98.12	CHEMBL4128	Homo sapiens	IC50	nM	98.12
	18355991	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2)n1		CHEMBL4160431	=	IC50	nM	21.52	CHEMBL4128	Homo sapiens	IC50	nM	21.52
	18355992	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)n1		CHEMBL4159244	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18355993	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)cc2)n1		CHEMBL4169889	>	IC50	nM	500.0	CHEMBL4128	Homo sapiens	IC50	nM	500.0
	18355994	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccccc3F)cc2)n1		CHEMBL4174374	=	IC50	nM	16.77	CHEMBL4128	Homo sapiens	IC50	nM	16.77
	18355995	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cc2)n1		CHEMBL4166465	=	IC50	nM	37.24	CHEMBL4128	Homo sapiens	IC50	nM	37.24
	18355996	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3c(C)cccc3C)cc2)n1		CHEMBL4170942	=	IC50	nM	134.67	CHEMBL4128	Homo sapiens	IC50	nM	134.67
	18355997	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cccc(F)c2)CCC1		CHEMBL4164800	=	IC50	nM	42.15	CHEMBL4128	Homo sapiens	IC50	nM	42.15
	18355998	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	C#Cc1cccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)c1		CHEMBL4167570	=	IC50	nM	22.15	CHEMBL4128	Homo sapiens	IC50	nM	22.15
	18355999	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)CCC1		CHEMBL4159645	=	IC50	nM	88.64	CHEMBL4128	Homo sapiens	IC50	nM	88.64
	18356000	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cccc(C(F)(F)F)c2)CCC1		CHEMBL4164127	=	IC50	nM	73.59	CHEMBL4128	Homo sapiens	IC50	nM	73.59
	18356001	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1		CHEMBL4174775	=	IC50	nM	133.47	CHEMBL4128	Homo sapiens	IC50	nM	133.47
	18356002	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)cc1Cl		CHEMBL4161287	=	IC50	nM	115.15	CHEMBL4128	Homo sapiens	IC50	nM	115.15
	18356003	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	Cc1cc(Br)ccc1NC(=O)C1(C(=O)Nc2ccc(-c3ccc4c(=O)nc[nH]c4c3)cc2)CCC1		CHEMBL4169220	=	IC50	nM	64.33	CHEMBL4128	Homo sapiens	IC50	nM	64.33
	18356004	CHEMBL4140581	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	7.85	CHEMBL4128	Homo sapiens	IC50	nM	7.85
	18379947	CHEMBL4145848	Inhibition of TIE2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-7.0	CHEMBL4128	Homo sapiens	INH	%	-7.0
	18379999	CHEMBL4145900	Inhibition of TIE2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	50.9	CHEMBL4128	Homo sapiens	IC50	nM	50.9
	18409088	CHEMBL4151622	Inhibition of TIE2 (unknown origin) at 1 uM	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	>	Inhibition	%	90.0	CHEMBL4128	Homo sapiens	INH	%	90.0
	18409100	CHEMBL4151634	Binding affinity to human TIE2	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Kd	nM	370.0	CHEMBL4128	Homo sapiens	Kd	nM	370.0
	18431085	CHEMBL4155766	Inhibition of recombinant GST-tagged human TIE2 cytoplasmic domain (817 to 1101 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	39.0	CHEMBL4128	Homo sapiens	INH	%	39.0
	18440478	CHEMBL4157302	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	78.0	CHEMBL4128	Homo sapiens	Activity	%	78.0
	18449871	CHEMBL4178105	Inhibition of human TIE2 (771 to 1124 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	106.0	CHEMBL4128	Homo sapiens	Activity	%	106.0
	18463808	CHEMBL4181224	Inhibition of recombinant human N-terminal His6-tagged Tie2 (771 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	14.0	CHEMBL4128	Homo sapiens	INH	%	14.0
	18484434	CHEMBL4186081	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	88.0	CHEMBL4128	Homo sapiens	Activity	%	88.0
	18484918	CHEMBL4186081	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	54.0	CHEMBL4128	Homo sapiens	Activity	%	54.0
	18489568	CHEMBL4187309	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	73.0	CHEMBL4128	Homo sapiens	Activity	%	73.0
	18506015	CHEMBL4190475	Inhibition of recombinant human GST-tagged TIE2 expressed in baculovirus infected Sf9 insect cells using Poly(Ala,Glu,Lys,Tyr)6:2:5:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Non standard unit for type	CHEMBL1290072	>	INH	uM	100.0	CHEMBL4128	Homo sapiens	INH	uM	100.0
	18507579	CHEMBL4191212	Inhibition of recombinant activated human Tie2 Y897S mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	18507580	CHEMBL4191211	Inhibition of recombinant activated human Tie2 R849W mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	18507581	CHEMBL4191210	Inhibition of recombinant activated human Tie2 (771 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-20.0	CHEMBL4128	Homo sapiens	INH	%	-20.0
	18577625	CHEMBL4222211	Inhibition of human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	20.3	CHEMBL4128	Homo sapiens	INH	%	20.3
	18577649	CHEMBL4222211	Inhibition of human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	3.8	CHEMBL4128	Homo sapiens	INH	%	3.8
	18577673	CHEMBL4222211	Inhibition of human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	2.2	CHEMBL4128	Homo sapiens	INH	%	2.2
	18653331	CHEMBL4230240	Inhibition of TIE2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	96.0	CHEMBL4128	Homo sapiens	INH	%	96.0
	18653332	CHEMBL4230240	Inhibition of TIE2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	61.0	CHEMBL4128	Homo sapiens	INH	%	61.0
	18655254	CHEMBL4230981	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	93.0	CHEMBL4128	Homo sapiens	Activity	%	93.0
	18658989	CHEMBL4231730	Inhibition of GST-tagged human TIE2 at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	-7.71	CHEMBL4128	Homo sapiens	INH	%	-7.71
	18663964	CHEMBL4232948	Inhibition of human TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	88.0	CHEMBL4128	Homo sapiens	Activity	%	88.0
	18664061	CHEMBL4233045	Binding affinity to human TIE2 (N804 to T1112 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4128	Homo sapiens	Kd	uM	5.0
	18665457	CHEMBL4233416	Inhibition of TIE2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	18674922	CHEMBL4235443	Inhibition of TIE2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL4128	Homo sapiens	Ki	nM	2000.0
	18674923	CHEMBL4235443	Inhibition of TIE2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4128	Homo sapiens	Ki	nM	2000.0
	18674924	CHEMBL4235443	Inhibition of TIE2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	2000.0	CHEMBL4128	Homo sapiens	Ki	nM	2000.0
	18694034	CHEMBL4253487	Inhibition of recombinant human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-6.0	CHEMBL4128	Homo sapiens	INH	%	-6.0
	18694116	CHEMBL4253569	Inhibition of recombinant human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-2.0	CHEMBL4128	Homo sapiens	INH	%	-2.0
	18697690	CHEMBL4254363	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	94.0	CHEMBL4128	Homo sapiens	Activity	%	94.0
	18702471	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	18702567	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	18702612	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	18702664	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	18702707	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	-1.0	CHEMBL4128	Homo sapiens	INH	%	-1.0
	18702750	CHEMBL4255136	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	-3.0	CHEMBL4128	Homo sapiens	INH	%	-3.0
	18737809	CHEMBL4261430	Inhibition of recombinant human Tie2 Q939H/Q940H double mutant (771 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	75.0	CHEMBL4128	Homo sapiens	IC50	nM	75.0
	18751253	CHEMBL4263962	Inhibition of TIE2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	18.0	CHEMBL4128	Homo sapiens	INH	%	18.0
	18752233	CHEMBL4264570	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	89.0	CHEMBL4128	Homo sapiens	Activity	%	89.0
	18763076	CHEMBL4266873	Inhibition of TIE2 (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	0.75	CHEMBL4128	Homo sapiens	INH	%	0.75
	18763109	CHEMBL4266906	Inhibition of TIE2 (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	35.69	CHEMBL4128	Homo sapiens	INH	%	35.69
Not Active	18847263	CHEMBL4304957	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	18858233	CHEMBL4308079	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL4128	Homo sapiens	Activity	%	93.0
	18892725	CHEMBL4314524	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	75.5	CHEMBL4128	Homo sapiens	Activity	%	75.5
	18892726	CHEMBL4314523	Inhibition of human Tie2 Q939H/Q940H/R849W mutant (771 to end residues) using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.5	CHEMBL4128	Homo sapiens	Activity	%	102.5
	18892727	CHEMBL4314522	Inhibition of human Tie2 Q939H/Q940H/Y897S mutant (771 to end residues) using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	114.5	CHEMBL4128	Homo sapiens	Activity	%	114.5
	18919483	CHEMBL4322839	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged TEK (unknown origin) (771 to 1124 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	395.0	CHEMBL4128	Homo sapiens	Kd	nM	395.0
	18919671	CHEMBL4322839	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged TEK (unknown origin) (771 to 1124 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	408.0	CHEMBL4128	Homo sapiens	Kd	nM	408.0
	18934111	CHEMBL4326643	Inhibition of human TIE2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	65.4	CHEMBL4128	Homo sapiens	INH	%	65.4
	18938355	CHEMBL4327904	Inhibition of human TIE2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.88	CHEMBL4128	Homo sapiens	Activity	%	95.88
	18938356	CHEMBL4327904	Inhibition of human TIE2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	91.43	CHEMBL4128	Homo sapiens	Activity	%	91.43
	18938749	CHEMBL4328268	Inhibition of human TIE2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4128	Homo sapiens	Activity	%	65.0
	18939136	CHEMBL4328632	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	65.5	CHEMBL4128	Homo sapiens	IC50	10'-8M	6.55
	18946674	CHEMBL4330209	Inhibition of TIE2 (unknown origin)	B	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1		CHEMBL3545365	=	IC50	nM	8.0	CHEMBL4128	Homo sapiens	IC50	uM	0.008
	18947848	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(Cl)c4)nn3)cc2)cn1		CHEMBL4452256	=	IC50	nM	0.36	CHEMBL4128	Homo sapiens	IC50	nM	0.36
Not Determined	18947849	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccccc4F)nn3)cc2)cn1		CHEMBL4440813		IC50			CHEMBL4128	Homo sapiens	IC50		
	18947850	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)cn1		CHEMBL4470400	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	18947851	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(C)cc4)nn3)cc2)cn1		CHEMBL4449700	=	IC50	nM	0.26	CHEMBL4128	Homo sapiens	IC50	nM	0.26
	18947852	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(C)c4)nn3)cc2)cn1		CHEMBL4556899	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	18947853	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)cn1		CHEMBL4528844	=	IC50	nM	0.3	CHEMBL4128	Homo sapiens	IC50	nM	0.3
	18947854	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(N)c4)nn3)cc2)cn1		CHEMBL4441465	=	IC50	nM	0.73	CHEMBL4128	Homo sapiens	IC50	nM	0.73
Not Determined	18947855	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(NC(=O)C5CC5)cc4)nn3)cc2)cn1		CHEMBL4473253		IC50			CHEMBL4128	Homo sapiens	IC50		
	18947856	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Clc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4447552	=	IC50	nM	0.28	CHEMBL4128	Homo sapiens	IC50	nM	0.28
	18947857	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cccnc3)cc2)nn1		CHEMBL4454065	=	IC50	nM	61.26	CHEMBL4128	Homo sapiens	IC50	nM	61.26
	18947858	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	c1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4556134	=	IC50	nM	24.19	CHEMBL4128	Homo sapiens	IC50	nM	24.19
	18947859	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4519953	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	18947860	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4570075	=	IC50	nM	0.45	CHEMBL4128	Homo sapiens	IC50	nM	0.45
	18947861	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4449321	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
Not Determined	18947862	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	FC(F)(F)c1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4443204		IC50			CHEMBL4128	Homo sapiens	IC50		
	18947863	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4456856	=	IC50	nM	265.72	CHEMBL4128	Homo sapiens	IC50	nM	265.72
	18947864	CHEMBL4330409	Inhibition of TIE2 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.39	CHEMBL4128	Homo sapiens	IC50	nM	0.39
	18959005	CHEMBL4333661	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	96.0	CHEMBL4128	Homo sapiens	Activity	%	96.0
	18964747	CHEMBL4335315	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	113.0	CHEMBL4128	Homo sapiens	Activity	%	113.0
	18964748	CHEMBL4335315	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	107.0	CHEMBL4128	Homo sapiens	Activity	%	107.0
	18964749	CHEMBL4335316	Inhibition of human Tie2 Q939H/Q940H/R849W mutant (771 to end residues) assessed as residual activity at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	91.0	CHEMBL4128	Homo sapiens	Activity	%	91.0
	18964750	CHEMBL4335316	Inhibition of human Tie2 Q939H/Q940H/R849W mutant (771 to end residues) assessed as residual activity at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	105.0	CHEMBL4128	Homo sapiens	Activity	%	105.0
	18964751	CHEMBL4335317	Inhibition of human Tie2 Q939H/Q940H/Y897S mutant (771 to end residues) assessed as residual activity at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL4128	Homo sapiens	Activity	%	103.0
	18964752	CHEMBL4335317	Inhibition of human Tie2 Q939H/Q940H/Y897S mutant (771 to end residues) assessed as residual activity at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL4128	Homo sapiens	Activity	%	98.0
	18972129	CHEMBL4337139	Inhibition of recombinant human TIE2 Q939H/Q940H mutant (771 to end residues) assessed as residual activity at 10 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	50.0	CHEMBL4128	Homo sapiens	Activity	%	50.0
	18972130	CHEMBL4337140	Inhibition of recombinant human TIE2 Q939H/Q940H/R849W mutant (771 to end residues) assessed as residual activity at 10 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	103.0	CHEMBL4128	Homo sapiens	Activity	%	103.0
	18972131	CHEMBL4337141	Inhibition of recombinant human TIE2 Q939H/Q940H/Y897S mutant (771 to end residues) assessed as residual activity at 10 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	81.0	CHEMBL4128	Homo sapiens	Activity	%	81.0
	18985708	CHEMBL4340007	Inhibition of TIE2 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	nM	10000.0
Not Active	19040187	CHEMBL4351610	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	19040188	CHEMBL4352088	Inhibition of human Tie2 Q939H/Q940H/R849W mutant (771 to end residues) using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Not Active	19040189	CHEMBL4352089	Inhibition of human Tie2 Q939H/Q940H/Y897S mutant (771 to end residues) using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
Active	19041306	CHEMBL4352567	Inhibition of human TIE2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	19059858	CHEMBL4358159	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	19090422	CHEMBL4365996	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	80.0	CHEMBL4128	Homo sapiens	Activity	%	80.0
	19092144	CHEMBL4366618	Inhibition of human TIE2 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	8.06	CHEMBL4128	Homo sapiens	INH	%	8.06
	19114523	CHEMBL4371361	Inhibition of TIE2 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114524	CHEMBL4371360	Inhibition of TIE2 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114587	CHEMBL4371361	Inhibition of TIE2 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114588	CHEMBL4371360	Inhibition of TIE2 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114669	CHEMBL4371360	Inhibition of TIE2 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114670	CHEMBL4371361	Inhibition of TIE2 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114820	CHEMBL4371360	Inhibition of TIE2 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19114821	CHEMBL4371361	Inhibition of TIE2 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4128	Homo sapiens	Efficacy	%	83.0
	19118515	CHEMBL4372359	Inhibition of recombinant human N-terminal His6-tagged Tie2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	IC50	nM	208.0	CHEMBL4128	Homo sapiens	IC50	nM	208.0
	19118541	CHEMBL4372385	Inhibition of recombinant human N-terminal His6-tagged Tie2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using Poly (Glu4-Tyr) (4:1) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	>	Inhibition	%	60.0	CHEMBL4128	Homo sapiens	INH	%	60.0
	19140692	CHEMBL4376521	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	=	IC50	nM	26.3	CHEMBL4128	Homo sapiens	IC50	nM	26.3
	19140801	CHEMBL4376565	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	=	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	19144909	CHEMBL4377925	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	29.0	CHEMBL4128	Homo sapiens	INH	%	29.0
	19144910	CHEMBL4377926	Inhibition of human Tie2 Q939H/Q940H/R849W mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	INH	%	12.0
	19144911	CHEMBL4377927	Inhibition of human Tie2 Q939H/Q940H/Y897S mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	20.0	CHEMBL4128	Homo sapiens	INH	%	20.0
	19146997	CHEMBL4378979	Inhibition of human Tie2 Q939H/Q940H mutant (771 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	18.0	CHEMBL4128	Homo sapiens	INH	%	18.0
	19148066	CHEMBL4379462	Inhibition of recombinant human TIE2 Q939H/Q940H double mutant (771 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4128	Homo sapiens	IC50	uM	10.0
	19159686	CHEMBL4382790	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	20.0	CHEMBL4128	Homo sapiens	Activity	%	20.0
	19181163	CHEMBL4387374	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	-2.0	CHEMBL4128	Homo sapiens	INH	%	-2.0
	19181388	CHEMBL4387374	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	-0.5	CHEMBL4128	Homo sapiens	INH	%	-0.5
	19191321	CHEMBL4389509	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	75.0	CHEMBL4128	Homo sapiens	INH	%	75.0
	19192172	CHEMBL4389986	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	99.0	CHEMBL4128	Homo sapiens	INH	%	99.0
	19200428	CHEMBL4391612	Binding affinity to wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	77.0	CHEMBL4128	Homo sapiens	Activity	%	77.0
	19238876	CHEMBL4399182	Inhibition of TIE2 (unknown origin)	B	CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(C#N)cc3)n2)cc1		CHEMBL4573547	=	IC50	nM	1390.0	CHEMBL4128	Homo sapiens	IC50	uM	1.39
	19238877	CHEMBL4399182	Inhibition of TIE2 (unknown origin)	B	O=C(CSc1nccc(Nc2ccc(N3CCOCC3)cc2)n1)c1ccc(F)cc1		CHEMBL4449189	=	IC50	nM	480.0	CHEMBL4128	Homo sapiens	IC50	uM	0.48
Not Determined	19238878	CHEMBL4399182	Inhibition of TIE2 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		IC50			CHEMBL4128	Homo sapiens	IC50		
	19239344	CHEMBL4399260	Inhibition of GST-tagged TIE2 (unknown origin) using biotin-Ahx-EPKDDAYPLYSDFG peptide as substrate by HTRF method	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	IC50	nM	1.5	CHEMBL4128	Homo sapiens	IC50	nM	1.5
	19266643	CHEMBL4405593	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	19276151	CHEMBL4408154	Inhibition of recombinant human TIE2 (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	23.0	CHEMBL4128	Homo sapiens	INH	%	23.0
	19276152	CHEMBL4408155	Inhibition of recombinant human TIE2 R849W mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	57.0	CHEMBL4128	Homo sapiens	INH	%	57.0
	19276153	CHEMBL4408156	Inhibition of recombinant human TIE2 Y897S mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	51.0	CHEMBL4128	Homo sapiens	INH	%	51.0
	19295882	CHEMBL4412359	Inhibition of Tie-2 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	83.6	CHEMBL4128	Homo sapiens	INH	%	83.6
	19295912	CHEMBL4412389	Inhibition of Tie-2 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	36.4	CHEMBL4128	Homo sapiens	INH	%	36.4
	19295942	CHEMBL4412419	Inhibition of Tie-2 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	10.4	CHEMBL4128	Homo sapiens	INH	%	10.4
	19312973	CHEMBL4416528	Inhibition of recombinant human N-terminal His6-tagged TIE2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
Not Determined	19364867	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Clc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4570733		IC50			CHEMBL4128	Homo sapiens	IC50		
	19364868	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cncnc3)cc2)nn1		CHEMBL4459732	=	IC50	nM	5.45	CHEMBL4128	Homo sapiens	IC50	nM	5.45
	19364869	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	c1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4456738	=	IC50	nM	51.86	CHEMBL4128	Homo sapiens	IC50	nM	51.86
	19364870	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4452405	=	IC50	nM	25.74	CHEMBL4128	Homo sapiens	IC50	nM	25.74
	19364871	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4553163	=	IC50	nM	13.71	CHEMBL4128	Homo sapiens	IC50	nM	13.71
	19364872	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4449073	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364873	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4448354	=	IC50	nM	210.0	CHEMBL4128	Homo sapiens	IC50	nM	210.0
	19364874	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1)C1CC1		CHEMBL4447942	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364875	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cn[nH]c3)cc2)nn1		CHEMBL4437530	=	IC50	nM	5.46	CHEMBL4128	Homo sapiens	IC50	nM	5.46
	19364876	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)c1		CHEMBL4472113	=	IC50	nM	46.39	CHEMBL4128	Homo sapiens	IC50	nM	46.39
	19364877	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)cc1		CHEMBL4575350	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364878	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)c1		CHEMBL4470139	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364879	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccccc4F)nn3)cc2)cn1		CHEMBL4469077	=	IC50	nM	2.69	CHEMBL4128	Homo sapiens	IC50	nM	2.69
	19364880	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)cn1		CHEMBL4453627	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364881	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cnn(C)c4)cc3)nn2)cc1		CHEMBL4543212	=	IC50	nM	77.42	CHEMBL4128	Homo sapiens	IC50	nM	77.42
	19364882	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cnn(C)c4)cc3)nn2)c1		CHEMBL4436670	=	IC50	nM	51.44	CHEMBL4128	Homo sapiens	IC50	nM	51.44
	19364883	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)cn1		CHEMBL4525897	=	IC50	nM	9.11	CHEMBL4128	Homo sapiens	IC50	nM	9.11
	19364884	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(C(F)(F)F)c4)nn3)cc2)cn1		CHEMBL4476000	=	IC50	nM	1.79	CHEMBL4128	Homo sapiens	IC50	nM	1.79
	19364885	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(N)c4)nn3)cc2)cn1		CHEMBL4516255	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19364886	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(NC(=O)C5CC5)c4)nn3)cc2)cn1		CHEMBL4539395	=	IC50	nM	0.82	CHEMBL4128	Homo sapiens	IC50	nM	0.82
	19364887	CHEMBL4423709	Inhibition of Tie-2 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.39	CHEMBL4128	Homo sapiens	IC50	nM	0.39
	19371162	CHEMBL4424914	Inhibition of human N-terminal His6-tagged TIE2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	nM	1000.0
	19432876	CHEMBL4429546	Inhibition of TIE2 (unknown origin) at 1 uM	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1		CHEMBL4463436	=	Inhibition	%	8.0	CHEMBL4128	Homo sapiens	INH	%	8.0
	19476638	CHEMBL4479786	Inhibition of recombinant human GST-tagged cytoplasmic TEK expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	4700.0	CHEMBL4128	Homo sapiens	IC50	nM	4700.0
	19476738	CHEMBL4479786	Inhibition of recombinant human GST-tagged cytoplasmic TEK expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	4700.0	CHEMBL4128	Homo sapiens	IC50	nM	4700.0
	19476838	CHEMBL4479786	Inhibition of recombinant human GST-tagged cytoplasmic TEK expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	660.0	CHEMBL4128	Homo sapiens	IC50	nM	660.0
	19476938	CHEMBL4479786	Inhibition of recombinant human GST-tagged cytoplasmic TEK expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	nM	100000.0
	20598208	CHEMBL4602935	Inhibition of human TIE2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL4128	Homo sapiens	IC50	uM	1.0
	20600688	CHEMBL4603640	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system using tyrosine-5 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4128	Homo sapiens	IC50	uM	100.0
	20683653	CHEMBL4623632	Inhibition of human TIE2 at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	2.0	CHEMBL4128	Homo sapiens	INH	%	2.0
	20683654	CHEMBL4623633	Inhibition of human TIE2 at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	33.0	CHEMBL4128	Homo sapiens	INH	%	33.0
	22391662	CHEMBL4666960	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system using Ser/Thr 05 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	12.0	CHEMBL4128	Homo sapiens	INH	%	12.0
	22391663	CHEMBL4666960	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system using Ser/Thr 05 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	3.0	CHEMBL4128	Homo sapiens	INH	%	3.0
	22391664	CHEMBL4666960	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system using Ser/Thr 05 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12	Outside typical range	CHEMBL4745474	=	Inhibition	%	-14.0	CHEMBL4128	Homo sapiens	INH	%	-14.0
	22392184	CHEMBL4667279	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system using Ser/Thr 05 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	8.5	CHEMBL4128	Homo sapiens	INH	%	8.5
	22423071	CHEMBL4674086	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4128	Homo sapiens	INH	%	80.0
	22423191	CHEMBL4674171	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	60.94	CHEMBL4128	Homo sapiens	Activity	%	60.94
	22423192	CHEMBL4674171	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	69.64	CHEMBL4128	Homo sapiens	Activity	%	69.64
	22425210	CHEMBL4674904	Inhibition of human TIE2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	Inhibition	%	97.4	CHEMBL4128	Homo sapiens	INH	%	97.4
	22426556	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	Outside typical range	CHEMBL388978	=	IC50	nM	59500000.0	CHEMBL4128	Homo sapiens	IC50	M	0.0595
	22426557	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1		CHEMBL4790677	=	IC50	nM	24800.0	CHEMBL4128	Homo sapiens	IC50	uM	24.8
	22426558	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccc(F)cc4)CC3)c(CN3CCN(Cc4ccc(F)cc4)CC3)c2c(=O)[nH]1		CHEMBL4742745	=	IC50	nM	8210.0	CHEMBL4128	Homo sapiens	IC50	uM	8.21
	22426559	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	IC50	nM	6840.0	CHEMBL4128	Homo sapiens	IC50	uM	6.84
	22426560	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4F)CC3)c(CN3CCN(Cc4ccccc4F)CC3)c2c(=O)[nH]1		CHEMBL4788342	=	IC50	nM	5800.0	CHEMBL4128	Homo sapiens	IC50	uM	5.8
	22426561	CHEMBL4675208	Inhibition of human TIE2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4)CC3)c(CN3CCN(Cc4ccccc4)CC3)c2c(=O)[nH]1		CHEMBL4787439	=	IC50	nM	8690.0	CHEMBL4128	Homo sapiens	IC50	uM	8.69
	22471791	CHEMBL4685331	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 100 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP by Z'-LYTE assay relative to control	A	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272	=	Inhibition	%	29.5	CHEMBL4128	Homo sapiens	INH	%	29.5
	22472880	CHEMBL4685520	Inhibition of TEK (unknown origin) at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay relative to control	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	>	Inhibition	%	80.0	CHEMBL4128	Homo sapiens	INH	%	80.0
	22472886	CHEMBL4685526	Inhibition of TEK (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	=	IC50	nM	19.0	CHEMBL4128	Homo sapiens	IC50	nM	19.0
	22759653	CHEMBL4701781	Inhibition of human TIE2 at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)c1ccc(Oc2nc(-c3cnc(N)s3)nc(N3CCOCC3)n2)cc1		CHEMBL4782133	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	22810003	CHEMBL4713440	Inhibition of TIE2 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	14.3	CHEMBL4128	Homo sapiens	IC50	nM	14.3
	22818134	CHEMBL4715357	Inhibition of recombinant human N-terminal His6-tagged TIE2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL4128	Homo sapiens	INH	%	50.0
	22820590	CHEMBL4716297	Inhibition of recombinant N-terminal His6-tagged human Tie2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	63.0	CHEMBL4128	Homo sapiens	Activity	%	63.0
	22820591	CHEMBL4716297	Inhibition of recombinant N-terminal His6-tagged human Tie2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	16.0	CHEMBL4128	Homo sapiens	Activity	%	16.0
	22826350	CHEMBL4717535	Inhibition of recombinant N-terminal His6-tagged human Tie2 (771 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL4128	Homo sapiens	INH	%	60.0
	22836420	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL4128	Homo sapiens	INH	%	5.0
	22836421	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	-10.0	CHEMBL4128	Homo sapiens	INH	%	-10.0
	22836422	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F	Outside typical range	CHEMBL4748367	=	Inhibition	%	-14.0	CHEMBL4128	Homo sapiens	INH	%	-14.0
	22836423	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1	Outside typical range	CHEMBL4776396	=	Inhibition	%	-11.0	CHEMBL4128	Homo sapiens	INH	%	-11.0
	22836424	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	0.0	CHEMBL4128	Homo sapiens	INH	%	0.0
	22836425	CHEMBL4718892	Inhibition of recombinant human GST-tagged TEK (817 to 1101 residues) expressed in baculovirus expression system at 500 nM using Tyr 05 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	1.0	CHEMBL4128	Homo sapiens	INH	%	1.0
	22843542	CHEMBL4720528	Inhibition of human TIE2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	29.9	CHEMBL4128	Homo sapiens	IC50	10^-8M	2.99
	22843884	CHEMBL4720870	Inhibition of human TIE2 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.38	CHEMBL4128	Homo sapiens	Activity	%	93.38
	22844883	CHEMBL4721558	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	108.27	CHEMBL4128	Homo sapiens	Activity	%	108.27
Not Active	22889565	CHEMBL4729084	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4128	Homo sapiens	INH		
	22950604	CHEMBL4766171	Inhibition of human recombinant TIE2 Q939H/Q940H mutant (771 to end residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	10.0	CHEMBL4128	Homo sapiens	IC50	uM	0.01
	22953017	CHEMBL4766954	Inhibition of recombinant human TIE2 (771 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	1.0	CHEMBL4128	Homo sapiens	Activity	%	1.0
	22953102	CHEMBL4767039	Inhibition of recombinant human TIE2 (771 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	408.0	CHEMBL4128	Homo sapiens	IC50	uM	0.408
	23122843	CHEMBL4805194	Inhibition of human TIE2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL4128	Homo sapiens	Activity	%	89.0
	23123538	CHEMBL4805782	Inhibition of human TIE2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	23123990	CHEMBL4806234	Inhibition of DNA-tagged human TIE2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	23125166	CHEMBL4806799	Inhibition of human TIE2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	72.0	CHEMBL4128	Homo sapiens	Activity	%	72.0
	23125167	CHEMBL4806799	Inhibition of human TIE2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4128	Homo sapiens	Activity	%	100.0
	23128644	CHEMBL4808023	Inhibition of TIE2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4128	Homo sapiens	Activity	%	75.0
	23128645	CHEMBL4808023	Inhibition of TIE2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4128	Homo sapiens	Activity	%	75.0
	23128646	CHEMBL4808023	Inhibition of TIE2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4128	Homo sapiens	Activity	%	75.0
	23128818	CHEMBL4808068	Inhibition of TIE2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	88.0	CHEMBL4128	Homo sapiens	INH	%	88.0
	23128819	CHEMBL4808068	Inhibition of TIE2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	53.0	CHEMBL4128	Homo sapiens	INH	%	53.0
	23128820	CHEMBL4808068	Inhibition of TIE2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	43.0	CHEMBL4128	Homo sapiens	INH	%	43.0
	23128821	CHEMBL4808068	Inhibition of TIE2 (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	25.0	CHEMBL4128	Homo sapiens	INH	%	25.0
	23208893	CHEMBL4822248	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	85.0	CHEMBL4128	Homo sapiens	Activity	%	85.0
	23208894	CHEMBL4822248	Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	5.3	CHEMBL4128	Homo sapiens	Activity	%	5.3
Not Active	23317679	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	89.0	CHEMBL4128	Homo sapiens	% Control	%	89.0
Not Active	23318147	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	85.0	CHEMBL4128	Homo sapiens	% Control	%	85.0
Not Active	23318813	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23319297	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23319933	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	90.5	CHEMBL4128	Homo sapiens	% Control	%	90.5
Not Active	23320409	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23321087	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	94.0	CHEMBL4128	Homo sapiens	% Control	%	94.0
Not Active	23321555	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23322185	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23322653	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	86.0	CHEMBL4128	Homo sapiens	% Control	%	86.0
Not Active	23323342	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23323810	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	70.0	CHEMBL4128	Homo sapiens	% Control	%	70.0
Not Active	23324148	CHEMBL4880766	Tie2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	10.0	CHEMBL4128	Homo sapiens	% inhibition	%	10.0
Not Active	23324664	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	74.5	CHEMBL4128	Homo sapiens	% Control	%	74.5
Not Active	23325299	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	86.0	CHEMBL4128	Homo sapiens	% Control	%	86.0
Not Active	23325767	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23326414	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
Not Active	23326882	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	69.0	CHEMBL4128	Homo sapiens	% Control	%	69.0
Not Active	23327582	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23328050	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	96.0	CHEMBL4128	Homo sapiens	% Control	%	96.0
Not Active	23328637	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23329105	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	94.0	CHEMBL4128	Homo sapiens	% Control	%	94.0
Not Active	23329552	CHEMBL4881259	Tie2 (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	84.0	CHEMBL4128	Homo sapiens	% residual kinase activity	%	84.0
Not Active	23330051	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	74.0	CHEMBL4128	Homo sapiens	% Control	%	74.0
Not Active	23330519	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	81.0	CHEMBL4128	Homo sapiens	% Control	%	81.0
Not Active	23331275	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23331743	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Active	23331873	CHEMBL4881413	KINOMEScan (DiscoveRx Corp) with TEK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		Kd	nM	1.6	CHEMBL4128	Homo sapiens	Kd	nM	1.6
Active	23331878	CHEMBL4881418	Bayer in-house kinase assay with TEK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		IC50	nM	0.45	CHEMBL4128	Homo sapiens	IC50	nM	0.45
Active	23331879	CHEMBL4881419	Cellular mechanistic assay: inhibition of TEK autophosphorylation in human umbilical vein endothelial cells (HUVEC), pTEK-ELISA	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		EC50	nM	1.3	CHEMBL4128	Homo sapiens	EC50	nM	1.3
Active	23331885	CHEMBL4881425	NanoBRET assay (SGC) with TEK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		IC50	nM	0.7	CHEMBL4128	Homo sapiens	IC50	nM	0.7
Not Active	23331892	CHEMBL4881432	NanoBRET assay (SGC) with TEK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1	Non standard unit for type	CHEMBL4526351		IC50	M	1.1	CHEMBL4128	Homo sapiens	IC50	M	1.1
Not Active	23331896	CHEMBL4881436	KINOMEScan (DiscoveRx Corp) with TEK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1	Non standard unit for type	CHEMBL4526351	>	Kd	M	20.0	CHEMBL4128	Homo sapiens	Kd	M	20.0
Active	23332330	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	3.1	CHEMBL4128	Homo sapiens	% Control	%	3.1
Not Active	23332796	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	84.2	CHEMBL4128	Homo sapiens	% Control	%	84.2
Not Active	23333514	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23334153	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	87.0	CHEMBL4128	Homo sapiens	% Control	%	87.0
Not Active	23334621	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23334968	CHEMBL4881588	Tie2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	26.0	CHEMBL4128	Homo sapiens	% inhibition	%	26.0
Not Active	23335600	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	95.0	CHEMBL4128	Homo sapiens	% Control	%	95.0
Not Active	23336068	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23336695	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL4128	Homo sapiens	% Control	%	89.0
Not Active	23337163	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
Not Active	23337797	CHEMBL4882168	TEK Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL4128	Homo sapiens	% Ctrl	%	97.0
Not Active	23338244	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23338712	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	88.0	CHEMBL4128	Homo sapiens	% Control	%	88.0
Not Active	23339324	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
Not Active	23339792	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	94.0	CHEMBL4128	Homo sapiens	% Control	%	94.0
Not Active	23340429	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23340897	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	84.0	CHEMBL4128	Homo sapiens	% Control	%	84.0
Not Active	23341554	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	96.0	CHEMBL4128	Homo sapiens	% Control	%	96.0
Not Active	23342022	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23342638	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	85.0	CHEMBL4128	Homo sapiens	% Control	%	85.0
Not Active	23343106	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	82.0	CHEMBL4128	Homo sapiens	% Control	%	82.0
Not Active	23343292	CHEMBL4882477	TEK Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	85.0	CHEMBL4128	Homo sapiens	% Ctrl	%	85.0
Not Active	23343736	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	83.0	CHEMBL4128	Homo sapiens	% Control	%	83.0
Not Active	23344204	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	82.0	CHEMBL4128	Homo sapiens	% Control	%	82.0
Not Active	23344842	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	87.0	CHEMBL4128	Homo sapiens	% Control	%	87.0
Not Active	23345415	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23345883	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23346459	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	99.0	CHEMBL4128	Homo sapiens	% Control	%	99.0
Not Active	23346928	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.2	CHEMBL4128	Homo sapiens	% Control	%	95.2
Not Active	23347527	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23348020	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	71.1	CHEMBL4128	Homo sapiens	% Control	%	71.1
Not Active	23348599	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	91.0	CHEMBL4128	Homo sapiens	% Control	%	91.0
Not Active	23349067	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
Not Active	23349654	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	85.0	CHEMBL4128	Homo sapiens	% Control	%	85.0
Not Active	23350272	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23350740	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	81.0	CHEMBL4128	Homo sapiens	% Control	%	81.0
Not Active	23351345	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23351813	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	88.0	CHEMBL4128	Homo sapiens	% Control	%	88.0
Not Active	23352248	CHEMBL4882937	TEK (Tie2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.363	CHEMBL4128	Homo sapiens	% Inhibition	%	2.3627
Not Active	23352837	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23353305	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	94.0	CHEMBL4128	Homo sapiens	% Control	%	94.0
Not Active	23354187	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23354655	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23355387	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23355855	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23356491	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	93.0	CHEMBL4128	Homo sapiens	% Control	%	93.0
Not Active	23356959	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23357568	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	98.0	CHEMBL4128	Homo sapiens	% Control	%	98.0
Not Active	23358215	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	94.0	CHEMBL4128	Homo sapiens	% Control	%	94.0
Not Active	23358683	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	84.0	CHEMBL4128	Homo sapiens	% Control	%	84.0
Not Active	23359269	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23359867	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	96.0	CHEMBL4128	Homo sapiens	% Control	%	96.0
Not Active	23360335	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
Not Active	23360920	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL4128	Homo sapiens	% Control	%	99.0
Not Active	23361388	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	78.0	CHEMBL4128	Homo sapiens	% Control	%	78.0
Not Active	23361961	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23362497	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23362965	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	80.0	CHEMBL4128	Homo sapiens	% Control	%	80.0
Not Active	23363318	CHEMBL4883275	TEK (Tie2) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-0.3292	CHEMBL4128	Homo sapiens	% inhibition	%	-0.3292
Not Active	23363319	CHEMBL4883275	TEK (Tie2) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	0.1084	CHEMBL4128	Homo sapiens	% inhibition	%	0.1084
Not Active	23364607	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	69.0	CHEMBL4128	Homo sapiens	% Control	%	69.0
Not Active	23365075	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	80.0	CHEMBL4128	Homo sapiens	% Control	%	80.0
Not Active	23365814	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23366357	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23366947	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23367415	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23367765	CHEMBL4884118	TIE2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL4128	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23368293	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL4128	Homo sapiens	% Control	%	93.0
Not Active	23368761	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23369360	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	99.0	CHEMBL4128	Homo sapiens	% Control	%	99.0
Not Active	23369828	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	87.0	CHEMBL4128	Homo sapiens	% Control	%	87.0
Not Active	23370261	CHEMBL4884500	Tie2 (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	81.0	CHEMBL4128	Homo sapiens	% residual kinase activity	%	81.0
Not Active	23370796	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	91.0	CHEMBL4128	Homo sapiens	% Control	%	91.0
Not Active	23371264	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	98.0	CHEMBL4128	Homo sapiens	% Control	%	98.0
Not Active	23372073	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23372541	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	73.0	CHEMBL4128	Homo sapiens	% Control	%	73.0
	23373749	CHEMBL4885526	TIE2(TEK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4128	Homo sapiens	pIC50		6.0
Not Active	23375121	CHEMBL4886108	Tie2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	6.5	CHEMBL4128	Homo sapiens	% Inhibition	%	6.5
Not Active	23375394	CHEMBL4886376	TEK tyrosine kinase, endothelial  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	1.0	CHEMBL4128	Homo sapiens	% inhibition	%	1.0
Not Active	23375968	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	76.0	CHEMBL4128	Homo sapiens	% Control	%	76.0
Not Active	23376436	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	85.0	CHEMBL4128	Homo sapiens	% Control	%	85.0
Not Active	23377013	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	99.0	CHEMBL4128	Homo sapiens	% Control	%	99.0
Not Active	23377481	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23378341	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	87.0	CHEMBL4128	Homo sapiens	% Control	%	87.0
Not Active	23378809	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23379976	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL4128	Homo sapiens	% Control	%	95.0
Not Active	23380444	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	85.0	CHEMBL4128	Homo sapiens	% Control	%	85.0
Not Active	23381138	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4128	Homo sapiens	% Control	%	100.0
Not Active	23381786	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	91.0	CHEMBL4128	Homo sapiens	% Control	%	91.0
Not Active	23382254	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	92.0	CHEMBL4128	Homo sapiens	% Control	%	92.0
Not Active	23382878	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	69.0	CHEMBL4128	Homo sapiens	% Control	%	69.0
Not Active	23383346	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	50.0	CHEMBL4128	Homo sapiens	% Control	%	50.0
Not Active	23384014	CHEMBL4887613	TEK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL4128	Homo sapiens	% Ctrl	%	93.0
Not Active	23384015	CHEMBL4887613	TEK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	82.0	CHEMBL4128	Homo sapiens	% Ctrl	%	82.0
Not Active	23384490	CHEMBL4888085	Tie2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.81	CHEMBL4128	Homo sapiens	% inhibition	%	12.81
Not Active	23384723	CHEMBL4888249	TEK (Tie2) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	13.0	CHEMBL4128	Homo sapiens	% Inhibition	%	13.0
Not Active	23384830	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	84.0	CHEMBL4128	Homo sapiens	% Control	%	84.0
Not Active	23385728	CHEMBL4879985	KinomeScan assay: inhibition of TIE2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	90.0	CHEMBL4128	Homo sapiens	% Control	%	90.0
